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ABSTRACT
Biochem ical, im m unological, an d  s tru c tu ra l charac te riza tions of 
th e  s tru c tu ra l p ro teins of sim ian im m unodeficiency v irus (SIV) were 
perform ed. V arious electrophoretic and  chrom atographic analyses of 
n a tive  an d  m etabolically radiolabeled v irus p repara tions coupled w ith  
im m unological procedures such a s  W estern  b lo tting  and  
radio im m unoprecip itation  were utilized  to identify  SIVXDeltaB670-encoded 
polypeptides. Two-dim ensional tryptic peptide m apping  of each pu tative  
v ira l p ro te in  was employed to confirm th a t  each of these  com ponents were 
unique and  no t cleavage products of p recursor polyproteins.
S ite-d irected  serological stud ies using  synthetic  peptides analogous 
to regions of the  SU  and  TM protein  predicted to  have h igh  antigenic 
po ten tial were perform ed. These studies resu lted  in  th e  identification  of 
several group-specific an d  type-specific antigenic d e te rm in an ts  of SIV 
envelope p ro teins and  dem onstra ted  serological sim ilarities betw een SIV 
and  several o ther len tiv iruses.
The len tiv irus lytic peptide (LLP), a  segm ent w ith in  th e  carboxyl 
te rm in u s of th e  TM protein  w hich has h igh  am phipath ic  po ten tia l and 
u n u su a lly  h igh  positive charge density, was identified  d u rin g  secondary 
s tru c tu ra l m odeling studies. Since the  LLP appeared  to sh a re  s tru c tu ra l 
p roperties w ith  n a tu ra l cytolytic peptides such as m again ins, cecropins, 
m elittin , etc., syn thetic  peptides homologous to the  LLP of HIV-1 and  SIV 
w ere employed in  stan d ard  assays designed to m easure  th e  ability  of 
cytolytic peptides to inh ib it prokaryotic or eukaryotic cells, an d  w ere found
to share functional characteristics w ith n a tu ra l cytolytic peptides. Results 
from m em brane perm eability studies and 51Cr-release assays suggested 
th a t the  LLPs inhib it cells via m em brane perturbation.
The LLPs also share struc tu ra l characteristics w ith calmodulin 
(CaM)-binding proteins. CaM is the prim ary  sensor of Ca2+ w ithin 
eukaryotic cells. Since Ca2+ is the  prim ary signal for activation of m any 
enzyme system s, CaM plays an  essential role in  the activation of m any 
cellular enzymatic processes. Using gel mobility shift assays and 
standard  phosphodiesterase competition assays, we have shown th a t LLPs 
bind CaM w ith high affinity and can inh ib it CaM -mediated activation of 
CaM -dependent enzymes. LLP-mediated interference w ith enzyme 
activation and/or alteration  of critical plasm a m em brane properties m ay 
explain m any of the unusual m anifestations of H IV -l-m ediated disease 
and m ay represen t a novel m echanism  of pathogenesis.
CHAPTER 1
INTRODUCTION
O f the  m any known hum an pathogens, the  retrovirus family of 
RNA viruses m ay be the greatest challenge to medical researchers to date. 
The m em bers of th is group of viruses contain an  unusual enzyme, reverse 
transcrip tase  (RT), th a t allows them  to reverse the  usual flow of genetic 
inform ation, hence the nam e "retrovirus". U sing RT, retroviruses are 
able to convert the ir genomic RNA to a DNA interm ediate  which inserts 
into the genome of their host cell forming a stable provirus th a t m ay 
rem ain la ten t in  the host for an  extended period; the  viral provirus is 
replicated along w ith the cellular genetic m ateria l and is passed to 
daughter cells of the  host. Using virus-encoded genetic signals, all 
retroviruses u tilize host-specific m echanism s and  m achinery to express 
th e ir genes. Interestingly, retroviruses often m uta te  genes of th e  host and 
sometimes even capture cellular genes. These viruses have a  very wide 
host range, as they have been isolated from a diverse group of vertebrate  
anim als including birds, reptiles and m am m als (Teich, 1982, 1985) 
resu lting  in  oncogenic, non-oncogenic, and/or progressive disease 
syndrom es.
The retroviruses comprise a fam ily of struc tu ra lly  and 
conceptionally related viruses which have been divided into th ree  
subfamilies, onco, spum a and lentivirinae, based on morphological and 
biochemical properties. Until the mid 1980’s, the  oncovirinae subfamily of 
retroviruses had  been the m ost thoroughly studied and well characterized
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of these  subfam ilies. The oncoviruses typically estab lish  persisten t, slowly 
progressive infections th a t  u ltim ately  induce cell transform ation  in  vitro, 
or m alignancy in vivo (Gelderblom et al., 1990). The m em bers of 
spum avirinae, or the  foamy viruses have been iso lated  from  m any species, 
including cattle , cats, m onkeys, and  hum ans. Spum aviruses have been 
show n to produce characteristic  cytopathic effects in  vitro  (Gelderblom  
and F rank , 1987; Hooks and  Gibbs, 1975), b u t th e ir pathogenic potential in  
vivo is still unknow n (Weiss, 1988). The m em bers of the  len tiv irinae 
subfam ily of retroviruses, such as equine infectious anem ia  v irus (EIAV), 
v isna v irus, and  caprine a rth ritis  and  encephalitis v irus (CAEV) have 
long been recognized as agen ts which induce slowly progressive b u t 
devasta ting  diseases of ungulates. However, in  1983 M ontagnier and  
associates (Barr6-Sinoussi et al., 1983) isolated a  re trov irus from  an  
im m unodeficient hum an  p a tien t th a t  was la te r  classified as a  len tiv irus 
and  w as determ ined to be the  etiological agent responsible for acquired 
im m unodeficiency syndrom e (AIDS; B arr6-Sinoussi et al., 1983; Gallo et 
al., 1984; Popovic et al., 1984). Since AIDS had  become recognized as a  
worldwide epidemic (Gottlieb et al., 1981; M asur et al., 1981; Siegal et al., 
1981; Lane et al., 1983; Ziegler et al., 1984), th e  hum an  immunodeficiency 
v irus (HIV) soon became one of the  m ost in tensely  studied  v iruses known 
to m an.
Since the  in itia l isolation of the  v irus now known as HIV-1, new 
im m unodeficiency v iruses of m an (HIV-2; Clavel et al., 1986), non-hum an 
prim ates (SIV; Daniel et al., 1985; Kanki et al., 1985a; M urphey-Corb et al., 
1986; Fultz et al., 1986a), cats (FIV; Pederson et al., 1986), an d  cattle (BIV;
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Gonda et al., 1988) have been discovered. HIV-1 and HIV-2 rep resen t two 
d istinc t serotypes of len tiv iruses th a t  have been isolated from  AIDS 
patien ts; those isolated in  the  U nited  S ta tes, Europe, an d  cen tral Africa a re  
designated HIV-1 (Barr6-Sinoussi et al., 1983; Popovic et al., 1984) while 
those isolated in  w est Africa have been designated  as HIV-2 (Clavel et al., 
1986,1987). These two distinct serotypes of HIV are  closely related , a s they  
share  sim ilar genetic organization and 50-60% prim ary  DNA sequence 
iden tity  (G uyader et al., 1987), and  they  cause a  sim ilar disease syndrome; 
the  p rim ary  clinical difference betw een these  v irus types is  th a t  th e  course 
of HIV-2 infection can be a ttenua ted  (Kong et al., 1988). S im ian  
im m unodeficiency v irus (SIV) w as originally iso lated  in  1985 from 
im m unodeficient Macaca m alatta  (rhesus m acaques; D aniel e t al., 1985; 
K anki et al., 1985a, Benveniste et al., 1986) and  was la te r  isolated from 
healthy  Cercopithecus aethiops (African green m onkeys; O h ta  et al., 1988; 
D aniel et al., 1988a) and  Cercocebus atys  (African sooty m angabeys; H irsch  
et al., 1989a; Fultz  et al., 1986a; Lowenstine et al., 1986). Virologic and 
seroepidemiological surveys suggested th a t  african  m onkeys w ere th e  
n a tu ra l hosts of SIV and act as asym ptom atic carriers  of th e  v irus 
(Lowenstein et al., 1986; Kanki et al., 1985b; Schneider et al., 1987; D aniel et 
al., 1988b) while the  A sian m acaques, w hich a re  no t n a tu ra l hosts, 
experience a  fa ta l AIDS-like syndrom e upon infection w ith  SIV (Letvin et 
al., 1985). In terestingly , SIV is approxim ately 80% homologous to HIV-2 a t  
th e  level of DNA sequence and is very sim ilar to HIV-2 serologically, b u t 
shares only 50% sequence iden tity  and lim ited  serological cross-reactivity 
w ith  HIV-1 (G ardner and  Luciw, 1988; P e terlin  and  Luciw, 1988). W hile
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SIV is obviously m ost closely related to HIV-2, i t  is  also very closely rela ted  
to HIV-1 both structu ra lly  and pathogenically.
Structural properties and classification o f retroviruses
M embers of retrovirinae are  enveloped, round or ovoid-shaped 
viruses th a t  contain two copies of th e ir 8-12 Kb RNA genome; a  general 
model of retrovirus virions is  presented in  F igure 1. The v iral genome 
contains th ree  m ajor genes (5' -gag-pol-env- 3’) th a t encode the  struc tu ra l 
proteins of the  virus. The gag  gene encodes a  precursor polyprotein th a t  is 
processed into th ree  or four in te rnal proteins of the  virus, including the 
m atrix  pro tein  (MA), the  m ajor capsid shell protein (CA), and  th e  RNA 
associated ribonucleoprotein (NC). The pol gene encodes a  polyprotein th a t 
is processed to produce the  protease (PR), the  reverse transcrip tase  
enzyme (RT), and the  in tegration  protein (IN). The env  gene encodes a 
polyprotein which is processed to yield the two glycosylated envelope 
projections of the virus. The highly glycosylated surface glycoprotein (SU) 
is anchored to the  virion by the slightly glycosylated transm em brane 
protein  (TM) which is  in tim ately  associated w ith  the  v ira l lipid bilayer. 
E ach virion contains several thousand copies o f each of th e  gag-encoded 
proteins, five to ten  copies of the  RNA associated RT (Parekh  et al., 1980), 
and several hundred copies of each e/zu-encoded protein  (Parekh  et al., 
1980; Gelderblom et al., 1987; Ozel et al., 1988; Takahashi et al., 1989). 
R etrovirus particles are composed of approxim ately 35% lipid, 60% protein, 
3% carbohydrate, and  1% RNA, and i t  has been shown th a t  v iral lipids are 
derived from  the host cell p lasm a m em brane and th a t  v ira l lipid 
composition resem bles th a t  of the  host cell (Aloia et al., 1988). A lthough all
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Figure 1. G e n era l s tru c tu ra l  m odel o f  a  re tro v iru s  v irion . This two- 
dim ensional d iagram  of the  HIV virion reflects the  morphological and 
im m unoelectron microscopic observations m ade during  stud ies of 
retrovirus virion structu re  as well as specific studies of HIV and  o ther 
len tiv irus struc tu re . G eneral designations for proteins of all retroviruses 
are  m ade according to the  nom enclature devised by Leis et al. (1988).
These acronym s are  as follows: SU, surface unit; TM, transm em brane 
protein; MA, m atrix  protein; LI, link protein; CA, capsid protein; NC, 
nucleocapsid protein; PR, protease; RT, reverse transcrip tase ; IN , 
in tegration  protein. Specific designations for HIV proteins reflecting the 
pro tein  m olecular w eight are m ade according to the  nom enclature of 
A ugust et al. (1974); according to th is nom enclature, "p" or "gp" stand  for 
protein  or glycoprotein, respectively, followed by the  approxim ate 
m olecular w eight of the  protein. Recently, a  struc tu re  designated the  core- 
envelope-link (CEL) h as been described (Hoglund et al., 1991); th is 
s truc tu re  is  thought to be th e  rem nants of of a  morphopoietic p ro tein  th a t  
m ight p lay  an  essential role in  the  budding process. I t  h as  been 
speculated th a t the  CEL is composed of LI (p6) in  HIV. In  support of th is 
hypothesis, deletion m utations th a t truncate  or delete LI negatively effect 
or elim inate the  budding process, respectively (Gottlinger et al., 1990,1991). 
LI proteins have been identified only in  lentiv iruses to date, and  there  
appears to be no comparable protein in  o ther retrov irus subfam ilies. 
S tructu res known as la tera l bodies have been observed in  all lentiv iruses, 
except m aedi-visna virus, b u t are  not observed in  th e  o ther retrov irus 
subfam ilies. I t  has been speculated th a t  these struc tu res a re  composed of 
excess gag  pro tein  or regulatory proteins, bu t there  is  little  evidence to 
date. Several copies of the m ajor histocom patability complex (MHC) of the  
host cell become a  component of the  viral envelope during  the  budding 
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retrov iru ses follow th is  basic  s tru c tu ra l model, th e re  a re  several 
m orphological charac teristics th a t  can be used  to d istingu ish  betw een 
d ifferen t re trov irus types.
R etroviruses have been classified in to  th ree  subfam ilies on th e  basis 
o f m orphological an d  m orphogenic charac te ristics (F igure 2; review ed in  
Gelderblom, 1991). One of these  subfam ilies, th e  oncoviruses, h a s  been 
fu rth e r  b roken in to  4  subtypes (types A-D). The spum avirus subfam ily is 
very  sim ila r to oncovirus type-B and  D v iruses, differing m ainly  in  th e  
leng th  of th e ir  envelope projections. M em bers of th e  len tiv iru s subfam ily 
a re  m ost sim ila r to oncovirus type-C viruses, as th e  shape of th e ir  
respective cores a re  th e  p rim ary  m orphological difference.
M em bers of th e  len tiv iru s subfam ily of re trov iru ses a re  v irtu a lly  
ind istingu ishab le  on th e  basis  of morphology. N egative s ta in in g  an d  th in  
section electron m icroscopy have revealed th a t  th e  core (composed 
p rim arily  of CA) of m a tu re  len tiv iruses is  a  cone shaped  stru c tu re  th a t  
spans alm ost the  en tire  d iam eter of the  virion. The b road  end of th e  core 
h as  a n  approxim ate d iam ete r of 60-65 nm  an d  i t  appears to be separa ted  
from  th e  core-associated MA pro tein  by a  c lear halo, w hile the  narrow  end 
of th e  core appears to be continuous w ith  th e  MA pro tein  (C hrystie and  
Alm eida, 1988; Gelderblom  et al., 1989). C om puter em ulation  m odeling 
h as  suggested th a t  th e  MA pro tein  of len tiv iruses form s a  60-sided (32 
vertices) icosahedral shell th a t  d irectly  underlies  th e  lip id  envelope (M arx 
et al., 1988); i t  is  postu la ted  th a t  th is  shell plays a  critical role in  particle  
assem bly and  in  a rran g em en t of envelope knobs, however, d irect 
in te rac tion  of MA w ith  CA or TM has no t been  directly  dem onstrated .
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Figure 2. M orpho log ica l c la ss ifica tio n  o f  th e  re tro v iru s  fam ily. One of 
these  subfam ilies, the  oncoviruses, has been fu rth e r subdivided in to  four 
groups based on virion particle  type. Type-A partic les a re  morphologically 
completely assem bled cores which th en  m igra te  to and  bud from  the 
p lasm a m em brane to form  type-B particles. S im ilarly, type-D particles 
a rise  from pre-form ed cores th a t  m igra te  to th e  p lasm a m em brane and  
th en  bud from the  host cell; type-D virions a re  d istinguished from  type-B 
particles by the  leng th  of th e ir envelope projections as th e  envelope spikes 
of type-B viruses are  approxim ately 4 nm  longer th a n  those of type-D 
oncoviruses. In  con trast to type-B and type-D virions, th e  type-C particle 
core is  formed concom itantly w ith  the  budding process, and  following the  
budding process, th e  core condenses into an  icosahedral s truc tu re . The 
m orphological charac teristics of th e  spum avirinae subfam ily of 
retrov iruses are  sim ilar to those of oncovirus types-B and  D in  th a t  th e ir  
cores a re  preform ed and  they  m igra te  to and bud from the  p lasm a 
m em brane, however, the  envelope projections of spum aviruses a re  3-4 nm  
longer th a n  those of type B and  7-8 nm  longer th a n  those of type D 
oncoviruses. M em bers of the  len tiv irus subfam ily of re trov iruses a re  
morphologically m ost re la ted  to th e  type-C oncoviruses as len tiv irus virion 
cores form a t  th e  plasm a m em brane during  th e  budding process. 
L entiv iruses can be d istinguished from type-C len tiv iruses by th e  shape of 
th e  m atu re  virion core as len tiv iruses contain a  cone-shaped core while 
type-C oncoviruses contain  an  icosahedral core. HTLV-I and  II, BLV, and  
STLV-I appear to belong to an  in te rm ed iate  group of re trov iruses, as they  
exhib it morphological fea tu res common to both len tiv iruses and  














U sing im age analysis and  ro tational techniques, several groups have 
determ ined  th a t  HIV  and SIV (and probably all len tiv iruses) have 72 
envelope projections per virion (Gelderblom et al., 1987; Ozel et al., 1988; 
T akahash i et al., 1989). Exam ination of TEM  m icrographs of HIV th in  
sections and  of negatively sta ined  SIV have revealed tr ia n g u la r  struc tu res 
existing  on th e  surface of virions suggesting th a t  surface knobs reflect 
trim eric  associations of env proteins (Gelderblom et al., 1988, 1989; G rief et 
al., 1989), while chem ical crosslinking studies suggest a  trim eric  or 
te tram eric  a rrangem en t of SU and TM proteins on th e  virion surface 
(P in ter et al., 1989; Schaw aller et al., 1989). The in tense  investigation of 
HIV  and  closely re la ted  viruses has rapid ly  led  to an  accum ulation of fine 
s tru c tu ra l deta ils of len tiv irus morphology and  has revealed a  fairly  s tric t 
conservation of morphological characteristics across th e  len tiv irus 
subfam ily.
Im m unological properties o f retroviral proteins
In  ligh t of th e  s tru c tu ra l and  morphological sim ilarities betw een 
th e  various m em bers of the  len tiv iruses, i t  is no t su rp rising  th a t  these 
v iruses also share  m any im m unological fea tu res. T here is  a  h igh  degree 
of im m unological cross-reactivity betw een th e  gag  an d  pol-encoded 
pro teins of HIV-1, HIV-2, SIV, and  EIAV (Clavel et a l., 1986; K anki et al., 
1986; B arin  et al., 1985; Montelaro et al., unpublished data). In  fact, all of 
th e  m ajor an tigens of HIV-2 and SIV a re  serologically ind istingu ishab le  
using  typical serological procedures (B arin  et al., 1988; K anki et al., 1988). 
The k inetics of im m une responses elicited by len tiv irus infection appear to 
be sim ilar am ong the  different virus system s. Usually, the  f irs t  detectable
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lentivirus-specific antibody th a t  can be identified reacts w ith  th e  CA 
protein  (Tindall and Cooper, 1991; Zhang et al., 1988). The nex t detectable 
response is usua lly  TM specific, followed by MA and  SU-specific 
responses. The SU pro tein  elicits the  h ighest tite r  antibody response, 
followed by the  TM and  CA proteins.
W estern  blot analysis of HIV-1 and HIV-2 reactive a n tise ra  have 
suggested th a t  the  m ajor type-specific de te rm inan ts of len tiv iruses are  
located on the envelope glycoproteins (Barin et al., 1985). Since the  surface 
glycoproteins of retrov iruses a re  the  p rim ary  ta rg e t of h o st im m une 
responses (M ontelaro and  Bolognesi, 1978) and since em ergence of point 
m u ta tions in  the  envelope proteins appears to be a  m echanism  of rap id  
antigenic varia tion  in  len tiv iruses (C lem ents et al., 1980; N arayan  et al., 
1977; Salinovich et al., 1986) i t  is  logical th a t  len tiv ira l envelope 
glycoproteins are  more diverse and  should contain type-specific 
de te rm inan ts . A t leas t one type specific d e te rm in an t th a t  d istinguishes 
H IV -l from  HIV-2 or SIV has been identified via site  d irected serology 
using synthetic peptides (Norrby et al., 1987 and 1989). The 
im m unogenicity and  variab ility  of len tiv ira l envelope p ro teins suggest th a t  
th ey  a re  th e  m ost im p o rtan t hum oral im m unological d e te rm in an ts  of 
these  v iruses, and  th a t  fu rth e r im m unological characteriza tion  of these  
p ro teins is  essential.
L entivirus genom e organization
W hile th e  genome organization of all re trov iruses is very  sim ilar, 
th e  genom es of len tiv iruses a re  more complex th a n  th e  genom es of m ost 
o ther re trov iruses. W hile all replication com petent re trov iruses encode
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the gag, pol, and env genes, mem bers of the  len tiv irus subfam ily typically 
encode several additional protein-coding genes. The prim ate  lentiv iruses 
each express a t  least six additional proteins, trans-activato r (tat), 
regulator of expression of virion proteins (rev), virion infectivity factor (vif), 
v iral p ro tein  R (vpr), and negative factor (nef; Gallo et al., 1988) and e ither 
v iral protein X (vpx; SIV and HIV-2; H enderson et al., 1988b) or viral 
protein U (vpu; HIV-1; Gallo et al., 1988) while an  equine lentivirus, equine 
infectious anem ia virus (EIAV), expresses th ree  additional proteins 
(Rasty et al., 1990; Schiltz et al. in  press). Most of these additional proteins 
have been shown to have regulatory functions and  are  expressed from 
spliced, subgenom ic-length mRNAs (M uesing et al., 1985; Guyader et al., 
1987; Viglianti et al., 1990; Rasty et al., 1990; Schiltz et al. in  press). Obvious 
sim ilarities in  the  organization of genetic m ateria l betw een several 
lentiv iruses, m ost specifically the  prim ate lentiv iruses, can be readily  seen 
upon comparison of genome m aps (Figure 3). As m entioned earlier, SIV 
shares a h igher degree of nucleotide sequence iden tity  w ith HIV-2 th an  
w ith HIV-1, however, all of these prim ate lentiv iruses appear to be highly 
rela ted  both genetically and  morphologically.
P oten tia l anim al m odels for AIDS.
As th e  AIDS epidemic continues to grow and to affect previously 
low-risk groups of people, development of chem otherapeutic and vaccine 
protocols becomes an  even more essential goal. The m ost productive tool 
for testing  the  efficacy of drug and vaccine candidates would be an  AIDS 
model in  which HIV infects and  induces an  AIDS-like disease syndrome 














Figure 3. G enom ic m aps o f severa l rep re se n ta tiv e  len tiv iru ses. In 
addition to the  gag, pol, and env genes encoded by all retroviruses, 
lentiv iruses possess several additional open reading  fram es (ORFs), m ost 
of which are  known to code for regulatory proteins. The HIV-1 genome 
encodes six of these additional genes: virion infectivity factor (vif), virion 
protein R  (vpr), virion protein U  (vpu), trans-activator of transcrip tion (tat), 
regulator of expression of virion proteins (rev), and  negative factor F  (nef). 
Sim ilarly, the  HIV-2 and SIV genomes encode v i f  (virion infectivity protein 
or vip for SIV), vpr, tat, rev, and nef, bu t do not code for vpu. However, 
HIV-2 and SIV do encode an  ORF for viral protein X (vpx). EIAV, an  
equine lentivirus, encodes th ree  additional ORFs designated S I ,  S2, and S3.
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been m ade to infect a  variety of laboratory anim als w ith HIV, the  only non­
hum an anim als th a t have become reproducibly infected a re  chim panzees 
(Altered al., 1984; Fultz et al., 1986b; Gajdusek et al., 1984,1985), gibbon apes 
(Lusso et al., 1988), and rabbits (Felice et al., 1988). Unfortunately, 
chimpanzees and gibbon apes are extrem ely scarce and they  do not 
develop any clinical signs of HIV infection and, therefore, are no t an  ideal 
model for AIDS infections. Rabbits are the only sm all laboratory anim al 
th a t can be infected w ith HIV, however, they do not develop a typical AIDS- 
like syndrome and, since th e ir im m une system  is clearly less sim ilar to 
th a t  of hum ans than  the closely-related non-hum an prim ates, the  rabbit 
does not represen t an  ideal anim al model.
Since there is not an  ideal anim al model for HIV infection, i t  is 
im portan t to investigate alternative lentivirus system s in  which an  AIDS- 
like disease resu lts from infection w ith the  particu lar virus. As was 
previously discussed, SIV is a  naturally-occurring len tiv irus isolated from 
m any species of non-hum an prim ates th a t is morphologically and  
genetically sim ilar to HIV-1 and HIV-2. This virus induces a  fata l AIDS- 
like syndrome in  macaques, and  among anim al lentiviruses, the  disease 
syndrome induced by SIV m ost closely approxim ates infection of hum ans 
w ith HIV (Desrosiers and Letvin, 1987; Schneider and H unsm ann, 1988; 
G ardner and Luciw, 1989). S im ilarities in  the disease include CD4+ 
lymphoid and macrophage cell tropism , CD4+ cell depletion, sim ilar 
serological and immunological responses, and  sim ilar pathology 
(including neuropathology and opportunistic infections). Since SIV does 
not induce disease in its  na tu ra l hosts (the african monkey species) bu t
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does induce le th a l AIDS-like disease in  A sian m onkey species, s tudy  of 
th is  v irus system  m ay lead to discovery of the  differences in  im m une 
responses produced by African species th a t  lead  to protection ag a in st SIV- 
induced pathology.
RESEARCH OBJECTIVES
The m ain  objectives of the  body of research  presen ted  here were to 
characterize the  pro tein  composition of SIV/DeltaB670 and  to identify  
de te rm inan ts of th e  v irus th a t  p lay an  im p o rtan t im m unological or 
pathogenic role(s) in  SIV infection and  disease progression. M ore specific 
questions regard ing  these  objectives a re  lis ted  below.
(1) W hat is the  pro tein  composition of SIV/DeltaB670? C an  we 
identify  s tru c tu ra l de te rm inan ts of these  pro teins th a t  m ay play an  
im p o rtan t role in  SIV-induced pathogenicity. A nsw ers to these  questions 
were necessary to determ ine w hether SIV/DeltaB670 would be a  desirable 
model for HIV; in  addition, identification of im p o rtan t s tru c tu ra l 
de te rm inan ts  of SIV would lead  to fu rth e r study of these de te rm inan ts 
and  possibly to tes ting  of chem otherapeutic and  vaccine stra teg ies based  
on these  determ inan ts.
(2) U sing synthetic  peptide methodologies coupled w ith  site-directed 
serology, can we identify  im m unological d e te rm in an ts  th a t  m ay p lay  an  
im p o rtan t role in  im m unological m anagem ent of SIV infection? Due to 
obvious risks associated w ith  a tten u a ted  or killed whole v irus vaccines, 
subun it vaccines th a t  induce protection ag a in st HIV/SIV m u st be the 
u ltim ate  goal of AIDS vaccine research. The proposed studies m ay lead  to 
the  identification of subun it vaccine candidates, b u t a t  the  ve ry  least, they
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will enable us to evaluate the immunological rela tedness betw een SIV and 
H IV .
(3) Does th e  region n ear the carboxyl term inus of the  TM of SIV and 
o ther lentivirus, th a t was identified while answ ering question #1 above, 
play a  role in  viral cytopathicity? Does th is segm ent of TM share  
functional, as well as s truc tu ra l sim ilarities to n a tu ra l cytolytic peptides? 
Answers to th is question could shed ligh t on one of the  prim ary  m ysteries 
confronting AIDS researchers: "How do the imm unodeficiency v iruses 
kill th e ir host cell?" Several lines of evidence have im plicated the  carboxyl 
end of TM as the  m ediator of cytopathicity. Identification of the  exact 
region of TM th a t  contributes to cytopathicity, and  its  m echanism  of action, 
m ay lead  to efficacious therapeutic  in tervention  strategies.
(4) Does the  potentially cytopathic segm ent of TM also play a  role in  
pertu rbation  of enzyme functions in  lentivirus-infected cells by competing 
w ith calm odulin-dependent enzymes for calm odulin binding? M any 
enzym atic pathw ays in  all eukaryotic cells require  calm odulin as a  Ca2+- 
second m essenger. As in trace llu lar Ca2+ concentration is a  m ajor 
signalling m echanism  for m any cellular enzyme system s, and  more 
specifically, is  the  prim ary  signal for lymphocyte activation, any 
in te rrup tion  in  the  delivery of th is signal could resu lt in  cellular 
dysfunction. Evidence th a t  HIV induces enzym atic dysfunction in  cells is 
m ounting, and  by answ ering th is question, we m ay identify  a  m echanism  
by which len tiv iruses induce th is  dysfunction.
CHAPTER 2
MATERIALS AND METHODS
Propagation o f virus
SIV/DeltaB670 was originally isolated from a  rhesus m onkey w ith 
AIDS-like disease syndrome (Baskin et al., 1986). SIV/Delta B670 virions 
were purified from infected H9 or CEM cell cultures th ree  to four days 
a fte r subculture. T issue culture supernatan ts were clarified to remove 
cellu lar debris and  th en  virions were concentrated using  a  tangential-flow  
filtration  device (Millipore, Bedford MA). Virions were th en  pelleted by 
centrifugation a t  53,000 X g  for 90 m in over a 20% glycerol cushion in  PBS. 
Pelleted v irus was resuspended gently in  PBS and banded by 
centrifugation a t  250,000 X g  in a  30-45% sucrose step grad ien t p repared  in  
0.01 M  phosphate buffer (pH 7.4). Virus a t the g rad ien t in terface was 
collected, diluted three-fold in  0.01 M  phosphate buffer, and  pelleted by 
centrifugation a t  250,000 X g  for 60 m in to remove residual sucrose. The 
resu lting  virion pellet was resuspended in  0.01 M  phosphate buffer and  
stored a t  -70°C until use.
Affinity purification o f viral glycoproteins
Lentil lectin  affinity chrom atography was perform ed as previously 
described (Montelaro et al., 1983). Briefly, lentil lectin-sepharose 4B, 
packed in  a  glass column (0 .8  cm diam eter) to a  bed volume of 
approxim ately 5 ml, was equilibrated in  s ta r t buffer (0.02 M  tris , 0.1 M  
sodium  chloride, 0.1% deoxycholate, pH 8.3). Virions w ere d isrupted  and  
lipids were removed by  precipitation in  10  volumes cold acetone prio r to
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chrom atography. V iral proteins were diluted to 0.5 mg/ml in  d isruption 
buffer (s ta rt buffer supplem ented w ith 0.5% deoxycholate), loaded onto the  
column a t  approxim ately 10  m l/hr, and lectin  non-binding proteins were 
eluted w ith s ta r t  buffer. Glycoproteins were eluted from the column using 
elution buffer (0.2 M  methylglucoside in  s ta r t  buffer). L entil lectin  binding 
and non-binding protein fractions were then  dialyzed extensively, 
lyophilized to dryness, and resuspended in  0.01 M  phosphate buffer. 
SDS-PAGE a n d  W estern  analysis.
The procedures for SDS-PAGE electrophoresis and W estern blotting 
has been previously described (Montelaro et al., 1984; Lo et al., 1990).
Briefly, SDS-PAGE was performed on 10:0.8% acrylamide:BIS slab gels 
containing 0.1 M  phosphate buffer using a  0.01 M  phosphate runn ing  
buffer a t  pH 7.2. Electrophoresis was performed on a  P ro tean  II 
electrophoresis u n it (BioRad Laboratories, Richmond,CA). P ro tein  bands 
were visualized by sta in ing  w ith Coomassie b rillian t blue for 30 m in, 
followed by im m ediate destain ing  w ith m ultiple changes of m ethanol- 
acetic acid-water (10:3:27). To identify im m unoreactive components, SDS- 
PAGE resolved proteins were transferred  to nitrocellulose in  150 m M  
Glycine (BioRad Laboratories), 20 m M  Trizm a Base (Sigma Chemical Co.) 
using a  Hoefer T ransphor U nit (Hoefer Scientific, San  Francisco, CA) as 
previously described (Burnette, 1981), im m unoblotted w ith e ith er reference 
serum  from an  experim entally-infected m acaque (#B845) o r am m onium  
sulfate concentrated hybridom a supernatan ts  containing monoclonal 
antibodies. Im m une complexes were detected using I125 labeled protein  A, 
or a  varie ty  o f secondary antibody-enzyme conjugates. P rior to 
im m unoblotting, glycosylated proteins were detected using a  previously
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described procedure (Clegg, 1982) w hile to ta l p ro te in  profile w as v isualized 
v ia  reversib le  s ta in in g  w ith  Ponceau S sta in in g  a s  previously  described 
(Salinovich an d  M ontelaro, 1986).
M etabolically radiolabeled v irus p rep ara tio n s w ere analyzed on 200- 
m m  cylindrical gels; th e  gels w ere th en  frac tiona ted  in to  1 -m m  fractions 
w ith  a n  au tom atic  frac tiona to r (Gibson M edical E lectronics, M iddleton, 
Wise.), an d  th e  fractions were assayed for rad ioactiv ity  (M ontelaro et al., 
1978; M ontelaro and Bolognesi, 1978; P arekh  et al., 1980). 
H P L C -purifica tion  o f  SIV/DeltaB670 p ro te in s
V iral p ro te in s w ere sep ara ted  v ia  reverse-phase  h igh  p ressu re  
liqu id  chrom atography (RP-HPLC) on a  W aters 600E H PLC system  
em ploying a  8  X 100-mm jiBondapak phenyl R adial-pak  cartridge  w ith  the  
R adial C om pression M odule-100 (W aters). G rad ien t-purified  v irions in  
0.01 M  sodium  phosphate, pH  7.4 were d isrup ted  in  two volum es of 6  M  
guan id ine  hydrochloride, pH  3.1 im m ediately  p rio r to injection. 
S epara tions w ere perform ed using  a  m ultistage  g rad ie n t an d  a  m obile 
phase  consisting  of w a ter w ith  0.1% TFA (solvent A) an d  2-propanol w ith  
0.1% TFA (solvent B) a t  a  flow ra te  of 0.7 m l/m in. The g rad ien t w as 
modified from  th a t  reported  by Ball and  associates (1988) for purification  of 
EIAV p ro te ins.
T w o-dim ensional try p tic  p e p tid e  m ap p in g
SIV /D eltaB670 p ro teins w ere purified  from  g rad ien t-purified  virion 
p rep a ra tio n s  v ia  reverse  phase  h igh  p ressu re  liqu id  chrom atography  (RP- 
HPLC) followed by SDS-PAGE. P ro te in  bands w ere excised directly  from  
Coom assie b lue-sta ined  SDS-PAGE gels, and  try p tic  pep tide  m app ing  w as 
perform ed as previously described (E lder et al., 1977a; E lder et a l., 1977b;
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M ontelaro et al., 1984; Salinovich et al., 1986). Briefly, following extensive 
w ash ing  in  25% isopropanol and  10% m ethanol, p ro te in  bands w ere 
labeled  by in  s itu  rad io iod ination  u sin g  the  chloram ine T  m ethod 
(Greenwood an d  H un te r, 1963) and  th en  w ashed thoroughly  in  10% 
m ethanol. The labeled pro teins w ere th e n  subjected to exhaustive 
d igestion w ith  try p sin  (D PC C -treated; Sigm a) an d  th e n  p ro te in  fragm ents 
w ere e lu ted  from  th e  gel slice. The peptides w ere applied  to  a  20 X 20 cm 
cellulose-coated th in -layer chrom atography  p la te  (EM In d u stries , 
D arm stad t, G erm any) and  sep ara ted  in  th e  horizontal d irection  by high  
voltage electrophoresis in  solvent consisting of 15% glacial acetic acid, 5% 
formic acid, an d  80% H 2O. The peptides w ere th e n  sep ara ted  in  th e  
vertica l d irection v ia  liquid chrom atography in  40% n-butanol, 30% 
pyridine, 6 % glacial acetic acid, and  24% H 2O. The sep ara ted  peptides 
w ere detected  by au torad iography  w ith Kodak X -O m at film  (XRP-5).
G as p h ase N -term inal am ino acid  seq u en cin g
P ro te in  sequencing w as perform ed on an  Applied B iosystem s 470-A 
gas phase  p ro te in  sequencer fu rn ished  w ith  a  fraction  collector capable of 
accom m odating th e  W aters W ISP 710B lim ited  volume in se rts . 
P heny lth iohydran to in  (PTH )-derivitized am ino acids genera ted  by the  
sequencer w ere analyzed using  a W aters H PLC system  equipped w ith  two 
h igh  perform ance pum ps (W aters Model 510), a  tem p era tu re  control 
m odule, a  variab le  w avelength  u ltrav io le t detector (W aters, Model 481), an  
au tom atic  sam ple injection m odule (W ISP 710B), an d  a W aters 840 
com puter in te rface  for d a ta  acquisition  and  processing.
Soluble p ro te in  sam ples, purified  via RP-H PLC as  previously 
described (Ball et a l., 1988), were applied directly  to T FA -treated  glassfiber
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discs and  in se rted  directly into the sequenator reaction cartridge. 
Sequencing w as perform ed according to m an u fac tu rer 's  in structions. 
PTH  derivatives o f th e  am ino acids cleaved from th e  am ino te rm inus 
du ring  each sequencing cycle were identified by RP-HPLC using  a  3.8 X 15 
cm N ovapak C18 column (W aters) via lin ear g rad ien t separation  w ith  a 
mobile phase consisting of 0.014 M  sodium  ace ta te  containing 5% aqueous 
te trah y d ro fu ran  and  acetonitrile.
Secondary structure predictions
The predicted am ino acid sequence of SIVmac251 (H irsch et al., 
1987) was analyzed m anually , using  C hou-Fasm an ru les for prediction of 
p ro tein  conform ation (Chou and Fasm an, 1978), to pred ict regions which 
have h igh  po ten tial to form a-helical, B-sheet, and  tu rn  secondary 
stru c tu re  m otifs. These sequences were also analyzed using  th e  UWGCG 
P ep tideS tructu re /P lo tS truc tu re  pro tein  s tru c tu re  prediction a lgorithm s 
(Starcich et al., 1986) on a VAX 750 host system ; these program s predict 
secondary s tru c tu re  by the C hou-Fasm an (1978) and  the  G am ier- 
Osquethorpe-Robson m ethods (G am ier et al., 1978) along w ith  th e  Hopp- 
Woods (1981) and  Kyte-Doolittle (1982) algorithm s for calculating 
hydropathy. In  addition, th e  com puter algorithm  AM PHI (M argalit et al., 
1987) was used to predict regions of the  predicted SIVmac251 env  and  gag  
sequences th a t  have high poten tial to form am phipath ic  helical segm ents. 
The o u tp u t from  each of these  com puter algorithm s w as considered as 
composite secondary s tru c tu re  predictions w ere m ade.
Prediction o f epitopes
The predicted am ino acid sequences of SIVmac (C hak rabarti et al., 
1987; H irsch et al., 1987) and SIVsm (Hirsch et al., 1989a) env polyproteins
were analyzed using  the  SurfacePlot com puter algorithm  w hich w as 
designed to predict continuous epitopes on the  basis of hydrophilicity 
(P arker et al., 1986), flexibility (Karplus and  Schulz, 1985), and  accessibility 
(Jan in , 1979). Sequence segm ents assigned antigenic index values over 50 
on the  60% composite SurfacePlot profile were considered strongly 
predicted  as po ten tia l epitopes. These sequences were also analyzed using  
th e  UWGCG P ep tideS tructu re /P lo tS tructu re  p ro tein  s tru c tu re  prediction 
algorithm s (Starcich et al., 1986) on a VAX 750 host system . The UWGCG 
algorithm s use th e  Jam eson  and Wolf m ethod (1988) of epitope prediction 
w hich consolidates calculated values for hydrophilicity  (Hopp and  Woods, 
1981), surface probability (Emini et al., 1985; Ja n in  et al., 1978), and 
flexibility (K arplus and Schulz, 1985). The resu lts obtained for each 
sequence from both  of these  com puter algorithm s were used  to pred ict a  
composite an tigenicity  profile of the  SIVmac251 env sequence.
Synthesis, purification, and characterization o f peptides
All synthetic  peptide sequences used in  these  stud ies w ere 
synthesized as am ides e ither m anually  on a  Rapid M ultiple Peptide  
S yn thesizer (Dupont, Boston, MA), u tilizing  F-moc chem ical s tra teg ies as 
described previously (A therton et al. 1988; Carpino and H an , 1972; Fontenot 
et al., 1991), or u sing  a  SAM II autom atic peptide synthesizer (Biosearch, 
S an  Rafael, CA) employing t-BOC chemical stra teg ies (B arany  and  
M errifield, 1979; Fontenot et al., 1991; Merrifield, 1963). Following cleavage 
from  supporting  resins, all peptides were in itia lly  subjected to gel 
filtra tion  using  Sepadex G25 (Sigma Chemical Co., St. Louis, MO) in  a  
glass colum n (3 cm X 53 cm) w ith a mobile phase consisting of 10-50%
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acetic acid depending on peptide solubility. E lu ting  peptides were detected 
using a  UA-5 absorbance detector (ISCO, Lincoln, NE).
Gel filtered peptide synthesis products were analyzed via reverse- 
phase high p ressure  liquid chrom atography (RP-HPLC) using  a  D elta 
Prep 3000 preparative chrom atography system  (W aters, Milford, MA) 
employing a  0.39 X 15 cm pbondapak C18 column (W aters). Separation 
was accomplished using lin ear g rad ien t elution of th e  mobile phase 
beginning w ith in itia l conditions of 95% solvent A (0.1% TFA in  w ater) and 
5% solvent B (0.1% TFA in  acetonitrile) w ith a  flow ra te  of 1.5 ml/min. 
Typically, a  2%/min linear g rad ien t was employed un til all peptide 
products elu ted  from the  column. Major components were collected 
m anually  upon elution and lyophilized to dryness. To identify  the  peptide 
component corresponding to the theoretical m olecular w eight, m ass 
spectrom etry was perform ed on HPLC-fractionated peptides using a  252C f 
P lasm a Desorption M ass Spectrom eter BIO ION 20 employing an  
acceleration voltage of 15 Kv with 8  k  channels for a  duration  of one 
million counts. The BIO ION 20 was interfaced w ith a  PD P 11/73 based 
d a ta  acquisition and processing system. Sam ples in  a  solution of ethanol: 
0.1% TFA in  w ater (50:50 ratio) were applied to a  nitrocellulose coated foil, 
allowed to absorb for 15 m inutes, spun dry, and  placed in  the  in strum en t 
for analysis. Once the desired peptide products were identified by m ass 
spectroscopy, they were purified via preparative RP-HPLC on a  1.9 X 15 cm 
pbondapak C18 column (W aters) using lin ea r 1%/min g rad ien t elution a t  
a  flow ra te  of 10 ml/min. E luting peptide w as collected m anually , frozen, 
and lyophilized to dryness. Purified peptide w as then  subjected to 
analytical RP-HPLC to access purity.
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M againin-2 peptide was purchased commercially (Calbiochem, La 
Jolla, CA). RP92 and RP93 peptides were a gift form Drs. Scott Pu tney  and 
K ashi Ja v h aria n  of Repligen Corporation, Boston, M ass.
P eptide enzym e-linked im m uno sorb ant assay (P-ELISA)
Poly-L lysine was diluted in  0.05 M  bicarbonate buffer (pH 9.6) to a  
final concentration of 10 ng/50 pl/well. This solution was allowed to adsorb 
onto the wells o f a  96-well Immulon I m icrotiter p late  for 1 h r  a t  room 
tem peratu re . The wells containing adsorbed poly-L lysine were w ashed 
once w ith phosphate buffered saline (PBS; 140 m M  NaCl, 2.7 m M  KC1,1.5 
m M  KH2PO4 , 8.1 m M  N a2 H P 0 4 , pH 7.4), trea ted  w ith 50 pi 1% 
glutaraldehyde in  phosphate buffered saline (PBS) for 15 m in a t  room 
tem peratu re , th en  w ashed once w ith PBS. Peptides corresponding to 
predicted epitopes of SIV and diluted to a final concentration of 10 ng/50 
pl/well in  PBS were dispensed into the  poly-L lysine coated wells. The 
p late  was sealed and the peptide allowed to adsorb overnight a t  room 
tem perature . The p late  was washed 2  tim es w ith PBS using a C om ing 
26305 ELISA p late  w asher (Corning, Corning, NY). In  order to m inim ize 
non-specific adherence of antibody to the  wells, 1 M  glycine (100 pl/well; 
Bio-Rad, Richmond, CA) in  PBS was added and incubated for 1 h r, 
followed by trea tm en t w ith 100 pi 2.5% non-fat dry m ilk and 0.5% gelatin  
(Difco, D etroit, MI) in  PBS. A 50 pi sam ple of te s t serum  diluted in  5% non­
fa t dry m ilk in  PBS (blotto) was then  added to each well and  incubated for 1 
h r  a t  room tem perature . After w ashing 5 tim es w ith approxim ately 200 pi 
ELISA w ash solution (E-wash; 1 M  NaCl, 0.05% polyoxyethylene-sorbitan 
m onolaurate (Tween 20; Sigm a Chemical Co.)) using an  U ltra  W ash 2 
m icroplate w asher (Dynatech Laboratories, Torrance, CA) to remove
unbound  antibody, 50 pi of urease-conjugated goat an ti-h u m an  IgG 
(Sigm a Chem ical Co.) d ilu ted  1/1000 in  blotto (to de tect m onkey p rim ary  
Ab) o r 50 fj.1 o f peroxidase-conjugated goat an ti-rab b it (Sigm a Chem ical 
Co.) d ilu ted  1:1000 in  blotto (to detect rabb it p rim ary  Ab) w ere added and  
incubated  for 1 h r  a t  room tem pera tu re . U nbound u rease-an tibody  
conjugate w as rem oved by w ashing  3 tim es w ith  approxim ately  200 pi E- 
w ash  followed by 3 w ashes w ith  w ater. The antibody reactiv ity  w as th en  
detected by addition of 100 pi su b stra te  solution (40 m g bromocresol purp le  
(Sigm a Chem ical Co.), 500 m g u rea  (Bio-Rad), 35 m g EDTA, 500 m l H 2 O; 
pH  to  5.0 w ith  0.1 N  NaOH). The calorim etric reaction  in  each well w as 
recorded a fte r  1 h r  and  th en  again  a fte r 4  h rs  to a ssu re  detection of w eak 
reactiv ities . Absorbance m easu rem en ts were m ade a t  570 n m  w ith  an  
au tom atic  ELISA  p la te  re a d e r (model MR700, D ynatech L aboratories).
T itra tio n  of rab b it an ti-pep tide responses w ere perform ed as 
described above except th a t  th e  secondary Ab used w as peroxidase- 
conjugated goat an ti-rabb it and  the  su b stra te  consisted of 40 m g 4-chloro-l- 
nap tho l, 5 m l cold H PLC grade m ethanol (F isher Scientific, F a ir  L aw n, 
N J), 25 ml PBS, and  15 pi H 2O 2 (Sigm a Chem ical Co.). Absorbance 
m easu rem en ts  w ere m ade a t  490nm .
SlV -in fected  m onkey serum  pan els.
F o u r d istinc t panels of SIV-infected m onkey se ra  w ere em ployed in  
these  analyses: SIV m ac-infected and  SIV /D eltaB670-infected rh esu s  
m acaques suffering  from  AID S-like syndrom e, an d  asym ptom atically  
infected sooty m angabeys and  African green  m onkeys. T he m acaque se ra  
w ere ob tained  from  an im als housed a t  th e  T u lane  Regional P rim ate  
C enter. The m angabey m onkey se ra  used  for th is  s tudy  w ere all obtained
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from  Y erkes Regional P rim ate  R esearch  C enter. The A frican g reen  
m onkeys used  for th is  study  w ere obtained from  m any  sources, both  
A frican and  A sian, an d  th e  source of v iru s  infection is unknow n in  a ll 
cases.
A nti-pep tide  a n tis e ra  p ro d u c tio n
Peptide  specific a n tise ra  (SAM35, SAM26, and  SAM56) w as 
produced in  N ew  Z ealand w hite  rab b its  (H azelton R esearch  P roducts, 
Denver, PA) by m ultip le  in tra m u scu la r injections (hip) o f pep tide  in  M DP 
ad juvan t (Syntex, Cam bridge, MA). The in itia l dosage of peptide w as 5 
mg. T hree w eeks a fte r  th e  in itia l dosage, a  5 m g boost w as adm inistered . 
A second boost consisting of 2  m g of pep tide  w as given following an o th e r 
th ree  week period. 5 w eeks a fte r th e  second boost, w eekly 1 m g dosages 
w ere adm in istered  for 4 w eeks and  the  an im als w ere sacrificed. All o th er 
peptide-specific a n tise ra  w ere produced in  New Z ealand w hite  rab b its  
(E ast Acres Biologicals, Southbridge, MA) by m ultip le  IM injections of 
pep tide  g lu taraldehyde-crosslinked  to keyhole lim pe t hem ocyanin  (Sigm a 
Chem ical Co.). Inoculations w ith approxim ately  1.5 m g of pep tide-carrier 
complex w ere perform ed a t  th ree  week in te rv a ls  and  serum  sam ples were 
collected weekly. Serum  sam ples from all an im als, tak e n  p rio r to each 
injection of peptide an tigen , were screened for an ti-pep tide  antibody v ia  P- 
ELISA.
N e u tra liz a tio n  assay s
The procedures for SIVmac251 n eu tra liza tio n  assays have been  
previously described (Langlois et al., 1991). Briefly, peptide-specific rabb it 
an tibody p repara tions w ere d ilu ted  two-fold in  m icro titer p la tes. A  30 |il 
a liquot of v irus, contain ing  1 0 0  syncytia-form ing u n its , w as added  to th e
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wells and  the  p lates were incubated for 30 m inutes a t  37°C. HUT-78 ta rg e t 
cells (3 X 103 cells in  30 p.1) were added to each well. Syncytia were 
enum erated  3-4 days post-challenge. The neu tra liza tion  t i te r  was 
expressed as th e  reciprocal serum  dilution inh ib iting  syncytium  
form ation by 90%.
N eutra lization  blocking experim ents were perform ed by p re ­
incubation  of a  neu tra liz ing  m acaque reference serum  w ith  each of the  
synthetic peptides described in  th is study prior to addition of the  se ra  to the  
assay. All rem aining  steps were perform ed as described above. 
Id en tifica tio n  o f p o ten tia l am ph ipath ic  a-helices
The transm em brane  protein  sequences of HIV-1 (R atner et a l.,
1985), HIV-2 (Guyader et a l., 1987), SIV (Hirsch et al., 1987), and  EIAV 
(Rushlow et al., 1986) were analyzed using  the  UWGCG Peptide 
S truc tu re /P lo t S truc tu re  secondary s tru c tu re  prediction algorithm s on a 
VAX 750 host system . Regions w ithin the carboxy te rm in a l end of th e  
tran sm em brane  protein  predicted to form a-helical s tru c tu re s  were 
fu rth e r analyzed using  the  Amphi algorithm  (M argalit et al., 1987) to 
iden tify  am phipath ic a-helical regions. E ach helical region was modeled 
u sing  th e  SYBYL m olecular graphics softw are on an  E vans and  
S u th erlan d  PS  390 in teractive graphics system  w ith  a  VAX 750 host 
system ; a-helical secondary struc tu re  w as assum ed for construction of 
these  models and  residue polarity  assignm ents w ere m ade according to 
th e  polarity  scale of transm em brane helices (Englem an et a l., 1986). 
P ro k a ry o tic  k illing  assays
The specific cytopathic activity of synthetic peptides for prokaryotic 
cells w as assayed using  standard  procedures (L ehrer et al., 1983). Briefly,
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one ml suspensions of Staphylococcus aureus and  Pseudom onas 
aeruginosa in  10  m M  K2HPO4 buffer were incubated for one hour a t  37°C 
w ith SIV-L, HIV-L, Magainin-2, RSV-Pep, HTLV-l-Pep, or Control-Pep a t 
1 pM, 10 pM, and  100 pM  concentration; three different concentrations of 
bacteria were treated. Each peptide was dissolved in 0.01% acetic acid 
solution to assure complete solubility prior to its  addition to bacterial 
suspensions. Following incubation, the bacterial suspensions were 
serially diluted (1 0 -fold) and 100  |il of each dilution was spread evenly over 
the surface of a  TSA plate and then incubated overnight a t 37°C. Colonies 
were th en  counted to determ ine the num ber of survivors of each 
treatm ent.
Eukaryotic k illing assays
The specific cytopathic activity of synthetic peptides w ith eukaryotic 
cells was assayed using standard  procedures previously for studies of 
retrovirus-induced cell killing (Rasheed et al., 1986; Tem in and Kassner, 
1974). One ml cultures (5 X 105 cells/ml) of the RH9 subclone of HuT78 
cells were incubated w ith HIV-L, SIV-L, RSV-pep, HTLV-l-pep, or control- 
pep a t the indicated concentrations. Each peptide was dissolved in  0.01% 
acetic acid solution to assure complete solubility prior to its  addition to 
bacterial suspensions. Following incubation for 24 hours a t  37°C in  RPMI 
1640 m edium  w ith 10% serum  supplem ent, the cells were stained  w ith the 
vital exclusion dye trypan  blue and the num bers of viable cells were 
determ ined by counting in  a hemocytometer.
51Cr-release assays
F resh  hum an peripheral blood leukocytes, obtained from various 
donors, were grown in  the presence of 51Cr for 24 hours. The cells were
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washed and then  cultured until confluent growth in  96 well p lates was 
attained. Various peptides, including LLPs were added exogenously to the 
cell cultures to a final concentration of 10 and 100 fjM  followed by a 24 hour 
incubation period. Following incubation, the supernatan ts were clarified 
and assayed for radioactivity to determ ine the  am ount of 51Cr th a t  was 
released by the cells. Viability of the cells was then  m easured by counting 
the  cells in  a hem acytom eter following staining w ith the  vital exclusion 
dye trypan blue. Cell pellets were lysed and assayed for radioactivity to 
determ ine the am ount of label not released from the cells.
M embrane perm eability assays
M em brane perm eability was assessed by quan tita ting  the  influx of 
radiolabeled molecules into cells by methods previously described (Cloyd 
and Lynn, 1991; Bashford et al., 1983; Smolen et al., 1986). Briefly, 30 pi test 
peptide suspension was added to suspensions of 1.2 X 106 CEM cells in  120 
pi of PBS lacking Ca2+ a t 0°C. Between 10 and 20 microcuries of 45Ca2+, 
[C14]sucrose, or [C14]inulin were then  added to these suspensions. To 
assay for perm eability of m em branes, an aliquot containing 2  X 105 cells 
(20 pi) were removed from the suspension every 30 seconds following 
addition of radioactive compounds. These cells were pelleted through 
silicone oil to separate the cells from th e ir aqueous environm ent. The tip  
of the microfuge tube containing the cell pellet was then  excised and 
placed in  a scintillation tube. The cell pellet was allowed to soak overnight 
in  scintillation solvent and was then  assayed for radioactivity. The cpm of 
45Ca2+, [C14]sucrose, or [C14]inulin in  pellets from peptide trea ted  cell 
suspensions were compared w ith those from un trea ted  cells and any 
increase in  cpm indicated increased m em brane perm eability. As a
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control for maxim um  perm eability, 1 |xl of 200 fiM  digitonin was added to 
the la s t aliquot of cell suspension and allowed to incubate for 1 m inute, 
and  the  influx of radioactive compounds was assayed as before. In 
addition, one aliquot of cell suspension was placed directly into 
scintillation vial/solvent and assayed to determ ine background cpm in  the 
cell suspension prior to cell separation.
Gel m obility sh ift assays
Gel mobility shift assays were performed as previously described 
(Head and Perry, 1974; Erickson-Viitanen and DeGrado, 1987). Briefly, 
w hen investigating calmodulin (CaM) binding in  the  presence of calcium, 
calmodulin was incubated for 1 hour a t room tem perature  in  the presence 
of te s t peptide in  binding buffer consisting of 100 m M  Tris base (Sigma), 4 
M  u rea  (Bio-Rad), and 0.1 m M  CaCl2 a t pH 7.2. Once the  binding reaction 
was complete, the  calmodulin/peptide m ixture was analyzed via non­
denaturing PAGE on 12.5% gels containing 0.375 M  Tris pH  8 .8  (Sigma), 4 
M  u rea  (Bio-Rad), and 0.1 m M  CaCl2 using electrophoresis buffer 
containing 25 m M  Tris (Sigma), 192 m M  glycine (Bio-Rad), and 0.1 m M  
CaCl2 a t  pH 8.3. W hen investigating CaM-binding in  the  absence of 
calcium, the  calcium-specific chelator ethylene glycol-bis(b-aminoethyl 
ether) n ,n ,n ',n '-tetraacetic acid (EGTA, Sigma) was substitu ted  for 
calcium in the  binding buffer, resolving gel, and  electrophoresis buffer a t  2  
m M  concentration.
Identification o f calm odulin-binding proteins on blots
E xtracts from HIVIIIB, HIVRF, and SIV/DeltaB670-infected CEM 
cells, as well as gradient purified HIV and SIV virions were resolved on 
12% SDS-PAGE as previously described (Laemmli, 1970) and transferred  to
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nitrocellulose as previously described (Burnette, 1981). As previously 
described (Billingsley et al., 1990), the m em brane was pre-incubated for 1 
h r  in  blocking solution (50 m M  Tris-HCl [pH 7.4] containing 150 m M  NaCl, 
2 m M  CaCl2, and 1% BSA). Following th ree 10 m in washes in  w ashing 
buffer (50 m M  Tris-HCl [pH 7.4] containing 150 m M  NaCl), the m em brane 
was incubated w ith biotinylated calmodulin (0.5 pg/ml in  blocking buffer) 
for 1 hr. Following three 10 min washes w ith washing buffer, the  
m em brane was incubated w ith V ectastain avidin-biotin-alkaline 
phosphatase conjugate (Vector Laboratories, Inc., Burlingam e, CA) for 30 
min. Following three washes in w ashing buffer, the m em brane was 
incubated in  alkaline phosphatase substrate  k it II (Vector) prepared in  100 
m M  Tris-HCl w ith 20 m M  CaCl2 until banding was complete.
Precipitation o f calm odulin-binding proteins o f HIV-1 and SIV/DeltaB670 
virus preparations.
E xtracts from HIVIIIB, HIVRF, and SIV/DeltaB670-infected CEM 
cells, as well as gradient purified HIV and SIV virions were d isrupted in  
0.1% deoxycholic acid. Approximately 80 jig of each protein sam ple was 
pipetted into an  eppendorf tube and the total volume of each sample was 
adjusted to 100 (il w ith 0.1% DOC/2 m M  CaCl2. 100 pi calmodulin- 
sepharose 4-B beads (Pharmacia), washed several tim es w ith 0.1% DOC/2 
m M  CaCl2 and sa tu rated  in  same buffer was added to each sample. The 
sam ples were vortexed gently overnight a t 4°C. The beads were washed 3X 
in  0.1%DOC/2 m M  CaCl2. During the final wash, the beads were 
transferred  to a  fresh eppendorf tube to assure th a t only CaM -sepharose 
bound proteins would be analyzed further. The beads were resuspended in  
electrophoresis sample buffer (10% SDS; 10% glycerol; 100 m M  Tris, pH  6 .8 ;
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0.001% brom phenyl blue; 0.5% 2-m ercaptoethanol), boiled for th ree  m inu tes 
to  rem ove pro teins bound to sepharose beads an d  to reduce disulfide 
crosslinking, and  th e  p ro te ins were analyzed via SDS-PAGE as previously 
described (Laem m li, 1970). Resolved pro teins were th e n  
e lectrophoretically  tran sfe rred  to nitrocellu lose or im m obilon m em brane 
an d  im m unoblo tted  using  se ra  from  HIV-1 or SIV im m une reference se ra  
as described by B u rn e tte , 1981). Im m une complexes w ere detected  using  
e ith e r  b iotin-conjugated an ti-h u m an  (Sigm a) or peroxidase-conjugated 
an ti-h u m an  (Sigm a) secondary an tibody p rep ara tio n s along w ith  
m atch ing  su b s tra te .
P h o sp h o d ie s te ra se  assays
To dem onstra te  th e  ability  of LLPs to b ind to an d  in h ib it norm al 
activ ities of CaM, and  to determ ine th e  affinity of LLPs for CaM rela tive  to 
a  know n CaM -binding peptide (DG-A, described in  C h ap te r 6 ), LLPs w ere 
em ployed in  s ta n d a rd  phosphodiesterase (PDE) assays as previously 
described (Schiefer, 1986). To estab lish  a  calibration curve of PD E activity  
in  th e  presence of CaM, these  solutions w ere added sequen tia lly  to a 
cuvette:
(1) 100 pi 0.1 M  glycylclycine (B oehringer M annheim , Ind ianapo lis, IN) pH 
7.5; (2) 700 pi 0.1 M  glycylglycine/3 m M  CaCl2; (3) 30 pi 40 m M  M gS04 
(Sigma); 10 pi 400 kU/1 adenosine deam inase (ADA, B oehringer 
M annheim ); (4) 20 pi 1500 kU/1 alkaline  phosphatase  (AP, B oehringer 
M annheim ); 100 p i CaM  (B oehringer M annheim ) s ta n d a rd  solution 
(dilu ted  10-fold from  a  1 mg/ml stock); (5) 10 pi 0.01% acetic acid; (6 ) 10 pi 
0.3 U/ml PD E in  0 .1  M  glycylglycine, pH 7.5. The reaction w as s ta r te d  by  
addition  of (7) 30 pi 2.9 m M  cyclic adenosine 3 ':5 '-m onophosphate (cAMP;
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Boehringer M annheim ) followed by thorough mixing. The resu lting  
decrease in  absorbance a t 265 nm  was monitored over a  12 m inute period 
using a  Shim adzu UV160U visible recording spectrophotom eter 
(Shimadzu, Kyoto, Japan) with a light pa th  length of 10 mm. Inhibition 
assays were performed by adding 10  |il te s t peptide solution (diluted series 
performed in  0.01% acetic acid) instead of adding solution 5 (10 pi 0.01% 
acetic acid) and  adding 100 pi of the standard  CaM dilution required for 
50% m aximal PDE activity (as determ ined from PDE-CaM calibration 
curve). Absorbance change was monitored as previously described.
CH A PTER 3
CHARACTERIZATION OF SIV/DELTA PRO TEINS
Introduction
In  1986, M urphey-Corb and  associates a t  th e  T u lane  P rim a te  C en ter 
repo rted  th e  iso lation  of an  H IV -related re trov iru s, SIV /D elta, from  
asym ptom atic  sooty m angabeys (Cerocebus atys) a n d  rh esu s  m acaques 
(M acaca m u la tto )  suffering  from  a tran sm iss ib le  AID S-like syndrom e 
(M urphey-Corb et al., 1986). The im m unosuppressive syndrom e 
experienced by m acaques consisted of opportunistic  infections, lym phoid 
a tropy  o r hyperp lasia , w asting, and  syncytium  form ation, along w ith  
g rea tly  reduced  OKT4/OKT8 ratios. P re lim in ary  im m unological stud ies 
u sin g  se ra  from  these  infected m onkeys estab lished  th e  re la tionsh ip  
betw een th is  SIV iso late  and  HIV and revealed  th e  presence of an tibody to 
SIV p ro teins w ith  estim ated  m olecular m asses of 110,000 D altons (110- 
kDa), 60-kDa, 45-kDa, 35-kDa, 26-kDa, and 16-kDa (M urphy-Corb et al.,
1986).
As previously  discussed, the  social an d  economic im plications o f th e  
rap id ly  grow ing AIDS epidemic have m ade th e  developm ent of a 
rep re sen ta tiv e  an im al model for vaccine an d  chem otherapeu tic  
investigations essen tia l. The rh esu s  m acaque is th e  m ost thoroughly  
charac terized  non-hum an  p rim a te  an d  i t  d isp lays a n  im m une system  
rem ark ab ly  sim ilar to th a t  of hum ans (Letvin et al., 1985; M artin  e t al., 
1983). T he estab lished  m orphological and  im m unological re la tionsh ip
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betw een HIV and SIV (Benveniste et a l ., 1986; M urphey-Corb et al., 1986), 
along w ith  the  clinical and  pathological sim ilarities betw een th e ir  
respective disease syndrom es, affirm  the need for a n  extensive 
characterization  of the  SIV/Delta system . W hen we em barked on th is 
project in  1986, isolation and nucleotide sequencing of only a  few stra in s  of 
SIV had  been reported. Since th a t  tim e, m any more s tra in s  of SIV have 
been isolated, b u t very  few protein  characterization  studies have been 
reported. The estab lishm ent of a virion pro tein  model for o ther 
len tiv iruses, such as equine infectious anem ia v irus (EIAV; P arekh , et al., 
1980; M ontelaro et al., 1982), have been in strum en ta l in  th e  investigation of 
these  v iral system s. The d a ta  p resented  here  describe a  virion pro tein  
model for SIV/Delta th a t  reveals obvious sim ilarities to th a t  of HIV and 




A nalysis o f  SIV/Delta proteins by  SDS-PAGE.
W hen subjected to analysis by SDS-PAGE, SIV/Delta yields a  
complex profile th a t  resem bles those of HIV  and  EIAV (Figure 4). Several 
m ajor p ro tein  bands th a t  appeared  to correlate w ith  the  gag-encoded 
pro teins of the  o ther len tiv iruses were evident. Due to the  complexity of 
th is  profile, SIV/Delta w as m etabolically labeled w ith  [S35]-m ethionine and  
w ith  [3H]-leucine to specifically label v iral proteins. These labeled v irus 
p repara tions were analyzed by SDS-PAGE in  cylindrical gels (20 cm in  
length) w hich were sliced into 1 m m  fractions which w ere assayed  for 
radioactivity  (Figure 5A & B). To identify  the  glycosylated v ira l proteins, 
v iru s p repara tions were m etabolically labeled w ith  [3H]-glucosam ine and  
analyzed in  the  sam e m anner (Figure 5C). The resu lting  profiles 
contained radioactive species corresponding to p ro teins of approxim ately  
43-kDa, 26-kDa, 17-kDa, 14-kDa, and 9-kDa and glycoproteins of 110-kDa 
and  35-kDa; the  heterogeneity of the  110-kDa component is probably due to 
varia tions in  glycosylation p a tte rn . In teresting ly , th e  radioactive species 
corresponding to a  43-kDa com ponent w as highly variab le  from one v irus 
p repara tion  to the  next, depending on the  stage of v irus production. W hen 
label w as added to cells prior to optim al v irus production, th e  43-kDa 
p ro tein  typically comprised a  h igh percentage of the  label recovered, 
w hereas upon addition of label during  optim al v irus replication, th e  43- 
kD a p ro tein  was usually  only a  m inor com ponent of the  p rep ara tio n  (data  
no t shown). To determ ine w hether the  43-kDa pro tein  w as of v iral or
Figure 4. SDS-PAGE analy sis  o f  g ra d ie n t p u rif ie d  SIV/Delta v irions. 10%
SDS-PAGE analysis of gradient purified (E) EIAV, (H) HIV-1, and  (S) 
SIV/Delta virions. The approxim ate m olecular w eights of m ark ers  a re  
labeled on the left.
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Figure 5. SDS-PAGE analysis o f m etabolically  rad io labe led  SIV/Delta.
Labeled virus preparations were analyzed via SDS-PAGE on tube gels 20 
cm in  length. Following electrophoresis, the cylindrical gels were sliced 
into 1 mm fractions and  the fractions were assayed for radioactivity. 
SIV/Delta-infected H9 cells were metabolically labeled w ith S35- 
m ethionine (Panel A), H 3-Leucine (Panel B), and H3-glucosamine (Panel 
C). Mock-infected H9 cells were metabolically labeled w ith S35-m ethionine, 
a  mock-purification was performed, and the mock-infected H9 cell 
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cellu lar origin, [S35]-m ethionine was added to m ock-infected H 9 cells. 
SDS-PAGE analysis of th is  p repara tion  revealed th a t  a  h igh  percen tage  of 
label w as incorporated  in to  th e  43-kDa com ponent (F igure 5D) ind ica ting  
th a t  th is  p ro te in  was probably cellular. However, the  possib ility  th a t  a  
v irus-encoded p ro te in  w as co-m igrating w ith th is  43-kD a cellu lar 
con tam inan t could no t be ru led  out on the  basis o f these  resu lts .
A nalysis o f  SIV/Delta protein s b y  len til lectin  affin ity  chrom atography.
To fu r th e r  evaluate  the  glycoprotein composition of SIV /D elta, v iru s 
p rep a ra tio n s w ere subjected to len til lectin  affin ity  ch rom atography  an d  
analyzed  by SDS-PAGE procedures. W hen visualized  by  coom assie blue 
sta in ing , th e  lectin  b ind ing  profile contained two d is tin c t b ands 
corresponding to p ro te ins of approxim ately  110-kDa an d  35-kDa m olecular 
m ass, and  th e  lec tin  non-binding profile revealed bands of 26-kDa, 17-kDa, 
14-kDa, an d  9-kD a (Figure 6 ). W hen visualized by a  glycoprotein-specific 
s ta in in g  procedure (Clegg, 1982), the  non-binding profile contained  no 
p rom inen t bands w hile th e  b ind ing  fraction contained  b ands rep re sen tin g  
p ro teins of 110-kDa and  35-kDa, and a  fa in t band  of approxim ately  9-kDa 
m olecular w eight (d a ta  no t shown). [S35]-m ethionine labeled  v ira l 
p rep a ra tio n s  w ere also subjected to len til lec tin  frac tionation  an d  analyzed  
on cylindrical gels. T he resu ltin g  profiles w ere s im ila r to previous re su lts  
ind icating  th a t  th e re  a re  a t  le a s t th ree  virus-encoded len til lec tin  non­
binding p ro teins, 26-kDa, 17-kDa, and  14-kDa, an d  a t  le a s t two len til lectin- 
b ind ing  v ira l glycoproteins of 110-kDa and  35-kDa m olecular m ass (F igure 
7). T he 35-kD a com ponent appears as a  doublet on Coom assie s ta in ed  gels, 
ind icating  th a t  both  p u ta tiv e  glycoproteins are  heterogeneous. In  addition
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Figure 6 . A nalysis o f  p ro te in  frac tio n s  o b ta in ed  from  lentil-lec t in  a ffin ity  
c h ro m a to g ra p h y  o f  SIV/DeltaB670. Panel A: SDS-PAGE analysis of protein 
stan d ard s (lane 1 ) w ith  m olecular w eights as indicated, SIV/DeltaB670 
gradient-purified  whole v irus (lane 2), lentil-lectin  non-binding (lane 3) 
and  binding (lane 4) pools. The to tal protein  profile was visualized by 
s ta in in g  w ith  Coomassie blue. Panel B: Im m unoblot analysis of whole 
v irus (lane 1), lentil-lectin  non-binding (lane 2) and  binding (lane 3) of 
SIV/DeltaB670 using  a  reference serum  from an  SIV-infected m acaque 
and  125I-labeled p ro tein  A. T hirty-six  m icrogram s of purified  whole virus, 
35 |ig  of th e  lentil-lectin  non-binding fraction, and  24 pg o f the  lentil-lectin  
b ind ing  fraction w as loaded in  each respective well. The characteristic  
m igration  positions of each of th e  SIV polypeptides a re  designated  on 
panels A and B. S im ilar im m unoblots using  pre-infection m onkey sera  
show no reactiv ity  w ith  any  components of these SIV p ro te in  pools (data  
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to the 110-kDa and 35-kDa components, a  small am ount of radioactive 
species corresponding to a protein of approxim ately 43-kDa was evident in  
the  len til lectin binding fraction of th is virus preparation (Figure 7C).
This glycosylated 43-kDa component, which appears to co-migrate w ith the 
43-kDa cellular contam inant of these SIV virion preparations, m ay 
represen t a  th ird  glycoprotein of SIV. However, the relationship of these 
glycoproteins is not clear from these analyses.
Serological analysis o f SIV/Delta proteins.
Whole SIV/Delta virion preparations and lentil lectin pools were 
analyzed by w estern blotting techniques (Burnette, 1981) using reference 
sera obtained from SlV-infected macaque #B845 (Baskin et al., 1986). 
Im m une sera reacted specifically with polypeptides of approxim ately 110- 
kDa, 43-kDa, 35-kDa 26-kDa, 17-kDa, 14-kDa, and 9-kDa molecular masses 
(Figure 6 ). The relative intensities of the bands indicated th a t the  110-kDa 
and 35-kDa components are highly immunogenic and the broadness of 
these bands depict the ir heterogeneity. This conclusion was draw n due to 
the apparen t low copy num ber of the envelope proteins per virion, as 
suggested by whole virus profiles on coomassie stained gels and as 
definitively shown by electron micrographic analyses (discussed in  
C hapter 1). The 26-kDa component, which is p resen t in  high copy num ber, 
is also highly immunoreactive while the 17-kDa, 14-kDa, and 9-kDa 
polypeptides appear to be less immunogenic. The specific reactivity of 
im m une sera with a 43-kDa protein contained in  both whole virus and the  
lentil lectin  binding fraction of SIV/Delta suggested th a t the  three 
glycoproteins identified in  preparations of SIV are  produced during viral
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Figure 7. A nalysis o f  p ro te in  frac tio n s  o b ta in e d  from  len til-lec tin  a ffin ity  
c h ro m a to g ra p h y  o f  S ^ -m e th io n in e  lab e led  SIVXDeltaB670. Metabolically 
radiolabeled SIW DeltaB670 preparations were subjected to len til-lectin  
affinity  chrom atography. Whole SIV s ta r tin g  m ateria l (Panel A), len til- 
lectin  non-binding (Panel B), and  binding (Panel C) pools w ere analyzed 
via SDS-PAGE on 20 cm cylindrical gels. Gels were sliced in to  1 m m  
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replication and are probably encoded by the  SIV genome. Sera  from 
healthy  m acaques failed to recognize any  of these proteins confirming th a t 
antibody specific for these proteins are  elicited by SIV/Delta infection (data 
no t shown).
Two-dim ensional peptide m apping o f tryptic digests.
Each of the  putative SIV/Delta proteins were analyzed by peptide 
m apping procedures in  order to exam ine w hether these  protein  
components were unique or were precursors or cleavage products of o ther 
v iral proteins. Following SDS-PAGE analysis w ith  coomassie staining, 
SIV-specific protein  bands were excised directly from the  gel, 
radioiodinated and trypsinized in  the  gel slice, and  then  the  peptides were 
eluted from the slice. These tryptic peptide fragm ents were subjected to 
electrophoresis in  one direction and th en  liquid chrom atography in  a 
perpendicular direction. P relim inary  resu lts revealed th a t  excision of 
homogeneous bands from these complex m ixtures was difficult, i f  no t 
impossible. Therefore, we subsequently used a  com bination of reverse 
phase high pressure  liquid chrom atography (RP-HPLC) purification 
procedures, as described by Ball et al. (1988) for EIAV proteins, and  SDS- 
PAGE to generate homogeneous protein  bands. R esulting two- 
dim ensional peptide profiles (Figure 8) dem onstrated  the  uniqueness of 
each of these proteins w ith the exception of the  35-kDa and  34-kDa 
components. As expected, these two profiles were very sim ilar and  
seemed to differ only in  th e ir relative degrees of glycosylation. Since 
glycopeptides do no t m igrate in  the  chrom atography solvent and  can be 
seen along the horizontal origin (Salinovich et al., 1986; Payne et al., 1987),
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Figure 8. T ryp tic  pep tide  m aps of  ̂ I - la b e le d  SIVZDeltaB670 p ro teins.
The two-dimensional analysis consisted of electrophoresis in the  
horizontal direction and liquid chrom atography in  the vertical direction. 
Samples were applied in  the lower left comer. The identity  of the  proteins 
analyzed are as follows: 110-kDa (Panel A), 35-kDa (Panel B), 34-kDa (Panel 
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these peptide m apping procedures can be useful in  evaluating  the  relative 
ex ten t of glycosylation of glycoproteins. The 110-kDa profile also revealed 
th e  presence of glycopeptides along the  horizontal origin; the  in ten sity  of 
th is  "layer" of glycopeptide suggests th a t  the  110-kDa component is heavily 
glycosylated. As expected the  26-kDa, 17-kDa and  14-kDa profiles a re  less 
complex th a n  those of th e  glycoproteins; however, the  9-kDa profile is  
highly complex suggesting a heterogeneous pro tein  band. In  fact, the  
heavy concentration of peptides a t the  origin of the  9-kDa peptide m ap 
(Figure 8G) a re  indicative of glycopeptides. Therefore, the  heterogeneity  of 
the  9-kDa band could be due to co-migration of glycoprotein breakdow n 
products, as glycoproteins typically are  extrem ely labile.
D irect am ino acid  sequencing o f putative SIV virion proteins.
To confirm th a t  each of th e  putative  SIV proteins w ere in  fact virus- 
encoded, we a ttem p ted  to perform  am ino-term inal amino acid sequencing 
of th e  110-kDa, 35-kDa, 26-kDa, 17-kDa, and  9-kDa proteins discussed above. 
Since p ro tein  sam ples for sequencing m ust be extrem ely hom ogeneous, 
pro tein  sam ples were purified via RP-HPLC, subjected to SDS-PAGE, and  
electrophoretically transferred  to an  activated glassfiber sheet for 
sequencing. Sequencing of the 26-kDa protein  yielded in te rp re tab le  d a ta  
from 15 of the  first 16 cycles a ttem pted  (Figure 9). T hirteen  of these  15 
residues m atched th e  predicted CA protein sequence of SIVmac251 
(H irsch et al., 1987); unfortunately , no sequence d a ta  from SIV/Delta 
iso lates were available for comparison. A ttem pts to obtain sequence d a ta  
from  the  17-kDa component were unsuccessful indicating  th a t  th is  pro tein  
w as probably am ino-term inally blocked. Since th e  MA pro teins of o ther
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26kDa NH2 - Pro-Val-Asn-Asn-Val -Gly-Gly-Asn-Tyr-Thr -Hls-Leu-Pro-Leu- ? -Pro
17kDa blocked, no sequence obtained
14kDa NH2 - Val-Leu-Ser-7-?-Asp
9kDa NH^- Val-Thr-Asn-Gly-Asn-Arg-Glu-Thr-Ile-lys- ? - ? - ? - ?  -Gly-Leu
Figure 9. A m ino-term inal sequenc ing  o f th e  p u ta tiv e  SIV/DeltaB670 
p ro te in s . SIV/DeltaB670 proteins were purified via RP-HPLC and soluble 
sam ples were directly applied to TFA trea ted  glassfiber discs and  then  
subjected to gas-phase sequencing. The amino acid sequence obtained 
from each of the  indicated proteins is listed. All residues in  bold p rin t 
differ from the reported amino acid sequence of SIVmac251.
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lentiviruses are  m yristylated a t  the ir amino term inus, and  since those 
MA proteins are sim ilar in  molecular weight to th is 17-kDa component, 
th is  protein is probably the MA protein of SIV/Delta. Analysis of the 14- 
kD a component yielded only four interpretable cycles out of six cycles th a t  
were attem pted  (Figure 9). Surprisingly, th is 4/6 residue sequence could 
not be located in  the gag-encoded polyprotein sequence suggesting th a t the 
14-kDa component was not a gag-encoded protein. Sequencing of the 9-kDa 
component yielded in terpretable data  from 12 of the 16 cycles performed 
(Figure 9). However, th is sequence did not correspond to any region of the 
predicted amino acid sequences of SIVgag or env polyproteins. A ttem pts 
were m ade to obtain sequence data  from the 110-kDa and 35-kDa 
components. However, due to the requirem ents for relatively large 
am ounts of extremely pure protein, these attem pts were soon aborted and 
no sequence data  was obtained.
Secondary structural m odeling o f putative SIV proteins.
G allaher and associates have previously performed extensive 
secondary struc tu ra l modeling of several lentiv irus TM (G allaher et al,,
1989) and SU (Gallaher et al., 1991) proteins. These studies have revealed 
strik ing  sim ilarities between lentivirus envelope proteins. Here, we have 
perform ed sim ilar modeling studies of the SIVmac251 envelope proteins 
for comparative purposes. Composite secondary structure  models for both 
SU and TM (Figure 10A & B) were prepared by analyzing predicted amino 
acid sequences of SIVmac251 both m anually, via application of Chou- 
Fasm an methodology (Chou and Fasm an, 1974), and  using several 
com puter algorithm s designed to predict secondary structu re  (detailed
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discussion in  C hapter 4). Disulfide linkages were predicted on the  basis of 
sim ilarities w ith HIV-1 SU linkages which have been experim entally 
derived (Leonard et al., 1990) and from the predicted disulfide linkages of 
HIV-2 and SIVmac SU (Hoxie, 1991).
A lthough results obtained from these predictive algorithm s are 
extrem ely speculative, the resu lting  structu ra l models were strikingly 
sim ilar to those of HIV-1, HIV-2, and EIAV, and they m ay be useful tools 
for experim ental design. On the basis of m utational (Kowalski et al., 1987; 
Laskey et al., 1987; Willey et al., 1988) and immunological (O'Brien et al.,
1990) analyses, as well as sequence and predicted structure  comparisons, 
lentiviral SU proteins have been conceptionally subdivided into three 
regions (G allaher et al., 1991). The amino-term inal one-third of SU 
appears to consist of a  relatively constant core structure  th a t  contains the 
TM contact sites. The central one-third of the SU protein generally 
contains sequences im portan t to both hum oral and cellular im m une 
responses, such as the  principle neutralizing dom ain and several 
potentially am phipathic sequences th a t may act as T-cell epitopes. The 
carboxy-term inal one-third of SU appears to contain the  binding site for 
the  CD4-receptor; the structural characteristics of th is binding site include 
a  core of J3-sheet which forms a hydrophobic pocket th a t  is stabilized by 
disulfide crosslinking. Lentiviral SU proteins have also been divided into 
five disulfide-bonded domains th a t are well conserved. G allaher and 
associates (1989) have also identified some highly conserved structu ra l 
features w ithin the amino term inal one-half of lentiv iral TM proteins. 
These structu res include the fusion domain (Gallaher, 1987), an  extended
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a-helical region, a  putative disulfide "loop” which stabilizes an  
im m unodom inant hum oral antigenic determ inant (Norrby et al. 1989, 
1991), and finally, a hydrophobic a-helical m em brane spanning domain. 
The secondary structural investigations of G allaher and associates 
identified no common structu ra l motifs w ithin the  carboxy-term inal one- 
h a lf  of the TM protein.
The secondary structure predictions reported here a re  consistent 
w ith those reported by G allaher and associates, further dem onstrating the 
sim ilarities between SIV and the other lentiviruses (Figure 10A & B). 
S im ilar to predictions for other lentivirus SU proteins, the SIVmac SU can 
be subdivided into five domains on the basis of predicted disulfide linkages. 
A putative CD4-binding domain can easily be identified from these 
modeling studies as an  extended hydrophobic B-sheet, lying between 
disulfide bonded domains IV and V, appears to form a  binding pocket or 
cleft th a t is stabilized by disulfide bonding; this structure is very sim ilar to 
th a t  predicted for HIV-1. The disulfide domain IV of SIV is also highly 
analogous to th a t predicted for HIV-1 as i t  contains a  structure sim ilar to 
th e  principle neutralizing determ inant of HIV-1. The struc tu ra l features 
of the  SIVmac TM protein are predicted to be sim ilar to those predicted for 
o ther lentiviruses as well. The five residue core sequence of the fusion 
domain (FLGFL) in  SIVmac is identical to th a t of HIV-1 and, also sim ilar 
to HIV-1, i t  begins a t  position 7 of the TM sequence. However, the  fusion 
domain of SIV is predicted to form a fl-sheet structure while o ther 
lentiv iruses are  predicted to assum e a random  coil conformation in  th is 
region. The SIVmac model also contains structures closely resem bling
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the  disulfide loop-stabilized im m unodom inant antigenic determ inan t and 
th e  hydrophobic helical transm em brane m em brane-spanning dom ain 
th a t is characteristic of other lentiviruses (G allaher et al., 1989). These 
studies did identify an am phipathic a-helical region n ear the  carboxy- 
term inus of SIVmac and several other lentiviruses th a t m ay play an 
im portant role in  the cytopathicity of lentivirus infections (Miller et al., 
1991; M iller and Montelaro, 1991). This structural m otif of SIV and other 
lentiviruses was examined in detail, and these studies are described in  
Chapters 5 and 6.
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F ig u re  10 S ec o n d a ry  s tru c tu ra l  m odels o f  SIVm ac251 SU  a n d  TM  
p ro te in s .  SIVmac251 SU and TM protein  sequences (H irsch et al., 1987) 
w ere analyzed v ia  C hou-Fasm an ru les m anually  an d  w ith  th e  
P ep tid eS tru c tu re  /  P lo tS truc tu re  com puter a lgorithm s designed to p red ic t 
secondary  s tru c tu ra l e lem ents from p rim ary  am ino acid sequences 
(S tarcich  et al., 1986). In  addition, the  sequences w ere analyzed u sin g  the  
AM PH I a lgo rithm  w hich is designed to locate am ph ipath ic  p ro te in  
segm ents (M argalit et al., 1987). The composite secondary s tru c tu re  
m odels of th e  SU  (A) and  TM (B) envelope p ro teins a re  p resen ted  here. 
Am ino acid  side chain  charac teristics w ere assigned  according to  th e  
po larity  scale of tran sm em brane  helices (E nglem an et a l., 1986). 
In tram o lecu la r d isulfide linkages, w hich a re  ind ic ted  by a double line, 
w ere predicted  on th e  basis of s im ilarities w ith  HIV-1 linkages w hich 
have been  experim entally  derived (Leonard et al., 1990) and  from  th e  
predicted  disulfide linkages of HIV-2 SU (Hoxie, 1991).
O o
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As a  resu lt of the protein characterization and immunological 
studies reported here, we propose a  partial model for the struc tu ra l 
components of the HIV-related SIV/Delta virion. The high 
immunogenicity and extensive glycosylation of the 110-kDa component 
isolated from SIV/Delta, implies its role as the external envelope 
glycoprotein (SU). The slightly glycosylated and less immunogenic 35-kDa 
protein probably represents the transm em brane protein or TM. Sim ilar to 
other lentiviruses, the m ost abundant protein present in  SIV/Delta 
preparations has an apparen t molecular m ass of 26-kDa. Serological 
analyses revealed th a t infected monkeys produce high levels of antibodies 
specific for th is protein, while amino acid sequencing revealed th a t th is 
protein is encoded by the gag  gene. Together, these d a ta  suggested th a t the 
26-kDa protein is the major capsid component (CA) of SIV/Delta. The 17- 
kDa component was predicted to be fatty acylated due to its  failure to yield 
a sequence upon autom ated sequencing and is therefore thought to be the 
m atrix  protein (MA). Due to their SDS-PAGE m igratory properties, the 
110-kDa, 35-kDa, 26-kDa and 17-kDa protein were predicted to be the SU, 
TM, CA, and  MA proteins, respectively, prior to these studies; the results 
of these studies confirmed those predictions.
Similarly, the 14-kDa and 9-kDa components of SIV/Delta virus 
preparations were predicted to be the nucleocapsid (NC) protein and a 
m inor core component, respectively. However, resu lts of the experim ents 
described here implied th a t these predictions were incorrect. These
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stud ies suggested  th a t  th e  14-kDa and  9-kD a p ro teins, w hich a re  rela tive ly  
a b u n d a n t com ponents of SIV /D elta v iru s  p rep a ra tio n s, a re  n o t encoded by 
th e  gag  gene. N e ith e r of th ese  p ro te ins appeared  to be breakdow n p roducts 
of th e  SU  or TM  e ith e r, as th e  p a rtia l am ino-te rm ina l sequences ob tained  
from  th ese  com ponents did n o t co rre la te  w ith  any  reg ion  of th e  p red icted  
am ino acid sequences of th e  envelope polyprotein.
T he re su lts  rep o rted  here  have been  corroborated, an d  in  some cases 
clarified by rep o rts  from  o th er laboratories. H enderson  et a l. (1988a) 
perform ed ex tensive am ino acid sequencing  s tu d ies  u sin g  H PL C -purified  
p ro te in s, a s  well as  p ro te in  fragm ents g en era ted  by enzym atic cleavage, 
an d  found th a t  th e  26-kD a and  17-kDa com ponents o f SIV m ne w ere th e  CA 
an d  MA pro tein , respectively . N e ith e r th e  stud ies repo rted  here , or those 
of H enderson  an d  associates (1988a) suggested  th a t  th e  14-kDa SIV pro tein  
w as encoded by th e  g a g  gene. However, a  la te r  rep o rt identified  th e  14-kDa 
p ro te in  as th e  p roduct of a  un ique  ORF found in  SIV and  HIV-2, b u t  no t 
HIV-1, th is  ORF w as designated  vpx  (H enderson et a l., 1988b). T his 
p ro te in  ap p ea rs  to  be req u ired  for efficient v ira l rep lica tion  in  fresh  
m onocytes and  m acrophages and  m ay function  by ac tiva ting  th e  
expression  of ce llu la r factors th a t  fac ilita te  v ira l rep lica tion  (Yu et al., 
1991). I t  h a s  been  specu lated  th a t  th is  vpx pro tein , an d  o th er regu la to ry  
p ro te ins, m ay  compose th e  la te ra l  bodies of len tiv iru s  v irions (Gelderblom ,
1991). We a re  c u rren tly  em ploying 14-kDa-specific m onoclonal an tibodies 
in  im m une-electronm icroscopic ana ly ses in  an  a tte m p t to localize th e  vpx 
p ro te in  w ith in  v irions. Since the  9-kD a p ro tein  does no t correspond to  an y  
of th e  know n SlV-encoded pro te ins, we speculate  th a t  i t  m ay re p re se n t a
62
virion-associated cellu lar p ro tein  th a t  e ith e r is  specifically or non- 
specifically incorporated in to  virions a t  re la tive ly  h igh  levels. U sing  
m onoclonal antibodies generated  to p u ta tive  SIV glycoproteins (110-kDa 
an d  35-kDa), Veronese et al. (1989) perform ed im m unoprecip itations 
coupled w ith  SDS-PAGE and  th en  excised p rec ip ita ted  p ro te ins from  th e  
gel, e lu ted  th e  p ro tein  from the  gel slice, and  th e n  analyzed th e  p ro tein  via 
am ino-term inal sequencing. Sequencing resu lts  ind icated  th a t  th e  110- 
kD a and  35-kDa SIV proteins a re  indeed th e  SU and  TM products o f th e  
env  gene, respectively, th u s  corroborating th e  observations repo rted  here.
N ucleotide sequence analysis of SIV m ac h as revealed  th a t  th e  env  
gene contains an  in-fram e stop codon th a t  tru n ca te s  th e  cytoplasm ic 
dom ain of th e  TM protein  (H irsch et al., 1987) resu lting  in  th e  expression 
of a  p ro te in  of approxim ately 35-kDa. This is consistent w ith  d a ta  
p resen ted  here. However, M ullins and  associates repo rted  th a t  tru n ca ted  
TM  pro tein  is the  p rim ary  form of TM observed in  vitro, b u t in vivo  a  full 
len g th  TM of approxim ately 41-kDa predom inates (H irsch e t al., 1989b).
The 43-kDa com ponent th a t  we observed in  len til lectin  b ind ing  fractions of 
SIV /D elta m ay rep resen t a  residual level of the  full leng th  TM protein . I t  
h a s  been  dem onstra ted  th a t  growing SIV in  cu ltu red  h u m an  cells selects 
for TM m u ta n ts  th a t  produce a  tru n ca ted  TM  protein . SIV  produced in  
m acaque PBLs in  vivo re ta in s  a full leng th  TM pro tein  (H irsch  et al.,
1989b).
Secondary s tru c tu ra l m odeling of SIV p ro te ins h a s  fu r th e r  show n 
th e  close resem blance of SIV proteins to those of th e  o ther len tiv iruses, 
specifically HIV-1, HIV-2, and  EIAV. These s tru c tu ra l m odels also
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rep resen t a useful tool for experim ental design as they  reveal s tru c tu ra l 
fea tu res of SIV  proteins th a t  m ay be essential for infectivity and  
cytopathicity of th e  v irus. F u rth e r  characterization  of these  s tru c tu ra l 
fea tu res m ay lead  to a b e tte r  understand ing  of len tiv irus pathogenic 
m echanism s and  developm ent of novel th erapeu tic  m easures designed to 
a lte r  len tiv irus-induced  disease progression.
CHAPTER 4
IDENTIFICATION OF CONTINUOUS EPITOPES OF SIV ENVELOPE
PROTEINS
Introduction
The sim ian imm unodeficiency virus (SIV) system  constitu tes an  
im portan t an im al model for exam ining m echanism s of HIV pathogenesis 
and for developing strateg ies for AIDS vaccine developm ent (G ardner and 
Luciw, 1988,1989; Desrosiers and Letvin, 1987; Daniel and Desrosiers, 1989; 
Desrosiers and  Ringler, 1989). A critical component to both of these 
aspects of AIDS research  is a characterization of SIV im m unogenicity in  
m onkeys and how specific im m une responses m ay correlate w ith  the  
progression of p e rs is ten t v iral infection and the clinical course o f disease. 
Infections of various monkey species w ith a pa rticu la r iso late  of SIV can 
resu lt in  a  diverse disease spectrum , ranging  from asym ptom atic 
infections of sooty m angabeys (Murphey-Corb et al., 1986; Fu ltz  et al., 1986a; 
Lowenstine et al., 1986) and African green monkeys (O hta et al., 1988; 
Daniel et al., 1988a) to the  development of fatal immunodeficiency disease 
in  rhesus m acaques (Letvin et al., 1985). In  addition, characterization of 
SIV stra in s  isolated from various species of monkeys has revealed a 
rem arkable degree of variation  in  v iral genetic and biological properties 
(Regier and  Desrosiers, 1990). Because of the  variations in trinsic  to SIV 
infections, i t  h as been difficult to identify common them es in  v iral 
im m unogenicity and  to characterize im m une responses th a t  can 
influence th e  course of SIV infection and disease. Thus, the  identification
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of group and type site-specific antigenic determ inants of SIV is an 
im portan t foundation for more detailed studies of how host im m une 
responses m ay affect virus replication and disease.
The kinetics of SIV-induced im m une responses has typically been 
studied using immunological techniques such as W estern blotting and 
radioim m unoprecipitation (Zhang et al., 1988). Results from these types of 
studies have shown th a t  core-specific responses, directed prim arily 
tow ard the 26-kDa major core protein (CA), are detectable prior to 
glycoprotein-specific responses which are directed toward th e  110-kDa 
external envelope glycoprotein (SU), the 32-kDa truncated  transm em brane 
protein  (TM32), and the full-length 41-kDa transm em brane protein (TM41; 
H irsch et al., 1986; H irsch et al., 1987). In anim als infected w ith non- 
pathogenic stra ins of SIV, these responses persist throughout the course 
of infection. Analysis of serial serum  samples from anim als infected w ith 
pathogenic stra ins of SIV revealed th a t responses specific for some of 
these proteins are transient, and the fluctuations observed m ay be 
predictive of disease progression (Zhang et al,, 1988).
W hile the aforem entioned immunological assays are  effective for 
m onitoring hum oral responses specific for individual proteins, they yield 
no inform ation concerning epitope-specific responses. In  the  cu rren t 
study we have utilized synthetic peptide methodologies to characterize 
linear B-cell determ inants in  the envelope glycoproteins of SIV. Toward 
th is  goal, we have performed a detailed computer-aided analysis of 
potential antigenic sites on the SIV envelope glycoproteins and have 
synthesized selected peptides for further analyses. The SIV envelope
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peptide  an tig en s w ere th en  assayed  for th e ir  serological reac tiv ity  w ith  
defined panels o f im m une serum  from  various species of SIV -infected 
m onkeys to iden tify  group and  type specific B-cell de te rm inan ts . In  
addition , th e  cand idate  peptide an tigens were exam ined for th e ir  ab ility  to 
induce n eu tra liz in g  antibodies in  rab b its  and  to block serum  
n eu tra liza tio n  of v iru s in  vitro.
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R esu lts
P redicting B -cell and T-cell ep itopes o f SIV.
A nalysis of deduced amino acid sequences of th e  env  polyproteins of 
two SIVmac isolates (H irsch et al., 1987; C hakrabarti et al., 1987), 
SIV/DeltaB670 (M urphey-Corb et al., 1986) and a  SIVsm isolate (H irsch et 
al., 1989a) using the  SurfacePlot (Parker et al., 1986; K arplus and  Schultz, 
1985; Jan in , 1979) and UWGCG Pep tideS tructu re  / P lo tS tructu re  com puter 
algorithm s (Starcich et al„ 1986) identified several p ro tein  segm ents w ith 
high  potential to form epitopes on the surface proteins of SIV. The 
SurfacePlot profiles (Figure 11) reveal several protein  segm ents 
corresponding to composite surface values over 50, th u s  pred icting  those 
am ino acid sequences to be antigenic regions of the  ex ternal glycoproteins. 
Analysis of these sequences w ith  the P ep tideS tructu re /P lo tS truc tu re  
algorithm s yielded sim ilar resu lts  (data  no t shown). R esults obtained 
from  com puter-aided analysis of each of these  SIV sequences were 
compiled to form a  consensus antigenic profile of SIV, and  th is  profile was 
used to select potential epitope regions from SIVmac251.
At le a s t nine regions of the  SIV env  polyprotein were predicted to 
have high potential to form antigenic sites. Seven of these  were w ith in  the  
SU  pro tein  and  two were identified in  the  TM portion of th e  polyprotein 
sequence. Peptides corresponding to all n ine of th e  high-index regions of 
the  env  polyprotein w ere produced synthetically  according to the  
SIVmac251 sequence reported by H irsch et al. (1987): residues 46-66 
(SAM42), 112-143 (SAM35), 178-207 (SAM26), 269-289 (SAM45), 365-389
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Figure 11. P re d ic tio n  o f SIV B-cell E p itopes. SurfacePlot 60% composite 
profiles from analysis of the deduced amino acid sequences of th e  envelope 
polyprotein of ( Panel A) SIVmac251 (Hirsch et al., 1987), (Panel B) 
SIV/DeltaB670 (LeRosa et al., 1992), (Panel C) SIVsm (Hirsch et al., 1989a), 
and (Panel D) SIVagm TYO-1 (Fukasaw a et al., 1988) have been aligned. 
Peaks correspond to the predicted antigenic index th a t  w as compiled from 
hydrophilicity, accessibility, and flexibility calculations (P arker et al.,
1986). Regions w ith surface values over 50 are strongly predicted as B-cell 
epitopes. Nine peptides corresponding to regions of SIVmac251 th a t  were 
predicted to have high antigenic index were synthesized; the  positions of 
these regions in  the  deduced amino acid sequence of SIVmac251 are 
indicated num erically in  the  upper region of panel A. T hree regions th a t  
were no t predicted to be antigenic are  also indicated num erically (near the 
m iddle of panel A); four peptides corresponding to these regions w ere also 
synthesized. The beginning of the TM protein is indicated by a  vertical line 
positioned betw een residues 527 and 528 of the SIVmac251 envelope 
polyprotein in  panel A, and by an  arrow in panels B,C, and D.
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(SAM69), 413-431 (SAM36), 452-481 (SAM52), 503-527 (RaMPS42), and  736- 
757 (SAM55) (Figures 11A & 12A).
Several peptides corresponding to regions of th e  SIV env polyprotein 
having  low antigenic poten tial b u t known to rep resen t antigenic regions of 
HIV-1 w ere also produced (Figures 11A & 12B). Two of these were 
overlapping peptides corresponding to the  pu tative  principle neu tra liz ing  
dom ain (PND) of SIV SU (S.D. Putney, personal communication), 313-336 
(RP92) and 323-345 (RP93), which span all b u t one residue of the  PND. A 
peptide constitu ting  the  im m unodom inant TM loop (Norrby et al., 1989) 
denoted SIV-M (597-619), w as also produced to provide a  broadly reactive 
peptide for com parative purposes. In  addition, a peptide corresponding to 
the  extrem e carboxy term inus of SIV TM designated SAM56 (852-879), 
w hich h as been im plicated as an  im portan t contributor to th e  cytopathicity 
of SIV (F isher et al., 1986; Lee et al., 1989; M iller et al., 1991; M iller and  
M ontelaro, 1991), w as also included in  these  studies; th is  peptide h as  also 
been show n to have high  am phipath ic po ten tial (E isenberg and  W esson, 
1990; M iller et al., 1991) and m ay therefore serve as a  T-cell de te rm inan t 
since T-cell epitopes a re  often am phipathic s tru c tu res  (M argalit et al. 1987; 
W ahren et al., 1989).
Several peptides corresponding to regions of SIV th a t  w ere predicted 
by the  AM PHI algorithm  (M argalit et al., 1987) to serve as T-cell epitopes 
were also synthesized (Fig. 2C). Each of these peptides, MR3 (env 81-105), 
MR4 (env 349-373), and  MR5 (env 434-458) correspond to regions of 
SIV/DeltaB670 SU. The resu lting  panel of peptides span  th e  en tire  env 
polyprotein and rep resen ts  nearly  44% of the  to ta l amino acid sequence,
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Figure 12. P r im a ry  A m ino A cid S equences o f S y n th e tic  P ep tid es . The 
p rim ary  am ino acid sequences of peptides synthesized to m im ic B-cell and  
T-cell epitope-containing regions of SIV a re  listed , and  th e ir  position in  the 
predicted env  polyprotein sequence is indicated num erically: (A) peptides 
corresponding to h igh antigenic index regions of SIVmac251, (B) peptides 
corresponding to low antigenic index regions of SIVmac251, and  (C) 
peptides corresponding to predicted T-cell epitopes of the  SIV/DeltaB670 
env polyprotein.
A Predicted B-cell Epitopes
Peptide Residue #s Linear Sequence
SAM42 env 46-66 n h 2-t k n r d t w g t t q c l pd n g d y se -c o n h 2
SAM35 env 112-143 NH2 -RCNKSQTDRWGLTKSSTTITTAAPTSAPVSEK-CONH2
SAM26 env 178-207 NH2 -KRDKTKEYNETWYSTDLVCEQRNSTDNESR-CONH2
SAM45 env 269-289 NH2-CETQTSTWFGFNGTRAENRTY-CONH2
SAM69 env 365-389 NH2 -CKHPRYTGTNNTDKINLTAPGGGDPE-CONH2
SAM36 env 413-431 n h 2-v e d k d v t t q r pk e r h r k n y -c o n h 2
SAM52 env 452-481 n h 2-l p p r e g d l t c n st v t sl ia n id w t d g n q t s-c o n h 2
RaMPS42 env 503-527 n h 2-eitpig l a pt d v k r y t t g g t sr n k r -c o n h 2
SAM55 env 736-757 n h 2-th tq q d pa l pt r e g k e g d g g e g -c o n h 2
B Potential B cell Epitopes With Low Antigenic Index
Peptide Residue #s Linear Sequence
RP92 env 313-336 NH2-CRRPGNKTVLFVTIMSGLVFHSQP-CONH2
RP93 env 323-345 NH2-PVnMSGLVFHSQPLTDRPKQAW-CONH2
SIV-M env 597-619 NH2-AIEKYLEDQAQLNAWGCAPRQVC-CONH2
SAM56 env 852-879 NH2-DLWETLRRGGRWILAIPRRIRQGLELTL-CC
c Predicted T-cell Epitopes
Peptide Residue #s Linear Sequence
MR3 env 81-105 n h 2-tvteqaiedvwnlfetsikpcvklt-c o n h 2
MR4 env 349-373 n h 2-ggsw kkaiqevketivkhprytgtn-c o n h 2
MRS env 434-458 n h 2-chirqivntw hkvgrnvylppregd-c o n h 2
73
including the TM41 region th a t is not present in  the truncated TM which 
prevails in  tissue culture-passaged SIV, bu t is contained in  the  TM th a t 
predom inates in vivo (Hirsch et al., 1989b).
Each of the peptides produced for these studies was synthesized, 
characterized, and purified as described in the  M aterials and Methods 
section. Following synthesis and cleavage from support resins, peptide 
preparations were characterized by m ass spectroscopy and the desired 
peptide component was purified via RP-HPLC. In each case, the  desired 
peptide product was purified to greater than  95% homogeneity according 
to analytical RP-HPLC (data not shown).
Each of the peptides corresponding to potential B-cell epitopes 
synthesized for these studies were made according to the SIVmac251 
sequence, while the putative T-cell epitopes reflect the SIV/DeltaB670 
sequence. There is considerable variability of envelope sequences among 
SIV isolates, and since differences in  peptide-specific reactivity displayed 
by members of the four monkey groups tested here could be due to either 
local sequence variations, or conformational differences between the 
envelope proteins of the different strains of virus w ith which these 
anim als are infected, analysis of derived SIVmac251 (Hirsch et al., 1987), 
SIVZDeltaB670 (LeRosa et al., 1992), SIVsm (Hirsch et al., 1989a), and 
SIVagm TYO-1 (Fukasawa et al., 1988) sequences was performed (Figure 
13). I t  should be noted th a t each of the anim als involved in  th is study are 
probably infected w ith relatively undefined m ixtures of virus, and 
therefore the sequences analyzed are merely representative of the
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Figure 13. S eq u en ce  v a ria tio n s  b e tw e e n  v a rio u s  SIV  iso la te s  w ith in  
re g io n s  c o rre sp o n d in g  to  p e p tid e  p a n e l. The sequences for SIVmac251 
(H irsch et al., 1987), SIV/DeltaB670 (LeRosa, m anuscip t in  p reparation ), 
SIV sm  (H irsch et al., 1989a), an d  SIV agm  TYO-1 (F ukasaw a et al., 1988) 
w ith in  th e  regions defined by th e  syn thetic  peptide panel a re  aligned. The 
pep tide  designation  an d  its  position  in  th e  SIVmac251 envelope sequence 
h as  been  no ted  above each alignm ent. Since the  syn thetic  pep tides w ere 
designed  according to th e  SIVmac251 sequence, a ll residues w hich v a ry  
from  th e  SIVmac251 sequence a re  ind icated  in  bold p rin t. In  several 
in stances, in se rtions o r deletions in  e ith e r  th e  SIV /D eltaB670, SIVsm , or 
SIV agm  TYO-1 sequences (w ith respec t to  SIVmac251) left gaps in  the  
a lignm ent; these  gaps have been  ind icated  using  dots.
SAM42 erw 46-66
SIV m ac251 NH2- TKNRDTWGTTQCLPDNGDYSE -C0NH2
S IV /D e lta B 6 7 0  NH2- TKNRDTWGTTQCLPDNGDYSE -C0NH2
SIVsm  NH2- TKNRDTWGTTQCLPDNSDYSE -C0NH2
SIV agm (T Y O -l) NH2- TPTTSLHAITNCIPDDHDYTE -CONH2
SAM 35 env 112-143
S IV m ac251 NH2- RCNKSETDRWGLTKSSTTITTAAPT...SAPVS.EK -CONH2
S IV /D e lta B 6 7 0  NH2- RCNKTETDKWGLTGHVTTTTTAAPTATA.. ,  .-CONH2
SIVsm
SIVagm  (TYO-1)
NH2- RCNKTETDRWGLTGKAjSTTTTAlmAT. .PSVAEN -CONH2 
NH2- HCVHHSTR1RATTPTIIPKSTCLPCVG..PTS.GZ -CONH2
SAM 28 erw 178-207
SIV m ac251 NH2- KRDKTKEY. NETWY5TDLV.CEQGNSTDNESR -CONH2
S IV /D e lta B 6 7 0  NH2- KRDKTKEY.NETWYSRDLI.CEQ.NTNXSESK -CONH2
SIVsm
SIV agm (TY O -l)
NH2- KRDKKKEY.NETHYSRDLI.CEQ.SABXSESK -CONH2 
NH2- VRDOKKBYYSWHBDAIIXCKHKINSTSKE.. -CONH2
8AM 45 erw 269-289
SIV m ac251 NH2- METQTSTWFGFNGTRAENRTY -CONH2
S IV /D e lta B 6 7 0  NH2- METQTSTWFGFNGTRAENRTY -CONH2
SIVsm  NH2- METQTSTWFGFNGTRAENRTY -CONH2
SIVagm (TYO-1) NH2- MHTTVTICLLLNGSYBENRTQ -CONH2
R P 92  313-336
S IV /m ac2 5 1  NH2- CRRPGNKTVLPVTIMSGLVFHSQP -CONH2
S IV /D e lta B 6 7 0  NH2- CRRPGNKTVLPVTIMSGLVFHSQP -CONH2
SIVsm NH2- CRRPINKTVLPVTIMSGLVFHSQP -CONH2
SIV agm (T Y O -l) NH2- CRRPGNKTVLPVTIMAGLVFHSQK -CONH2
SIV m ac251
R P93 erw 323-345
NH2- PVTIMSGLVFHSQPLTDRPKQAW -CONH2
S IV /D e lta B 6 7 0  NK2- PVTIMSGLVFHSQPIHKRPKQAW -CONH2
SIVsm NH2- PVTIMSGLVFHSQPUHRPKQAW -CONH2
S IV agm (T Y O -l) NH2- PVTIMAGLVFHSQKYMTR1KQAW -CONH2
SAM 69 env 3654589
S IV m ac2S l NH2- VKHP..RYTGTNNTDKINLTAPGGGDPE -CONH2
S IV /D e lta B 6 7 0  NH2- VKHP. .RYTGTNDTKKINLTAPRGGDPE -CONH2
SIVsm NH2- VKHP. .RYTGTNDTRKINLTAPAGGDPE -CONH2
SIV agm (T Y O -l) NH2- VKLPKDRYKGTNNTIHIYLQRQW.GDPE -CONH2
SAM36 env 413-131
SIV m ac251 NH2- VEDKDVTTQRPKERH. .RK .
S IV /D e lta B 6 7 0  NH2- VEDKDVTTQRPKERH RK.
..N Y  -CONH2 
..N Y  -CONH2
SIVsm
SIV agm (TY O -l)
NH2- VEDRDQKGGRN-'QQB RK1QQ1KNY -CONH2
NH2- DAYHNTCBSKKKCHAPCPCV QR.TY -CONH2
SAM 52 env 452-481
SIV m ac251 NH2- LPPREGDLTCNSTVTSLIANIDWTDGNQTS -CONH2
5 IV /D e lta B 6 7 0  NH2- LPPREGDLTCNSTVTSLIANIDWIDGNQTH -CONH2
SIVsm  NH2- LPPREGDLTCNSTVTSLIA1IDH1HSN1TN -CONK2
SIVagm (TYO-1) NH2- APPREGHLQCRSTVTGMTVZLNYNSKNRTN -CONH2
IU M P S 42 erw 503-527
SIV m ac251 NH2- EITPICLAPTDVKRYTTGGTSRNKR -CONH2
S IV /D e lta B 6 7 0  NH2- EITPIGLAPISVRRYTTTGASRNKR -CONH2
SIVsm NH2- EITPIGLAPTSVRAYTTTGASRNKR -CONH2
SIVagm (TYO-1) NH2- EITPIGPAPT1VHRYT.GGH1RQKR -CONH2
SIV-M  env 597-619
S IV m ac2S l NH2- AIEKYLEDQAQLNAWGCAFRQVC -CONH2
S IV /D e lta B 6 7 0  NH2- AIEKYLKDQAQLNSWGCAFQWC -CONH2
SIVsm NH2- AIEKYLKDQAQLNSWGCAFRQVC -CONH2
SIVagm (TYO-1) NH2- ALEKYLEDQARLNSWGCAMXQVC -CONH2
SAM 55«u> 736-757
S IV nac251  NH2- THTQQD.PALPTREGKEGDGGEG -CONH2
S IV /D e lta B 6 7 0  NH2- IP1HKG.Q1PPTKEG1EGDGGD1L -CONH2
SIVsm  NH2- TPIHKQ.KMPTKEGIEGDGGDJl -CONH2
SIV agm (T Y O -l) NH2- IHIHQV5KGRPDBADIPG1GGDH -CONH2
SAM56 env 852-879
SIV m ac251 NH2- DLWETLRRGGRWILAIPRRIRQGLELTL -CONH2
S IV /D e lta B 6 7 0  NH2- DLWETLSKVGRKVLAIPRRIRQGLELTL -CONH2 
SIVsm  NH2- DIWETLGKYGRGILAIPRRIRQGLELTL -CONH2
SIV agm (TY O -l) NH2- QIN1ACRMYRNIVHSPRRVRQGLEIIL -CONH2
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predom inant infecting s tra in  of each panel. The resu lts  of these analyses 
are  discussed below.
Site-directed serology.
Serum  panels from experim entally infected m acaques (infected 
w ith SIV/DeltaB670 or SIVmac) and infected b u t asym ptom atic 
m angabeys and  African green m onkeys (AGMs) were screened for 
peptide-specific antibody by P-ELISA using each of the  peptides as antigen 
substra te . Each screening was perform ed in  quadruplicate using  te s t 
serum  dilutions of 1:50. A panel of 14 sera  from uninfected an im als were 
also screened for purposes of comparison. A positive reaction was defined 
as any absorbance value g rea ter th an  th ree  tim es the  average of the  
norm al serum  values. The resu lts  of these  screenings a re  sum m arized in  
Table 1 and Figure 14.
Peptide-specific im m une responses in  in fected  m onkeys.
W hile all of the  peptides in  th is panel were recognized by a  num ber 
of the monkey sera tested, five broadly reactive determ inants of th e  SIV 
env polyprotein were identified. The SIV-M, RP92/RP93, and RaMPS42 
peptides, which correspond to reportedly im m unodom inant regions of 
HIV-1 and HIV-2, each reacted w ith a h igh  percentage (50-90%) of the  sera 
tested. In  addition, the  two regions of SIV envelope corresponding to 
SAM35 and  SAM26 display an  in term ediate  reactiv ity  of about 40% w ith 
the  serum  panels. M ost of the  rem aining peptides, SAM69, SAM56, 
SAM36, SAM42, SAM45, and  SAM52 appear to rep resen t type specific 
determ inants as they  react w ith a  significant percentage o f m em bers of
Table 1. Immunological reactivities of SIV env peptide panel vs. monkey serum panels as measured by P-ELISA
SIVmac env polyprotein-speciflc peptides
Serum Panel3 External Envelope Protein (SU) Transmembrane Protein (TM)
SAM42 SAM35 SAM26 SAM45 RP92 RP93 SAM69 SAM36 SAM52 RaMPs42 SIV-M SAMS5 SAM56
macaque (21)
(SIV/Delta) 33b 43 57 29 81 48 5 19 33 38 100 0 33
macaque (15) 
(SIVmac) 13 60 67 67 40 27 73 93 13
mangabey (26) 4 46 27 77 65 42 12 35 96 15 65
African green (48) 
monkey 15 33 25 85 52 17 25 23 81 15
Overall (110) 15 42 37 8 80 53 15 15 20 36 90 12 25
a source species with number of serum samples In parentheses 
b reactivity values listed as percentage of sera yielding positive reactions
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Figure 14. R e ac tiv ity  o f  m o n k ey  se ru m  p a n e ls  a g a in s t sy n th e tic  p e p tid e s  
c o rre sp o n d in g  to  p u ta t iv e  B-cell ep ito p es o f  SIV  env  p ro te in s . Peptide- 
specific Ab responses produced by 5 d ifferent m onkey te s t  g roups w ere 
m easu red  v ia  P-ELISA. A570 va lues obtained  from  each an im al screened 
in  these  stud ies a re  p lo tted  according to th e  te s t  group. E ach peptide w as 
screened a g a in s t 14 non-infected control an im als o (1st line), 2 1  SIV /D elta
infected m acaques ♦ (2nd line), 15 SIVmac infected m acaques a  (3rd  line), 
26 n a tu ra lly  infected m angabeys + (4 th  line), an d  48 n a tu ra lly
infected  A frican g reen  m onkeys A (5 th  line) o f each figure panel. A 
positive reaction  is  defined as any A570 value h igher th a n  th re e  tim es th e  
average of th e  control se ra  values (th is value is  indicated  by a  s tra ig h t line  
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one serum  panel, b u t a  low percentage of m em bers of the  o ther serum  
p an e ls .
F ou r of the  broadly reactive peptides ap p ea r to rep resen t group 
specific d e te rm in an ts  of the  SIV envelope pro tein . SIV-M, w hich 
rep resen ts  the  "im m unodom inant TM loop" of SIV (Norrby et al., 1989), 
w as recognized by 91% of all se ra  tested . The in ten sity  of anti-SIV-M  
responses w as typically h igher th a n  th a t  detected  for any  of th e  o ther 
pep tides in  th is  study  (Figure 14). As show n in  F igure  13, th e  p rim ary  
am ino acid sequence w ith in  the  region corresponding to SIV-M is  well 
conserved am ong various iso lates of SIV. S im ilarly , th e  two overlapping 
pep tides which span  th e  PND of SIV SU  also reacted  w ith  a  h igh  
percen tage of sam ples from  each m onkey se ra  panel, consisten t w ith  
observations m ade for HIV-2 (Norrby et al., 1991). M ost of th e  reactiv ity  to 
th is  region appears to be directed tow ard th e  am ino h a lf  of th e  PND as a  
h igher percentage of an tise ra  contained antibodies to RP92 (80%) th a n  to 
RP93 (53%) (Table 1, F igure 14). Again, as would be expected for a  group- 
specific de te rm inan t, the  am ino acid sequence of th e  pu tative  PND 
appears to be highly  conserved (Figure 13) Two peptides corresponding to 
regions w ith in  th e  am ino term ina l one th ird  of SU, SAM35 an d  SAM26, 
w ere recognized by 42% and  37% of the  se ra  tested , respectively. Since 
SAM35 and  SAM26-specific Ab responses were produced by a  sim ilar 
percentage of an im als from each te s t group (Table 1), an d  th e  in tensitie s  of 
these  responses w ere sim ilar w ith in  each te s t  group (Figure 14), these  two 
pep tides ap p ea r to rep resen t group-specific d e te rm in an ts  of SIV.
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In teresting ly , both of these regions appear to have a  m uch h igher degree 
of overall sequence varia tion  th a n  observed for SIV-M or the  PND.
The RaM PS42 peptide, which encom passes th e  carboxyl end of SIV 
SU, is  recognized by a significant num ber of each sera  panel, b u t i t  
appears to rep resen t a  type specific antigenic d e te rm in an t of SIV. This 
peptide w as recognized by 73% of th e  SIVmac-infected an im als, b u t by  only 
38% o f SIV/Delta-infected m acaques, 35% of infected sooty m angabeys, and  
23% of the  infected African green monkeys tested . In terestingly , the  
p rim ary  am ino acid sequence w ith in  th is  region is a lm ost iden tical 
betw een the  represen ta tive  SIV/DeltaB670 (73% reactive) an d  SIVsm  (35% 
reactive) isolates (Figure 13). The resu lts  reported  here ap p ea r to  be 
consisten t w ith  observations being m ade elsew here. The carboxy term inal 
region of HIV-1 (Palker et al., 1987), HIV-2 (Norrby et al. 1991), SIVmac 
(Baillou et al., 1991) and EIAV (Ball et al., 1992) have previously been 
reported  to be broadly reactive. In  addition, a  recen t repo rt by  Baillou et al. 
(1991) suggested th a t  th is  region m ay d istingu ish  subtypes am ong 
len tiv iruses, including HIV-1, HIV-2, and  SIV.
Several of th e  o ther peptides tested  appeared  to rep resen t species- 
specific epitopes as they were recognized by a  relatively  high  percentage of 
one or more of the  te s t serum  panels, b u t few or none of a t  le a s t one panel. 
F o r instance, 42% of the  se ra  from naturally-infected  m angabeys 
contained SAM69-specific Ab while very few of th e  rhesus or African 
green  m onkeys produced SAM69-specific Ab (Table 1). I t  is in te res tin g  
th a t  so few of th e  m acaques recognized th is  peptide as th e  p rim ary  
sequence of SIVmac251 and  SIV/DeltaB670 a re  very  sim ila r to SIVsm
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w ith in  the  SAM69 region (Figure 13). Sim ilarly, SAM56-specific Ab w as 
produced by 65% of the  m angabey panel and  33% of th e  SIV/Delta-infected 
m acaques, b u t by very  few of the  anim als in  the  o ther te s t  groups (Table 1). 
Again, the  SIVmac251, SIV/DeltaB670, and  SIV sm  sequences a re  m ostly 
conserved w ith in  th e  region defined by SAM56 (Figure 13). W hile 
relatively  high  tite r  SAM36-specific responses were produced by 27% of 
SIVmac251-infected m acaques, only 13% of th e  o th er an im als tested  
recognized th is  peptide (Figure 14; Table 1). In  contrast, 33% of th e  
SIV /D elta-infected m acaques m ade SAM42-specific responses, b u t the  
in tensity  of these responses was relatively  low. O nly a  sm all percentage of 
th e  o ther te s t  groups produced SAM42-specific responses. Sim ilarly, 33% 
of SIV/Delta-infected m acaques and  25% of AGMs produced anti-SAM 52 
antibodies, b u t few of the  an im als from th e  rem ain ing  te s t  groups m ade a 
sim ila r response. SAM55-specific responses w ere m ade in  only a  low 
percentage of each m onkey group and  the  in ten sity  of th ese  responses 
w ere relatively  low.
Peptides corresponding to predicted T-cell epitopes (F igure 12C) 
w ere also employed as an tigen  in  P-ELISA for screening of th e  four 
m onkey se ra  panels. T-cell de te rm inan ts  a re  typically  am phipath ic  a - 
helical pro tein  segm ents (M argalit et al., 1987; W ahren  et al., 1989) th a t  
have low surface probability and  generally  do no t serve as B-cell epitopes 
(W ahren et al., 1989, Schrier et al., 1989). As expected, very few of the  te s t 
an im als produced Ab specific for any  of these  peptides (Table 2). In  fact, of 
th e  110 anim al se ra  tested , only one recognized MR3 w hile two reacted 
w ith  MR4 and  two others reacted  w ith  MR5.
Table 2. Immunological reactivities ofputative T-cell epitopes;
SIV env peptide panel vs. monkey serum panels as 
__________ measured by P-ELISAa_________________________
SIV/DeltaB670 specific peptides







African green (48) 
monkey 0
“reactivity values are listed as percentage of sera 
tested ( )b yielding positive reactions
M
Rabbit peptide-specific antisera characterization.
Rabbit an tisera  were raised to each of the  putative B-cell epitopes 
described in  th is study. Approximate tite rs  of peptide-specific an tisera  
were m easured via P-ELISA and each of the tite rs  were a t  least 1:10,000 
(Table 3). Using standard  ELISA procedures, each of the  sera were also 
screened against whole SIV/DeltaB670, baculovirus-expressed 
recom binant SIV/DeltaB670 gpllO  and gpl40, and  baculovirus-expressed 
recom binant SIVmac251 gpl40, to determ ine relative tite rs  and  specificity 
of the an tise ra  w ith respect to whole SIV proteins (Table 3). Each of the 
an tise ra  specifically recognized a t least one of the  SIV antigens (Table 3). 
Results obtained from W estern blotting of these sera against the  same 
panel of antigens confirmed th a t the rabbit an tise ra  specifically recognize 
SIV envelope proteins (data not shown).
U sing standard  in vitro neutralization assays and neu tralization  
blocking assays, the ability of each of these peptides to induce neutralizing 
im m une responses were also examined. None of these peptides, including 
RP92 and RP93, were able to elicit neutralizing Ab in  rabbits, and  none of 
them  were able to block neutralization by a reference neutralizing 
m acaque an tisera .
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Table 3. Immune Reactivities of rabbit anti-peptide antisera
ELISA"
SIVAB670 SIVmac251
Peptide An»iserac Peptide'* W.V.' RgpllOf £gp!4Qg Rgpl40
SA M 42(<m > 46-66) > 1 0 5 1 0 2 1 0 2 1 0 3 1 0 2
SA M 35(em > 112-143) > 1 0 5 1 0 2 neg. 1 0 3 1 0 4
S A M 2 6  (env  178-207) > 1 0 4 1 0 2 1 0 3 1 0 3 1 0 3
S A M 4 S  (env  269-289) > 1 0 s neg. neg. 1 0 2 neg.
S A M 6 9  (env  365-389) V N-
t
o u
* neg. 1 0 2 1 0 3 1 0 3
S A M 3 6  (env 413-431) > 1 0 5 1 0 2 neg. 1 0 2 1 0 4
S A M 5 2  (env 452-481) 1 0 5 neg. 1 0 2 lo3 1 0 2
R aM P S 4 2  (env  503-527) > 1 0 6 neg. 1 0 4 1 0 4 1 0 4
S IV -M  (env  597-619) > 1 0 5 1 0 2 lO 2 1 0 4 1 0 3
S A M 5 5  (env 736-757) > 1 0 4 1 0 2 neg. lO2 neg.
S A M 5 6  (env 852-879) 1 0 5 1 0 2 neg. neg. neg.
a values represent titer detected via ELISA using a 10-fold dilution series 
b rabbit anti-pcptide antiscra specific for indicated peptide 
c rabbit anti-peptide antibody titer; homologous peptide 
d gradient-purified SIV/DeltaB670 whole virus 
" baculovirus-expressed recombinant gpllO 
f  baculovirus-expressed recombinant gpl40
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D iscussion
Serum  sam ples from four d ifferent m onkey te s t  groups were 
analyzed via site-directed serology in  the  studies p resen ted  here. Two of 
these  te s t groups were composed of sym ptom atic m acaques infected w ith 
SrVZDeltaB670, or SIVmac251. Both of these v irus isolates were originally 
obtained from infected m acaques. The nucleotide sequence of SIVmac251 
h as been known for some tim e while th e  SIV/DeltaB670 sequence was 
obtained very  recently  (LeRosa, m anuscrip t in  preparation); th e  derived 
am ino acid sequences of these two SIV iso lates a re  quite  sim ilar. The 
m angabey m onkeys used for th is  s tudy  were all obtained from  Yerkes 
Regional P rim ate  R esearch C enter and  i t  is reasonable to assum e th a t  
they  are  all infected w ith re la ted  s tra in s  of SIV; th e  sequence of a v irus 
isolate (SIVsm) isolated from one of these m onkeys a t  D elta Regional 
P rim ate  C en ter h as  been reported and  shown to be very  sim ilar to SIVmac 
(H irsch et a l.,1989a). The African green monkeys used  for th is  study  have 
been obtained from m any sources, both  African and A sian, and  m ay be 
infected w ith  highly divergent s tra in s  of SIV (B aier et a l., 1990). Infected 
m angabeys and AGMs are  in ap p a ren t carriers  of SIV and  never suffer 
from  disease symptoms. I t  is also im portan t to note th a t  serum  sam ples 
w ere collected from  anim als a t various poin ts during  disease progression 
or in ap p a ren t infection.
These studies have identified several regions of the  SIV env  
polyprotein th a t  appear to contain conserved epitopes o f the  env 
glycoproteins. S im ilar to HIV-1 and  HIV-2, SIV contains broadly  reactive
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epitopes near the NH2-term inus of TM (SIV-M), w ithin th e  PND 
(RP92/RP93), and a t  the extreme carboxy term inus of SU (RaMPS42).
There are  also two regions near the amino term inus of SU, defined by 
SAM35 and  SAM26, which appear to be broadly reactive. Interestingly, 
none of these regions of SIV SU and TM appear to be highly conserved 
w ith respect to prim ary sequence (Figure 13) indicating th a t  th e  overall 
struc tu re  of SU and TM are relatively well conserved leaving these regions 
accessible to the  im m une system  despite variations in  prim ary  sequence.
These studies have also identified regions w ithin SIV SU (defined by 
SAM69, SAM36, SAM42, and SAM52) and  TM (defined by SAM56, and 
SAM55) th a t  appear to elicit species-specific hum oral responses. 
Interestingly, SAM69 and SAM56-specific responses were produced by a  
high percentage of naturally-infected asym ptom atic m angabey monkeys, 
b u t were produced by only a  low percentage of the  rem aining monkey test 
groups. W hile the  SIVagm TYO-1 sequence appears to be quite different 
from the o ther SIV isolates in  these regions, the sequence variation 
betw een SIVmac251, SIV/DeltaB670, and SIVsm in  these regions is 
m inim al and is probably not responsible for the  differences in  im m une 
recognition by the different serum  panels. Although the  in tensities of 
these particu lar im m une responses is relatively low, these  populations of 
Ab m ay play a  critical role in  control of SIV which prevents disease 
progression in  m angabey monkeys infected w ith the virus.
One of the predicted B-cell determ inants, SAM55, appears to 
represen t a region of the  TM, th a t is buried and inaccessible to host 
hum oral im m une responses. Only 12% of the infected monkeys m ade
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SAM55-specific Ab, and  anti-SAM55 rabbit an tisera  reacted poorly w ith 
SIV proteins in  ELISA (Table 3) and W estern analyses (data not shown). 
H ost hum oral im m une responses to the region of TM defined by th is 
peptide are  probably inconsequential w ith respect to infection.
Recently there  have been several reports describing vaccine 
protocols th a t elicit protection against lentiviral infection (Murphey-Corb 
et al., 1989,1991; Desrosiers et al., 1989; Issel et al., 1992). Although i t  is 
unclear w hether protection is a  resu lt of hum oral and/or cellular 
responses, a  recent study revealed th a t passive transfer of anti-HIV-2 or 
anti-SIV  an tise ra  resulted  in  protection of cynomolgus m onkeys from 
HIV-2 or SIV infection, respectively (Putkonen et al., 1991). These resu lts 
suggest th a t  hum oral im m une responses alone m ay be sufficient to 
protect against lentivirus infections. E valuating the kinetics of specific 
im m une responses of SIV-infected verses protected m onkeys resu lting  
from vaccine tria ls  m ay allow the identification of critical antigenic 
determ inants of SIV. I t  will be in teresting to evaluate the  kinetics of 
peptide-specific Ab responses in  longitudinal serum  sam ples from 
protected and unprotected vaccinates (Murphey-Corb et al., 1989,1991) to 
determ ine w hether any site-specific hum oral im m une responses correlate 
w ith protection.
Evidence th a t HIV-1 and other lentiviruses cause mis-direction of 
hum oral im m une responses is mounting. The resu lts  reported here 
reveal th a t Ab specific for a t least three regions of the  envelope proteins 
(defined by SIV-M, RP92/RP93, and RaMPS42) are  produced very soon after 
infection and persist throughout disease progression. Since anim als
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succum b to disease despite  these  responses, i t  ap p ea rs  th a t  Ab specific for 
th ese  epitopes m ay no t be requ ired  for a n  an im al to m oun t protective 
im m une responses. In  fact, some specific Ab populations have been 
show n to be de trim en ta l to the  host. T here have been  several repo rts  th a t  
HIV-specific Ab can cause enhancem ent o f infection (Robinson et a l., 1988; 
Hom sy et al., 1988, 1990; Takeda et al., 1988). Zolla-Pazner and  associates 
have repo rted  th a t  Ab specific for th e  im m unodom inant TM  loop region of 
HIV-1 can lead  to increased  infectivity in  vitro  (Zolla-Pazner et a l., 1990). I t  
h a s  also been  show n th a t  v iruses som etim es induce au to im m un ity  by 
m olecular m im icry (Fujinam a and  O ldstone, 1989). R ecently  i t  w as 
reported  th a t  a  MAb directed  tow ard a  syn thetic  pep tide  corresponding to 
th e  im m unodom inan t TM loop region of HIV-1 cross reac ts  w ith  
astrocy tes an d  th a t  antibodies specific to th is  region of H IV  m ay  be 
responsib le for th e  neuronal d isorders experienced by  some AIDS p a tien ts  
(Y am ada et al., 1991). Im m unization  of m onkeys w ith  peptide-based  
vaccines m ay red irec t im m une responses re su ltin g  in  a  m in im ization  of 
deleterious Ab production and  a n  a lte red  ra te  o f d isease  progression  
following challenge w ith  pathogenic v irus.
T hese stud ies have identified  several hum oral an tigen ic  
d e te rm in an ts  of SIV. T hree of the  broadly  reactive B-cell epitopes 
iden tified  du rin g  these  stud ies a re  located in  regions very  s im ila r to  those 
iden tified  in  HIV-1, HIV-2, and  EIAV th u s  d em o n s tra tin g  im m unological 
s im ila rities betw een th e  glycoproteins of each of th ese  len tiv iruses. These 
s tud ies have also identified  type-specific hum oral responses th a t  m ay 
correlate  w ith  protection from disease progression. T he pep tides used  for
90
site-directed serology in  these studies a re  curren tly  being employed as 
subun it vaccines to  evaluate th e ir  ab ility  to m odulate th e  k inetics of 
im m une responses and  a lte r th e  outcome of disease progression in  
m acaques. By identify ing group and  type-specific an tigenic de te rm inan ts 
of the  SIV env  p ro teins, these studies have laid  the  groundw ork for 
thorough evaluation  of hum oral im m une k inetics in  vaccinated an im als 
th a t  have been protected from  SIV infection.
CH A PTERS
CYTOPATHICITY OF LENTIVTRUS TRANSMEMBRANE
PROTEINS
Introduction
The fate of any  virally-infected host can be influenced by 
physiological and  environm ental conditions, b u t i t  u ltim ately  depends on 
the  v irus-host cell combination. For exam ple, i t  m ay be possible to 
a ttr ib u te  th e  differential fates of oncovirus and len tiv irus infections to 
th e ir  respective ta rg e t cells, since oncoviruses usually  infect lym phocytes, 
w hile len tiv iruses typically infect cells from th e  m onocyte-m acrophage 
lineage (H aase, 1986). However, lymphocytes are  also a  n a tu ra l ta rg e t cell 
for certa in  len tiv iruses, including th e  im m unodeficiency v iruses of m an  
(HIV-1), nonhum an  p rim ates (SIV), cattle  (BIV), and  cats (FIV). 
Therefore, th e  d ifferential outcome of len tiv irus and  oncovirus infections 
of a  common ta rg e t cell population suggests th a t  th e  cytopathology 
characteristics a re  indeed in trin sic  to th e  virus.
M any researchers have a ttem pted  to characterize  th e  m echanism s 
th a t  a re  responsible for differing biological properties betw een oncoviruses 
and  len tiv iruses. M uch of th is  research  is based on th e  novel genetic 
content and  complex p a tte rn s  of gene regulation  th a t  have been  observed 
in  len tiv iruses (Peterlin  and Luciw, 1988; Sodroski et al., 1986). O thers 
have concentrated th e ir  efforts on s tru c tu ra l com ponents of th e  v iru s th a t  
m ay contribute to cytopathicity since envelope pro teins of several different
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viruses have been shown to m ediate a variety of cytotoxic effects, such as 
fusion, syncytium formation, and cell killing (Rasheed et al., 1986; P in ter et 
al., 1986; C h a tte lee  and H unter, 1970; Nagy et al., 1983; Redmond et al.,
1984) during infection of target cells. By m easuring m em brane 
perm eability of HIV-infected cells to Ca2+ and glycerol, Cloyd and Lynn 
(1991) have shown th a t  a  prim ary mechanism  of HIV-1 cytopathicity 
appears to be perturbation  of host cell m em branes by the  insertion of virus 
coded envelope proteins. In  addition, purified retrovirus transm em brane 
(TM) proteins have previously been reported to be fusogenic (Gallaher, 
1987), cytopathic (Garry et al., 1988), and imm unosuppressive (Cianciolo et 
al., 1985; Cianciolo et al., 1986; M athes et al., 1978) to cultured cells. Due to 
th e  documented abilities of retrovirus TM proteins to a lte r critical 
m em brane properties and the obvious requirem ent for in tim ate  
in teraction between TM proteins and host cell m em branes, m any 
investigators a re  concentrating the ir studies on retrovirus TM proteins.
Detailed comparative analyses of retrovirus TM proteins have 
revealed strik ing  struc tu ra l sim ilarities, although there  are  only 
negligible degrees of sequence identity reported for the different viruses. 
According to secondary structure  predictions, G allaher and  associates 
have proposed a  common structural m otif for the  amino term inal 
extracellu lar portion of lentivirus and oncovirus TM proteins; th is  
struc tu re  appears to resemble the structure of the influenza HA2 protein 
th a t  has been determ ined by x-ray crystallography (G allaher et al., 1989). 
This model can be used to identify several im portant correlations betw een
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TM struc tu res and functions, eg., antigenicity, m em brane anchoring, and  
binding to the viral surface glycoprotein (SU).
In  contrast to the  structural sim ilarities observed in  the amino 
term inal portion of the various TM proteins (Gallaher et al., 1989), careful 
exam ination of the carboxyl h a lf of the  TM molecules failed to reveal a 
common struc tu ra l m otif for oncoviruses and lentiviruses. However, one 
d istinct s truc tu ra l domain was observed in lentiv irus TM proteins th a t 
was absen t in  oncovirus TM molecules. This characteristic  len tiv irus TM 
domain consisted of strong am phipathic helices w ith the special feature  of 
an  unusually  high and distinctly organized clustering of positively 
charged residues, predom inantly arginines. This chapter deals w ith  the 
properties of am phipathic helices and the work th a t we have done 
suggesting an  im portant role for the  am phipathic sequence n ear the  
carboxyl term inus of lentivirus TM proteins.
The am phipathic helix  m otif.
X-ray crystallography, nuclear m agnetic resonance (NMR), and  
circular dichroism studies of soluble proteins rem ain  the  only reliable 
m ethods for determ ining the  exact secondary struc tu re  conformations 
formed w ithin polypeptides. Results from these studies have yielded a  
large database of inform ation regarding the propensity of different amino 
acids for residing in  certain secondary structures th a t  allow the  prediction 
of secondary structure  from prim ary amino acid sequences. Due to the 
difficulties involved in  obtaining quantities of purified m em brane- 
associated proteins, the physical properties of m em brane proteins th a t  
prevent crystallization, and the difficulties in  working w ith these proteins
outside o f an  aqueous m ilieu, few of these  p ro teins have been 
characterized  a t  th e  level of atom ic struc tu re . Since th e  m ost reliab le  
m ethod  c u rren tly  availab le  for p redicting  secondary s tru c tu re s  w ith in  
p ro te in s is  based  on com parisons d raw n  from  h igh-reso lu tion  s tru c tu ra l 
de te rm ina tions of homologous pro teins, to d a te  th e re  is  no dependable 
m ethod  for p red ic ting  m em brane p ro te in  s tru c tu re s  from  p rim ary  
sequence d a ta . However, several basic s tru c tu ra l them es th a t  can be 
app lied  to  p ro te in  s tru c tu ra l m odels have em erged th ro u g h  m em brane 
stud ies. The f irs t is  th a t  any  segm ent of a  p ro tein  consisting of 
approxim ately  20 residues and  hav ing  a h igh  average hydrophobicity  is  
likely  to form  a  tran sm em b ran e  a-helix (E isenberg, 1984; E ngelm an  e t al., 
1986; K aiser and  Kezdy, 1987); however, th ree  dim ensional electron 
m icroscopy im age reconstruction  analyses of E. coli porin  p ro te ins have  
revealed  th a t  hydrophilic regions can also trav e rse  lipid b ilayers (P au l and  
Rosenbusch, 1985). In teresting ly , there  appears to be a  b ias tow ard hav ing  
a  p ro line  res id u e  w ith in  m em brane-spann ing  regions o f tran sm em b ran e  
p ro te ins even though  proline is know n to destabilize a-helical s tru c tu re s  
folding in  aqueous env ironm ents (Chou and  F asm an , 1974). Since th e  
cyclic side chain  o f proline cannot form  a  hydrogen bond w ith  th e  residue  
in  th e  preceding  tu rn , i t  is postu la ted  th a t  these  residues a re  le ft availab le 
for hydrogen bonding w ith  o ther m onom ers of th e  p ro te in  o r w ith  o ther 
dom ains o f th e  sam e p ro te in  molecule; th is  type in te rac tio n  w ould favor 
th e  form ation o f oligom ers or stab le  te r tia ry  s tru c tu res , respectively  (Deber 
et al., 1986; B rand i an d  Deber, 1986). The second basic them e concerns any  
a-helical reg ion  in  w hich th e  hydrophobic side chains p a rtitio n  on one
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face of th e  helix  w hile the  hydrophilic side chains segregate  on th e  
opposite helical face; th is  type of s tru c tu re  is  designated  a n  am phipath ic  
a-helix . T hese am ph ipath ic  helical s tru c tu re s  ten d  to seek m em brane 
in te rac tions an d  a re  frequently  m em brane associated (K aiser an d  Kezdy, 
1987; E isenberg  et al., 1984). In  addition, th e re  is a  large  am ount o f ind irect 
evidence th a t  suggests th a t  am ph ipath ic  helices often sp an  m em branes as 
agg regates in  w hich th e  hydrophobic faces of th e  m u ltim ers  in te ra c t w ith  
th e  lip id  b ilayer w hile the  hydrophilic faces form  a  stab le  pore (F igure 15) 
th a t  m ay  allow flow of w ater and  electrolytes across th e  cytoplasm ic 
m em brane (K aiser and  Kezdy, 1987; E isenberg et al., 1984; L ear et al., 1988). 
Therefore, in  th e  absence of m ethodology th a t  enables defin itive s tru c tu ra l 
ch arac te riza tio n  of in teg ra l m em brane pro teins, th e re  is  an  abundance of 
ind irec t evidence th a t  allows investigato rs to apply  these  general them es to 
p rim a ry  am ino acid sequences, re su ltin g  in  theo re tica l approx im ations of 
secondary s tru c tu re . These proposed secondary s tru c tu re  m odels can 
th e n  be re la ted  to specific biological consequences, th u s  fac ilita ting  
experim ental design th a t  can  be used  to te s t  these  m odels.
M ethods for p red ictin g  am phipathic h elica l structures.
W ith  th e  adven t of com puter a lgorithm s w hich req u ire  only 
p rim ary  sequence d a ta  as inpu t, th e  identification  of regions w ith in  a  
p ro te in  th a t  have h igh  po ten tia l to form  am phipath ic  a -helical secondary 
s tru c tu re s  h a s  become a  rap id  process. A m phipath ic helical s tru c tu re s  
a re  am ong th e  m ost conspicuous of secondary s tru c tu ra l e lem ents as they  
a re  large ly  composed of a hydrophobic face and  a  p rim arily  hydrophilic 
face due to a  charac teristic  periodicity o f hydrophobic an d  hydrophilic
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Figure 15. M odel o f  a  tra n sm e m b ra n e  p o re  fo rm ed  b y  a  m u lt im e r  o f  a n  ot- 
h e lic a l a m p h ip a th ic  p e p tid e . Two different views of a  m ultim er of an 
am phipath ic  peptide as i t  forms a  transm em brane  pore. E ach  peptide 
m onom er is rep resen ted  as a  cylinder; the  hydrophilic am ino acid side 
chains a re  segregated to one side of the  helix (shaded) w hile th e  
hydrophobic am ino acid side-chains are  segregated on th e  opposite face of 









residues. The am phipathic property of helical structures can be 
graphically dem onstrated using "helical wheel" d iagram s (Schiffer and 
Edmondson, 1967) or the helical ne t or grid representation (Lim, 1978). 
P reparing  these type diagram s is a simple m ethod for visualization of 
am phipathic potential, b u t they are lim ited in  th a t  they often over-estimate 
am phipathicity (Flinta et al., 1983) and they are too tedious for application 
to long sequences. A more quantitative m ethod for identification of 
am phipathic helical protein segm ents, designated the  "helical 
hydrophobic moment" (Eisenberg et al., 1982), has been developed as a 
com puter algorithm  th a t  expresses am phipathicity e ither num erically or 
graphically. The "Eisenberg plot" not only identifies am phipathic 
segments, bu t additionally i t  has lim ited ability to differentiate between 
different types of am phipathic structures (i.e. transm em brane helices, 
lipid associated helices, receptor-binding helices, etc.) according to 
characteristic  hydrophobicity and hydrophobic m om ent values common to 
these type structures. Another com puter algorithm  based on sim ilar 
param eters, designated "Amphi", scores the potential of protein segm ents 
to form am phipathic helical structures; th is  program  was in itially  
designed to identify im m unodom inant T cell epitopes since there  is a  good 
correlation betw een am phipathicity and T-cell im m unogenicity (M argalit 
et al., 1987). While new algorithm s for identification of am phipathic 
peptide segm ents w ithin proteins are still being developed, there  is a  full 
range of methods currently in  use th a t enable investigators to detect 
am phipathic helical domains from prim ary  sequences.
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B iological sign ifican ce o f am phipathic h elices.
A large  body of evidence suggests th a t  th e  am ph ipath ic  a-he lical 
secondary  s tru c tu re  m otif is critical for cellu lar im m une recognition. 
T here  have been several reports th a t  the  antigenic en tity  for T-cell 
recognition is  a  peptide fragm ent derived from  th e  whole p ro te in  
(Berzofsky, 1980; Benacerraf, 1978; Berzofsky, 1987); i t  has  also been 
reported  th a t  T-cell an tigen ic  d e te rm in an ts  involve local fea tu res  o f 
p ro te in  s tru c tu re  such as sequence p roperties involving charge and  
hydrophilicity , and  certa in  types of secondary s tru c tu re , such as helicity, 
th a t  do no t depend on th e  te r tia ry  folding of the  en tire  p ro te in  (M argalit et 
a l.,1987). M ore specifically, Delisi and  Berzofsky (1985) showed th a t  short 
pep tides recognized by he lper T-cells a re  u su a lly  am ph ipath ic  p ro te in  
segm ents. I t  h as  been proposed th a t  th e  hydrophobic face of a n  
am ph ipath ic  pep tide  in te rac ts  w ith  the  MHC m olecule w hile th e  
hydrophilic face in te rac ts  w ith  the  T-cell recep tor (Pincus et a l., 1983;
D elisi an d  Berzofsky, 1985). This hypothesis w as experim entally  supported  
by s tru c tu ra l analyses o f 12 im m unodom inant T-cell epitopes of sperm  
w hale m yoglobin (Berkow er et al., 1986; Cease et al., 1986) an d  w as fu rth e r  
supported  by Spouge and co-workers (Spouge et al., 1987) who analyzed  23 
im m unodom inan t class II  res tric ted  T-cell an tigen ic  s ite s  from  12 
p ro te ins an d  showed th a t  helical am ph ipath ic ity  and  a-he lic ity  a re  both  
s ta tis tica lly  significant correlates o f T-cell an tigenicity , independen tly  of 
each o ther. These resu lts  together suggest th a t  following an tigen  
processing, am ph ipath ic  a-helical segm ents o f th e  processed p ro te in  are  
th e  basis  of cellu lar im m une recognition.
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The am phipath ic helical m otif has also been found in  several 
m em brane-spann ing  helical regions of pro teins th a t  form  m em brane 
pores. The m ost well established is bacteriorhodopsin, an  in teg ral 
m em brane pro tein  of a  m arine archaebacterium , H alobacterium  
halobium . B acteriorhodopsin functions as a  pum p producing a  proton 
electrochem ical po ten tial across the  cellu lar m em brane. T his pro tein  
contains seven transm em brane helical regions th a t  a re  though t to 
associate th rough  hydrophobic in teractions betw een th e  apolar faces of 
th e ir  am phipath ic  helical transm em brane  regions an d  lip ids w ith in  the  
m em brane bilayer. This in terac tion  allows the  polar faces of the  helices to 
form  a  hydrophilic pore spann ing  th e  m em brane (E ngelm an and  Zaccai, 
1980).
In  addition , am phipath ic  helical s tru c tu res  a re  also characteristic  
of n a tu ra lly  occurring m em brane-d isruptive pep tides such as a lam eth icin  
(Engel et al., 1985), m elittin  (Terwilliger et al., 1982; Terw illiger and  
E isenberg, 1982a & b), m againins (Zasloff, 1987), and  cecropins (Andreu et 
al., 1985). A lam ethicin is a  20 am ino acid long peptide antibiotic th a t  
oligomerizes (6-11 molecules) to form voltage-gated channels in  bacterial 
m em branes; i t  is proposed th a t  conform ational changes in  th e  s tru c tu re  
during  oligom erization allow a voltage across th e  b ilayer th a t  stabilizes 
the  "open" form  of the  channel (Fox and  Richards, 1982). M elittin  is a  well 
studied  peptide com ponent of bee venom  which also p e rtu rb s  m em branes 
by form ing voltage-gated channels (K em pf et al., 1982). The atomic 
stru c tu re  of m elittin  te tram ers has been determ ined and  refined to <2.5 A. 
The crystal s truc tu re  reveals th a t  each m elittin  m onom er exists as an
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am phipath ic  a-helical s tru c tu re  (Terwilliger et al., 1982; Terw illiger and  
E isenberg, 1982a & b). M againins and  cecropins a re  an tibac teria l peptides 
found in  the  sk in  of frogs (Zasloff, 1987; Zasloff et al., 1988), and  in  the  
hem olym ph of Cecropia m oths (H ultm ark  et al., 1980; H u ltm ark  et al., 
1983; Bowman and Steiner, 1981; Bowman et al., 1985; van  Hofsten et al.,
1985), respectively. These peptides are  sim ilar to m elittin  in  th a t  they  form 
am phipath ic  helical s tru c tu res  th a t  have a  h igh  positive charge density , 
and  they  are  believed to form m ultim eric s truc tu res th a t  in se rt in to  
cellu la r m em branes form ing ion channels. In  each of these  cases, ion 
channels form ed by m ultim ers of am phipath ic  helical pep tide  s tru c tu re s  
allow flow of H 2O and  electrolytes across cellu lar m em branes resu ltin g  in  
a  loss of osmotic in teg rity  and  eventual lysis of the  cell (Jaynes et al., 1986). 
These cytolytic peptides can inh ib it both prokaryotic and  eukaryotic cells 
(Zasloff et al., 1988; Jaynes et al., 1988; Jaynes et al., 1989). I t  should be 
em phasized th a t  n a tu ra l cytolytic peptides are  heterogeneous a t  the  
p rim ary  am ino acid sequence level, b u t all of them  have th e  po ten tial to 
form  am phipath ic  secondary struc tu res (Figure 16). I t  appears th a t  th e  
am phipath ic  helical secondary s tru c tu ra l m otif is  commonly exploited to 
fac ilita te  specific pathologic or protective ends in  n a tu re , an d  th u s  m ay 
even be utilized by viruses to cause cytopathic effects in  host cells.
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Figure 16. P r im a ry  am in o  ac id  sequences a n d  he lica l w h ee l d iag ram s o f 
th e  HIV-1 TM a m p h ip a th ic  h e lica l reg ion , M elittin , a n d  M againin-2.
P rim ary  amino acid sequences (A) and  helical wheel d iagram s (B) of 
HIV-1 (.env 828-855), m elittin, and  m againin-2 showing non-homology of 
sequences, b u t sim ilar am phipathic structure . Each residue has been 
coded by differential shading. Residues w ithin  non-shaded boxes are  
hydrophobic while those w ithin  shaded boxes a re  hydrophilic. To fu rther 
detail side chain characteristics, th ree  different box-fills have been
employed: f f l represents basic, 0  acidic, and  ESI polar non-charged
residues. These assignm ents have been m ade according to the  polarity  
scale of transm em brane helices (Engelman et al., 1986).
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A m phipath ic h e lices o f  HIV-1 an d  SIV  TM protein .
We have recen tly  reported  th a t  th e  extrem e carboxy-term inus of 
HIV-1 TM pro tein  contains a  region of h igh  am phipath ic  po ten tia l th a t  is  
ab sen t from  th e  TM pro tein  of oncoviruses (M iller et al., 1991; M iller and  
M ontelaro, 1991). Sequence analysis of various iso lates of HIV-1 h as 
revealed  th a t  th is  am phipath ic  m otif is h igh ly  conserved betw een d ifferent 
s tra in s  o f HIV (M yers et al., 1988). The a p p a ren t conservation of these  
am ph ipath ic  regions w ith in  th e  H IV  TM pro te in  m ay  im ply a n  im p o rtan t 
biological role. F igu re  17 sum m arizes rep resen ta tiv e  segm ents of helices 
identified  in  th e  carboxyl portion of len tiv irus TM pro teins and  th e  lin ea r 
d is tribu tion  of th e  charged residues. In  F igure 18, selected TM helices and  
th e ir  charge d is tribu tion  a re  p resen ted  in  com puter-derived m odels to 
illu s tra te  the  am ph ipath ic  n a tu re  of th e  len tiv iru s helical segm ents. F o r 
purposes of com parison, rep resen ta tiv e  oncovirus TM  p ro te in  segm ents 
a re  included in  each figure. The d a ta  p resen ted  in  th ese  two figures 
clearly  dem onstra te  th e  charac te ristic  arg in ine-rich , positively  charged 
am ph ipath ic  helix  p resen t in  all len tiv iru s TM pro teins exam ined. For 
exam ple, HIV-1 (R atner et a l., 1985) contains a  28 residue  am phipath ic  
helix  th a t  contains a  to ta l o f 7 arg in ines for a  n e t  positive charge of 5 
across th e  am ph ipath ic  helical segm ent (Figure 17). S im ila r s tru c tu re s  
and  charge d is tribu tion  a re  read ily  eviden t in  o th er len tiv iru ses  such as 
HIV-2 (G uyader et a l., 1987), SIV (H irsch et al., 1987), and  EIAV (Rushlow 
et al., 1986).
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Figure 17. P r im a ry  am ino  a c id  sequences o f  p ro p o sed  len tiv ira l ly tic  
p e p t id e  se g m e n ts . The prim ary  amino acid sequences of potentially 
am ph ipath ic  a-helical s tru c tu res  from each of these  viruses a re  listed , 
and  th e ir  position in  the  predicted env polyprotein sequence is indicated  
num erically . E ach residue has been coded by differential shad ing  to show 
the  s tru c tu ra l sim ilarities betw een these  sequences. Residues w ith in  non­
shaded boxes are  hydrophobic while those w ith in  shaded boxes a re  
hydrophilic. To fu rth e r deta il side chain characteristics, th ree  d ifferent
box-fills have been employed: OH represen ts basic, □  acidic, and  OH
polar non-charged residues. These assignm ents have been  m ade 
according to th e  polarity  scale of transm em brane  helices (Englem an et al.,
1986). For com parative purposes, the  sequences of M againin-2, a  n a tu ra l 
cytolytic peptide produced by am phibians, an d  corresponding segm ents 









 fclvl iKM  VE§| G| A|C|j A) iffiM iM M  i l l m m
iSEEDSEBI l G G l W I I A I g l l l TL
IHl|A|G^|G|Lfi|G|L|AlV|l|l|i|l|C|l[l|G|LlKjL|l|Ft^l|l|l
g i g ! F L l & A l l F G l l A f  v g S  :IM&&
I  IS L 1 1 L & ;g 11V I M g  !  $ $ L i m g g &i SL
s f v  is; & :sl i  i  i  m i  & a  s  i »  $  i  t ?I X l i M i g G G A
LL F Gg C  I L j j l L V ^ F  V l g l l g V V g A L
107
Figure IS. C o m p u te r-g en e ra ted  m odels o f  a m p h ip a th ic  a -he lica l 
se g m en ts  f ro m  le n tiv ira l  tra n s m e m b ra n e  p ro te in s . Each panel contains 
an  am ino acid chain  d iagram  (left), and  a  space-fill m odel (right). E ach 
residue h as been  color-coded to show s tru c tu ra l characteristics; 
hydrophobic residues a re  colored blue, basic residues a re  red , acidic 
residues a re  yellow, and  polar non-charged residues a re  green. Included 
in  th e  chain d iagram s is a  w hite ribbon used  to trace th e  backbone of the  
helix; any  distortion of th is  ribbon is due to th e  presence of proline in  the  
sequence. The chain  diagram s a re  viewed down the  barre l o f th e  helix 
from  th e  carboxy te rm ina l to th e  amino term ina l end of each struc tu re . 
The space-fill m odels a re  viewed la tera lly  w ith  the  carboxy te rm ina l end 
tow ard the  lower r ig h t side of the  struc tu re . The iden tity  of each of the  
peptide segm ents a re  as follows: (A) HIV-1 (R atner et al., 1985), (B) HIV-2 
(G uyader et al., 1987), (C) SIV (Hirsch et al., 1987), (D) EIAV (Rushlow et 
al., 1986), (E) M againin-2, (F) HTLV-1 (Seiki et al., 1983), (G) RSV (Schwartz 






In  con trast, exam ination  of th e  oncovirus TM pro teins fails to reveal 
a  com parable s tru c tu ra l m otif (F igures 17 & 18). In  certa in  oncoviruses, 
th e re  does ap p ea r to  be some po ten tia l for th e  form ation of helical 
segm ents a t  the  carboxyl portions of th e  TM m olecules, however, none of 
these  helical segm ents d isplay th e  strong  am ph ipath ic  p roperties ev iden t 
in  len tiv iru s  TM pro teins (Figure 18). I t  is  im p o rtan t to note th a t  
oncoviruses u su a lly  also lack  th e  h igh  concentra tion  o f a rg in ine  residues 
observed in  len tiv iruses (Figure 17), even in  those TM pro teins th a t  have 
w eak po ten tia l to form  an  am phipath ic  helix. T hus, i t  appears th a t  th e  
am ph ipath ic  helix  contain ing  a h igh density  of positive charges is  a  
s tru c tu ra l m otif un ique to len tiv iruses and  ab sen t from  oncoviruses. T his 
fu n d am en ta l difference in  TM  s tru c tu re  m ay  correlate  w ith  th e  
differences in  cytopathicity  exhibited by oncoviruses an d  len tiv iruses. 
B ioactiv ity  o f  len tiv iru s  ly tic  pep tides (LLPs).
To te s t  th is  hypothesis directly, we synthesized peptides 
corresponding to th e  HIV-1 (HIV-L) and  SIV (SIV-L) LLP sequences 
show n in  F igure  1, as well as a  peptide of s im ila r size corresponding to a 
region of SIV gp l2 0  (residues 112-143, control-pep) th a t  does n o t sh a re  the  
p o ten tia l s tru c tu ra l m otif or h igh  positive charge density  described for th e  
proposed len tiv ira l lytic peptides; the  p rim ary  am ino acid sequence of th is  
pep tide  is  N H 2-RCNKSQTDRW GLTKSSTTITTAAPTSAPVSEK-CONH2. 
F o r com parative purposes, peptides corresponding to  th is  reg ion  of two 
oncoviruses, RSV (RSV-pep) an d  HTLV-1 (H TLV -l-pep, F igu re  17), w ere 
also synthesized. Since synthetic  peptides w ere produced to be em ployed in  
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Figure 19. C h a ra c te r iz a tio n  o f  sy n th e tic  p e p tid es  co rre sp o n d in g  to  th e  
p ro p o se d  cy to ly tic  se g m en t o f  le n tiv ira l  TM  p ro te in s . Analytical HPLC 
profiles o f purified  (A) HIV-L, (C) SIV-L, an d  (E) control-pep reveal g rea te r  
th a n  95% hom ogeneity of each pep tide  p repara tion . P lasm a  desorption 
m ass spectrom etry  d a ta  from  (B) HIV-L (3309.2 am u), (D) SIV-L (3390.5 
am u), an d  (F) control-pep (3425.1 am u) reveal th a t  th e  desired  pep tide  
p roduct w as ob tained  in  each case. S im ilar d a ta  for RSV-pep an d  HTLV-1- 
pep is no t shown.
I l l
were performed to insure th a t any bioactivity detected was inheren t to the 
desired peptide product (Fontenot et al., 1991). Representative HPLC and 
m ass spectom etry profiles of purified peptide preparations a re  shown in  
Figure 19. Following purification and characterization, synthetic peptide 
preparations were employed in  standard  assays designed to m easure the 
ability of cytolytic peptides to kill prokaryotic cells (Lehrer et al., 1983).
The resu lts sum m arized in Figure 20 reveal th a t both HIV-L and 
SIV-L have the ability to kill significant num bers of Staphylococcus 
aureus (gram-positive) a t 10 pM  and 100 pM  peptide concentration, 
respectively, while concentrated RSV-Pep, HTLV-l-Pep, and  control-pep 
are unable to kill these bacteria. Assays in  which 1 X 104, 1 X 105 and 1 X 
1 0 6 Staphylococcus aureus were treated  yielded very sim ilar resu lts 
(Figure 20) and thus, dem onstrated th a t cell killing was independent of the 
num ber of bacteria treated. Sim ilar assays using approxim ately 1 X 104, 1 
X 105 and  1 X 106 Pseudomonas aeruginosa (gram-negative) resu lted  in  
total killing by HIV-L and SIV-L a t 1 pM  and 10 pM  peptide concentration, 
respectively (data not shown). As expected, S. aureus is less sensitive 
th an  P. aeruginosa to trea tm en t with the LLPs, probably due to differences 
in  glycolipid and phospholipid content of bacterial cell m em branes and  the 
peptidoglycan content of bacterial cell walls. Clearly, HIV-L is more active 
against both species of bacteria th an  SIV-L, presum ably because of the 
higher positive charge density and greater degree of overall am phipathy 
across HIV-L (Figures 17 & 18).
These resu lts dem onstrate th a t LLPs, like natu ra l lytic peptides, are 
able to specifically kill prokaryotic cells. In  fact, the specific activity of the
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Figure 20. L en tiv iru s  TM  ly tic  pep tid es  m ed ia te  k illin g  o f  p ro k a ry o tic  
c e lls . One ml suspensions of Staphylococcus aureus  in  10 m M  K 2H PO 4 
buffer w ere incubated  for 1 hour a t  37°C w ith  SIV-L, HIV-L, RSV-pep, 
H TLV -l-pep, or Control-Pep a t  1 pM , 10 pM , and  100 p M  concentration; 
approxim ately (A) 1 X 104, (B) 1 X 105, and  (C) 1 X 106 bacteria  w ere trea ted  
in  sep a ra te  assays. Following incubation, the  bacteria l suspensions w ere 
se ria lly  d ilu ted  (1 0 -fold) and  1 0 0  jil of each dilution w as sp read  evenly over 
th e  surface of a  TSA p late  and  then  incubated  overnight a t  37°C. Colonies 
w ere th e n  counted to determ ine  th e  num ber of survivors. R esu lts show n 
re p re se n t th e  average of duplicate p la ting  and  a re  p resen ted  as percen tage 
of cells surv iv ing  incubation  w ith  peptide. All assays w ere perform ed a t  
le a s t  two tim es to in su re  reproducibility.
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HIV-1 LLP appears to be higher th an  th a t observed for synthetic 
m againin-2; in  these assays, lytic activity of m againin-2 was very  sim ilar 
to th a t  observed for SIV-L (data not shown).
As lentiv iruses infect eukaryotic ra th e r  th a n  prokaryotic cells, we 
next exam ined the  cytopathic properties of the synthetic LLPs using the 
RH9 subclone of HuT78, a  CD4+ T-lymphocytic cell line susceptible to HIV 
and SIV cytopathic effects (Garry et al., 1988; Figure 21). I t  is clear from 
comparison of these resu lts with those in  Figure 20, th a t  the  
concentrations of HIV-L and SIV-L required to reduce viable cell num bers 
of the  eukaryotic cells by 1-2 logs were sim ilar to the concentrations 
required to kill like num bers of prokaryotic cells. Assays w ith RSV-pep, 
HTLV-l-pep, and Control-pep revealed th a t trea tm en t w ith these  peptides 
resu lted  in  no reduction in  num bers of viable cells. We have begun to 
investigate the  actual m echanism  of synthetic LLP-m ediated cell 
inhib ition  by perform ing 51chrom ium  (51Cr)-release assays on fresh 
hum an  peripheral blood leukocytes (PBLs). P relim inary  resu lts  indicate 
th a t  synthetic LLPs do, in  fact, pertu rb  plasm a m em branes as 51Cr is 
released  by 51Cr-loaded cells following trea tm en t w ith e ith er HIV-L or 
SIV-L (Figure 22). Addition of as little  as 100 fjM  of e ither LLP to resting  
PBLs loaded w ith 51C r resu lts in  release of 70-75% of the  to ta l 51C r content 
and  in  death  of all cells treated . Addition of Control-pep, RSV-Pep, or 
HTLV-l-Pep resu lted  in  only background levels of 51Cr release and cell 
inhibition. S im ilar resu lts  were obtained from assays using H9 cells and 















Figure 21. L entivirus TM lytic peptides m ediate k illin g  o f eukaryotic cells.
One m l cultures (5 X 105 cells/ml) of the  RH9 subclone of HuT78 cells were 
incubated  w ith HIV-L, SIV-L, RSV-pep, or Control-pep a t  th e  indicated 
concentrations. Following incubation for 24 hours a t  37°C in  RPM I 1640 
m edium  w ith  10% serum  supplem ent, the  cells were sta ined  w ith  th e  vital 
exclusion dye trypan  blue and the  num bers of viable cells were determ ined 
by counting in  a hemocytometer. The values rep resen t the  average of 
quadruplicate  determ inations and the S.E.M. was sm aller in  each case 
th a n  the  size of the  symbols as draw n. The resu lts a re  represen tative  of a t  
le a s t th ree  independent experim ents w ith each peptide.
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Figure 22. L L P -m e d ia ted  51C r  re le a s e  fro m  PB L s. U nstim ulated (Panel 
A) an d  m itogen-stim ulated  (Panel B) h u m an  periphera l blood leukocytes 
(PBLs), and  u n stim u la ted  H 9 cells (Panel C) loaded w ith  51C r w ere tre a te d  
w ith  10 and  100 /±M concentrations of HIV-L, SIV-L, Control-Pep, RSV- 
Pep, an d  HTLV-1-Pep. Following a  24 hour incubation  period, cell 
su p e rn a ta n ts  w ere assayed for 51C r con ten t and  viable cells w ere counted 
in  a  hem acytom eter v ia try p an  blue dye exclusion. All va lues w ere 
corrected for spontaneous 51C r release  and  cell d ea th  as m easu red  for 
u n tre a te d  cell cu ltu res.
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correlate w ith  cell death , i t  appears th a t  a  loss of osmotic in teg rity  leads to 
death  of these  cells.
To fu rth e r  investigate  the  m em brane p ertu rb ing  properties of HIV -1 
and  SIV LLP, these  peptides were employed in  assays in  w hich th e  influx 
of several radioactive m olecules in to  CEM cells w ere m easured  following 
exogenous addition of LLP in  vitro. R esults obtained from these  
experim ents w ere very  sim ilar to those reported  for HIV -infected cells 
(Cloyd and  Lynn, 1991). T reatm ent of CEM cells w ith  HIV-L resu lted  in  
influx of significant levels of 45C a2+ and  C14-sucrose, and  only a  sm all 
influx of C 14-inulin  (Figure 23A). Influxes of 45C a2+ and  C14-sucrose w ere 
also m easured  in  cells trea ted  w ith SIV-L, a t  low er levels, while no influx 
of C14-inulin  w as detected (data  no t shown). S im ilar assays employing 
Control-Pep (data  not shown), and  MR-7 (random ized HIV-L peptide; 
discussed fu rth e r  in  C hap ter 6) revealed no influx of any  of these  
compounds (Figure 235). These d a ta  suggest th a t  sm all pores a re  rap id ly  
form ed in  th e  cytoplasm ic m em brane of the  LLP trea te d  cells allowing th e  
passage o f sm all m olecules across the  m em branes. These resu lts  a re  
consisten t w ith  those obtained from 51C r-release assays, and  a re  also 
consisten t w ith  our original hypothesis th a t  th e  LLPs oligomerize, in se rt 
in to  biological m em branes, and  d isrup t th e  osmotic in teg rity  o f th e  cell.
O verall, these  resu lts  indicate th a t  HIV-L an d  SIV-L a re  capable of 
k illing both  eukaryotic and prokaryotic cells. W hile th e  exact m echanism  
of e ith er bacteria l or eukaryotic cell killing m ediated by th e  len tiv irus TM 
lytic peptides cannot be determ ined  from these resu lts , p relim inary  
studies reveal th a t  LLPs do pertu rb  cellu lar m em branes and  therefore
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share  functional as well as s truc tu ra l characteristics of n a tu ra l cytolytic 
peptides.
12 0
Figure 23. LLP-m ediated m em brane perm eab ility  alterations.
Approximately 5 X 106 CEM cells were treated  w ith 10 (iM, 30 [lM, or 100 
fjM  HIV-L, SIV-L, Control-pep, or MR7 (negative control). Influx of 45Ca2+ 
(Panel A), C14-sucrose (Panel B), and C14-inulin (Panel C) into peptide- 
trea ted  CEM cells was then m easured. Samples of 5 X 105 cells were 
removed 30, 60, 90, and 120 seconds after addition of peptide and radiolabel, 
centrifuged through m ineral oil to separate the  cells from the 
supernatant, and  the cell pellets were assayed for radioactivity. The MR7 
peptide has the  same amino acid composition as HIV-L, bu t the  sequence 
has been scrambled so th a t the peptide has no am phipathic potential. This 
peptide is fu rther described in  C hapter 6.
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D iscussion
The assignm ent of cytopathic properties to th e  indicated carboxyl 
am phipath ic  helices in  len tiv irus TM proteins m ay explain several 
observations being m ade w ith lentiviruses. For example, a  v a ria n t of HIV- 
1 designated X10-1 has been described th a t replicates in  norm al hum an  T 
cells in  vitro, b u t does not kill the  infected cell (Fisher et al., 1986).
Sequence analysis of th is v a rian t HIV-1 genome revealed a  replacem ent of 
th e  four carboxy-term inal amino acids w ith a  14 residue segm ent th a t  
does no t appear to have am phipathic character. U sing a  panel of m u tan ts  
containing deletions from the carboxyl end of HIV TM protein, Lee et al. 
(1989) have shown th a t  deletions as small as 12-15 residues a re  sufficient 
to im pair infectivity and cytopathicity of some clones. In  fu rth e r support of 
th is  concept is  the  report th a t isolates of HIV differing in  th e ir  relative 
cytopathicity display amino acid sequence varia tions in  the  env  gene 
sequences encoding the  proposed cytopathic helices described here 
(Kowalski et at., 1987; Sakai et al., 1988). I t  also has been reported th a t 
propagation of SIV in  cultured cells resu lts in  the  production of trunca ted  
TM proteins, the  resu lt of term ination  codons introduced in to  the  env  gene 
during  replication in  vitro  (Hirsch et al., 1989b; Kodama et al., 1989). These 
env  te rm ina tion  codons are always upstream  from th e  predicted 
cytopathic peptide segm ents. Thus, passage of SIV in  cell cu ltures m ay be 
selecting for noncytopathic varian ts  produced by the  loss o f cytopathic env 
sequences in  the  TM proteins.
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The lytic p roperties of n a tu ra l cytolytic peptides requ ire  the  
form ation of peptide m ultim ers (Jaynes et al., 1986; Jay n es et al., 1988; 
Ja y n es  et al., 1989; Zasloff et al., 1988). For len tiv irus TM am phipath ic  
helices to  affect h o st cell m em branes, i t  is  reasonable  to assum e a  sim ila r 
req u irem en t for TM  m ultim er form ation. In  th is  regard , Ozel et a l. (1988) 
have  repo rted  th a t  th e  envelope pro teins o f H IV  ap p ea r to ex ist as  trim ers  
of gpl20-gp41, w hile Schaw aller et al. (1989) have concluded a  te tram eric  
a rran g em en t. M oreover, H affar et al. (1991) have show n th a t  the  
cytoplasm ic ta il of HIV  TM form s a stab le  association w ith  th e  lipid 
b ilayer of host cells, while Venable et al. (1989) have used  extensive 
com puter m odelling and  energy  calculations of th e  HIV  TM  pro te in  to 
p red ic t a n  aggregation  of th e  carboxyl am phipath ic  helices w hich could 
sp an  th e  lip id  b ilayer o f a  cell m em brane. R esu lts of bacterial-inh ib ition  
assays w ith  th e  H IV  and  SIV am ph ipath ic  pep tides suggested  a  
req u irem en t for m u ltim er form ation since inh ib ition  w as dependen t on 
pep tide  concentration  b u t w as independen t of th e  num ber of b ac te ria  used  
in  each  assay  (M iller et al., 1991). T aken together, these  observations 
suggest th a t  len tiv irus TM m ultim ers should be able to form , to in se r t in to  
cell m em branes, and  to  a lte r  m em brane p roperties a s  described for 
n a tu ra l  cytolytic peptides.
I t  is  difficult to correlate  th e  concentration of exogenous LLP 
requ ired  to  produce cytopathology w ith  a  p a rticu la r level o f v irus envelope 
p ro te in  expression in  infected ta rg e t cells. In  th e  case o f len tiv iru s 
infected  cells, th e  TM p ro te ins rap id ly  form  oligomeric s tru c tu re s  th a t  a re  
a lw ays in tim a te ly  associated  w ith  in te rn a l and  p lasm a m em branes o f th e
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cell (Ozel et a l., 1988; Schaw aller et al., 1989). T hus there  is  no 
concentration  threshold  requ ired  to facilitate  m ultim eriza tion  and  
cytopathic effects can re su lt from chronic exposure to even low levels of 
m em brane a lte rin g  TM proteins. In  contrast, exogenous am phipath ic  
peptides requ ire  critical concentrations for assem bly in to  m ultim ers th a t  
can in te rac t only w ith  the  plasm a m em brane of ta rg e t cells, w here 
cytopathic effects are  relatively  rapid. The role of LLP concentration is 
dem onstra ted  by the  observation th a t  bacterial inhib ition  w as dependent 
on peptide concentration, b u t independent of bacteria l cell concentrations. 
In  addition, the  specific cytolytic activity of th e  LLPs appeared  to correlate 
w ith  th e  specific am phipathic potential and, th u s, p ropensity  to form  
oligomeric struc tu res. The g rea te r am phipath ic  po ten tia l o f th e  HIV-L 
peptide com pared to SIV-L m ay explain th e  h igher cytopathic activ ity  of 
th e  form er in  certa in  assays.
Several groups have reported  th a t  the  carboxy-term inal end of HIV- 
1 and  HIV-2 gp41 contains two dom ains (residues 768-788 and  826-854, and  
757-779 and  828-854, respectively) th a t have a  very h igh  hydrophobic 
m om ent ind icating  th a t  these  regions m ay form am phipath ic  a-helices 
(E isenberg and  Wesson, 1990; Eisenberg et al., 1988; Fuji et al., 1988; H affar 
et al., 1987). The second of these dom ains in  both HIV-1 and HIV-2 
correspond closely to the  LLPs described in  the  p resen t study. Recently, 
Segrest et al. (1990) devised a  classification schem e in  w hich am phipath ic  
a-helical dom ain-containing proteins and peptides w here placed in to  one 
of seven groups according to th e ir  physiochem ical an d  s tru c tu ra l 
properties. According to th is  classification scheme, th e  HIV-1 and  HIV-2
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am phipath ic  dom ains, and  th u s  the LLPs described here, m ost closely 
resem ble th e  calm odulin-binding am phipathic helices (class K), while 
n a tu ra l cytolytic peptides constitute class L. M embers o f class K and class 
L characteristically  have both a  very high m ean hydrophobic m om ent and  
a h igh positive charge density, bu t they  differ prim arily  in  th e ir  lysine to 
arginine ratio , as m em bers of class K typically have a  significantly lower 
lysyl to arginyl ratio  th a n  do m em bers of class L. Since calmodulin (CaM) 
is a  ubiquitous in tracellu lar protein th a t  is im portan t for regulation of th e  
activity of m any cellular enzymes, any interference w ith  CaM "activity" 
could produce a variety  of a lterations in  individual cells. P relim inary  
investigations regarding the  CaM -purtubation potential of th e  LLPs are  
underw ay, and  resu lts  from these  studies are  discussed in  C hapter 6. 
Im plication of the  LLP dom ain of len tiv irus TM proteins as a  m odulator of 
CaM cascade kinetics, along w ith the dem onstrated lytic activity of th is  
s truc tu re , suggests th a t  th is am phipathic helical struc tu re  could play a  
very  im portan t role in  lentivirus-induced cytopathology.
Previous studies w ith  a  variety  of retroviruses have identified 
fusogenic peptides (G arry et al., 1988) and im m unosuppressive peptides 
(M athis et al., 1978; Cianciolo et al., 1985; Cianciolo et al., 1986; Ruegge* al., 
1989a; Ruegg et al., 1989b) in  the  TM proteins of both oncoviruses and 
len tiv iruses. Recently, Kowalski and coworkers dem onstrated th a t 
m utations in  the  fusion dom ain of HIV-1 greatly  reduced cytopathicity as 
well as syncytia form ation (Kowalski et al., 1991). The lytic peptides 
described here  a re  distinct from these other cytopathic sequences in  th e ir  
location and  in  th e ir biochemical properties. For example, the  HIV fusion
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peptide is  a  highly hydrophobic sequence located a t  the  amino term inus of 
the  TM protein  (Garry et al., 1988), while the  HIV im m unosuppressive 
peptide is a  hydrophilic peptide located toward the middle of the  TM 
polypeptide chain (Ruegg et al., 1989b). Thus, it  appears th a t lentivirus TM 
proteins have in tegrated  a  repertoire of different m em brane altering  
protein segm ents th a t  all contribute to cell cytopathicity and presum ably to 
the  development of disease.
Although the  proposed LLPs m ay traverse the  cell m em brane, they 
are evidently nonessential and not required for assem bly of the  viral 
envelope. S trains of SIV encoding truncated  TM proteins produce 
infectious virus particles containing the TM protein lacking the  proposed 
cytopathic peptide segments (C hakrabarti et al., 1989). Thus, other 
hydrophobic sequences in  the SIV TM protein m ust serve to anchor the  
envelope complex to the viral lipid bilayer as proposed by G allaher et al. 
(1989).
In  sum m ary, we have reported a variety  of observations and 
experim ental evidence th a t m ake a in teresting  case for a  correlation of 
len tiv irus cytopathicity w ith unique structural dom ains in  the  v iral TM 
protein, specifically the highly positively charged am phipathic helices a t  
the  carboxyl end of the TM protein. Although the  model described here is 
som ewhat hypothetical, i t  does provide an  im portant fram ework for 
experim ents th a t  can directly tes t the relationship of these LLPs w ith 
cytopathogenesis. These include more intensive functional and  struc tu ra l 
analyses of lentiviruses containing altered  transm em brane proteins 
produced natu ra lly  or by in  vitro m utagenesis procedures.
CHAPTER 6
ALTERATIONS IN  CALMODULIN ACTIVITIES BY L L PS
Introduction
One of the m ost perplexing problems in  current AIDS research is 
defining the  m olecular determ inants and m echanism s of HIV-1 
pathogenesis. HIV-l-associated disease is characterized by a variety  of 
d istinct pathologies, ranging from depletion of specific cell populations, to 
severe imm unosuppression, to CNS disease, to the development of 
Kaposi's sarcoma. At this tim e i t  is uncertain w hether the  diversity of 
disease symptoms is the resu lt of a single m echanism  th a t  produces a  
rem arkably pleiotropic disease pa ttern  or i f  distinct pathologies resu lt 
from different aspects of virus gene expression and replication processes. 
To unravel the  genetic determ inants of HIV-1 pathogenesis, a  num ber of 
laboratories have utilized site directed m utagenesis to analyze the  role of 
specific genes (structural and  nonstructural) in  virus m ediated 
cytopathicity in  vitro. O ther laboratories have attem pted to correlate 
n a tu ra l variations in  HIV-1 isolates w ith specific pathogenic properties in  
vivo. A conclusion of both approaches is th a t  the envelope gene is a  major, 
b u t no t exclusive, determ inant of critical biological and pathogenic 
characteristics of different virus strains.
Com plem entary to these genetic studies have been a num ber of 
reports dem onstrating th a t viral replication can produce deleterious 
modifications in  cell m em brane properties th a t  m ay contribute to
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cytopathogenesis and  cell d ea th  (Cloyd and  Lynn, 1991; L ynn et a l., 1988; 
G arry  et al., 1988). M oreover, stud ies on purified  HIV-1 envelope p ro te ins 
an d  pep tide  segm ents reveal a  v a rie ty  of in trin sic  m em brane 
p e rtu rb a tio n s, includ ing  a lte ra tio n s  in  perm eability , fusion o f m em branes, 
an d  suppression  of lym phoproliferation (G arry  et al., 1988; G a llah er 1987; 
Cianciolo e t al., 1985). In teresting ly , m ost of these  cytopathic effects a re  
associated  w ith  th e  HIV-1 tran sm em b ran e  p ro te in  (TM) w hich is m ost 
in tim ate ly  involved w ith  th e  cell m em brane an d  w hich is  in  th e  un ique  
o rien ta tion  of accessing bo th  th e  ex terio r and  cytoplasm ic sides of th e  
p lasm a cell m em brane. In  lig h t of th e  num erous regu la to ry  processes 
th a t  a re  cell m em brane associated, i t  is no t su rp ris in g  th a t  v ira l envelope 
p ro te in  in se rtio n  in to  th e  organized s tru c tu re  o f th e  p lasm a  m em brane 
should  re su lt in  sign ifican t p e rtu rb a tio n s  in  m em brane s tru c tu re  and  
function .
W hile depletion of CD4+ cells is  a  h a llm ark  of HIV-1 infection 
(Fauci, 1988; K opelm an and  Zolla-Pazner, 1988; Y archoan an d  B roder, 
1989; Spickett and  D algleish, 1988), p a ram ete rs  o f im m une responses such 
as T-cell activation  (reviewed in  S h eare r an d  Clerici, 1991), IL-2 
production, an d  interferon-y production have also been  reported  to be 
a ltered  by HIV-1 infection (Ciobanu e t al., 1983; L ane et al., 1985;
K irkpatrick  et al., 1985; M urray  et al., 1984; N otka and  Pollard, 1989; N otka 
an d  Pollard , 1990). Several stud ies have show n th a t  T -helper functions 
can  be defective in  assym ptom atic  H IV -seropositive ind iv idua ls a lthough  
levels o f CD4+ cells have no t been significantly  reduced (P eterson  et a l., 
1989; S h eare r et al., 1986; Clerici et al., 1989) suggesting th a t  H IV  infection
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resu lts  in  a ltera tions of norm al lymphocyte functions th a t  a re  
independent of cellu lar depletion. Activation of T-cells is  in itia ted  through 
p resen ta tion  of ligand by MHC to the  T-cell an tigen  receptor complex 
(H askins et al., 1983; M euer et al., 1983, W eiss et al., 1986) which leads to 
the  m obilization of Ca2+ (Finkel et al., 1987); the  sudden increase in  free 
cytosolic Ca2+ is considered to be a  universal signal for cell activation 
(D urham  and W alton, 1982) because enzyme system s requ ired  for T-cell 
activation are  e ith e r directly, or ind irectly  dependent on in trace llu la r 
[Ca2+]j fluxes. Thus, pertu rba tion  of th e  Ca2+ second m essenger system  in  
these  lymphocyte populations could lead  to unresponsiveness o f these 
cells.
Calm odulin (CaM), a ubiquitous 16,700 Da protein  th a t  is  found in  
all eukaryotic cells (Asselin et al., 1989), regu la tes a  wide range of cellular 
and  enzym atic functions in  response to in trace llu la r [Ca2+]j (Figure 24; 
Cheung, 1980; Cheung, 1985; Feinberg et al., 1987) and is believed to be th e  
p rim ary  in trace llu la r receptor for Ca2+ (Levin and  Weiss, 1978). CaM  
contains four Ca2+-binding sites w hich a re  unoccupied a t  norm al 
in trace llu la r [Ca2+]i w ith in  unstim u la ted  T-cells. U pon Ca2+ influx, due to 
m itogenic or receptor-m ediated activation of T-cells, th e  four Ca2+-binding 
sites of CaM become fully sa tu ra ted  resu ltin g  in  a  conform ational 
a lte ra tio n  which increases the  affinity  of CaM for ta rg e t enzym es and 
proteins by several orders of m agnitude (Klee, 1988). Previous studies 
revealed th a t  shortly  following m itogenic stim ulation, cytoskeletal 
contractile  pro teins of hum an  T lym phocytes undergo a  dynam ic 
reorgan ization  by a  poorly understood calm odulin-dependent m echanism
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Figure 24. S ch em atic  d iag ra m  o f  c a lm o d u lin -d ep en d en t p rocesses. At 
norm al res tin g  in trace llu la r [Ca2+], the  four Ca2+-binding sites of CaM  are 
em pty (CaM, C a2+-unbound) and  CaM  has low affinity  for its  effector 
enzym es. U pon cellu lar stim ulation, which begins as a n  influx of Ca2+ 
across th e  p lasm a m em brane and/or release  of Ca2+ from  in trace llu la r  
stores, all four of the  Ca2+-binding sites of CaM  become filled and  th e  CaM 
undergoes a  conform ational sh ift (CaM -Ca2+) th a t  re su lts  in  a  trem endous 
increase  in  its  affinity  for its  effector enzymes. These enzym es, which are  
inactive w hen not bound by CaM (effector enzym es, inactive), become 
activated  w hen bound by CaM (effector enzyme-CaM  complex, active).
This d iagram  depicts a  non-exhaustive lis t  of m any of the  CaM -dependent 
enzym es and  the  processes they are involved in; in  several cases, CaM  is 
known to be involved in  the  process th a t  is indicated, y e t th e  effector 
enzyme has no t yet been identified.
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(BachvarofFet al., 1980; BachvarofFet al., 1984). I t  has been postulated th a t 
m itogen-induced C a2+ influx resu lts  in  the  form ation of Ca2+-CaM 
complexes which activate v ita l enzyme system s and  m ediate cytoskeletal 
a ltera tions th a t  a re  essential to th e  transm ission  of the  m itogenic signal 
(Cheung et al., 1983; Mookerjee and Jung, 1990). Mitogenic activation of T- 
lymphocytes resu lts in  proliferation of cells in  th e  presence of in terleukin- 
2 (IL-2; Figure 25; Nisbet-Brown et al., 1985; Crispe et al., 1985; Ledbetter et 
al., 1987). Since IL-2 is an  essential signal for im m une cell proliferation, 
and since CaM has been shown to participate  in  IL-2 secretion (Colombani 
et al., 1985; Kronke et al., 1984), CaM has a  pivotal role in  T-cell 
proliferation. In  fact, the resu lts  of several studies suggest th a t  
ex tracellu lar CaM stim ulates DNA synthesis and is  therefore in tim ately  
involved in  cell proliferation (Crocker et al., 1988; G orbacherskaya et al., 
1983; Boynton et al., 1980).
In  addition to its  role(s) in  activation and proliferation of T-cells, 
CaM plays a  critical role in  m any other cellular processes. For instance, 
evidence suggests th a t  CaM is essen tia l for interferon-y (IFN-y)-induced 
HLA class II expression on m any cell types. Upon binding to its  receptor, 
IFN-y m ediates Ca2+ influx and activation of th e  CaM second m essenger 
cascade which in  tu rn  induces class II expression (Koide et al., 1988). 
Following cellular activation, CaM also plays an  in tegral role in  
regulation of in trace llu lar Ca2+ by binding to and activating the  plasm a 
m em brane Ca2+-pump in  a  Ca2+-dependent m an n er (G opinath and  
Vincenzi, 1977; J a r re t t  and Penniston, 1977; Jam es et al., 1988), thereby 
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Figure 25. Schem atic  d iag ram  show ing  in terleukin-2  (IL-2) invo lvem ent 
in  lym phocy te  e x p an s io n  cascade. IL-2 acts on lymphocytes th a t have 
already been activated (*) by antigen. IL-2 signals activated cells to 
expand, and drives th e ir differentiation into effector cells. Acronyms used 
are: CTL, cytotoxic T lymphocyte; IL, interleukin; NK, n a tu ra l killer; Th, T 
helper; Bp, B lymphocyte. From Swain, 1991.
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R equirem ent for CaM  has also been  im plicated in  th e  process of exocytosis 
of g ra n u la r  com partm ents th a t  con tain  cytolytic p ro te ins an d  enzym es 
necessary  for cytotoxic T-lym phocyte-m ediated lysis of ta rg e t cells 
(T akayam a and  Sitkovsky, 1987). S tud ies using  the  CaM  an tagon ist, 
cyclosporin A, suggest th a t  CaM  m ay  also p lay  an  in teg ra l role in  the  
incorporation  of fa tty  acids in to  m em brane phospholipids (Szam el et al., 
1986; Szam el et al., 1985). The resu lts  of one study  even suggests th a t  
ex trace llu la r CaM accum ulates du ring  th e  S phase  of th e  cell cycle and 
th e n  ac tiva tes several in trace llu la r  processes lead ing  to cell division 
(Tomlinson et al., 1984). In  addition to these  processes th a t  depend on 
CaM, th e re  a re  m any o ther enzym es th a t  perform  a  v arie ty  of cellu lar 
functions th a t  require  functional CaM to re lay  th e  Ca2+-activa tion  
m essage (F igure 24).
P oten tia l calm odulin-binding regions o f  len tiv iru s transm em brane (TM) 
proteins.
As described in  C h ap te r 5, we have recently  reported  th e  
identification  of a  region n e a r  th e  carboxyl te rm inus of th e  TM p ro te in  of 
several len tiv iru ses w hich s tru c tu ra lly  and  functionally  resem bles 
n a tu ra l cytolytic peptides. We have provisionally designated  th is  region of 
len tiv irus TM pro tein  as a  len tiv irus lytic peptide (LLP) and  have 
dem onstra ted  th a t  synthetic  peptide analogs indeed a re  functionally  
cytopathic (M iller et al., 1991; M iller and  M ontelaro, 1991). T hese in itia l 
stud ies an d  th e  repo rts of o thers describing a  correlation  betw een  n a tu ra l 
an d  experim ental genetic varia tions in  th e  LLP env  gene sequences an d  
v ira l cytopathicity  suggest th a t  th is  un ique s tru c tu ra l dom ain
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significantly  contributes to HIV-1 pathogenesis th rough  cell m em brane 
pertu rbation . As w as also m entioned in  C hap ter 5, th is  LLP s tru c tu ra l 
m o tif is  very  sim ilar to the  CaM -binding regions of m any  calm odulin- 
dependent enzym es. CaM h as  been shown to bind tigh tly  to peptides 
w hich have th e  properties of form ing am phipath ic  a-helices an d  which 
have a  h igh positive charge density  (Cox e t al., 1985; DeGrado, 1988; 
Persechini and K retsinger, 1988; O’Neil and  DeGrado, 1989). The 
described LLPs also have an  unusually  h igh  hydrophobic m om ent 
(Eisenberg and Wesson, 1990; Eisenberge* al., 1988; Hafifar et al., 1987) and 
a  h igh  arg in ine  to lysine ratio , which a re  also characteristics o f CaM- 
binding peptides (Segrest et al., 1990). As CaM is an  essential com ponent 
of activation  an d  proliferation pathw ays of T-cell populations and  plays an  
im p o rtan t role in  m any o ther cellu lar processes, any  virus-specific 
subversion of CaM activity could be detrim ental to the  host cell.
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R esults
G el m obility sh ift analyses.
To determ ine w hether th e  am phipath ic  helical m otifs common to 
len tiv ira l TM pro teins bind to CaM and thereby  in te rru p t th e  Ca2+ second 
m essenger cascade w ith in  infected cells, we firs t exam ined th e  CaM- 
b ind ing  p o ten tia l of synthetic  peptide analogues of these am phipath ic  
sequences. The peptides HIV-L and  SIV-L, which correspond to the  LLP 
of HIV-1 and  SIVmac251 respectively (as described in  C hap ter 5), as well 
as several control peptides, w here tested  for CaM binding activ ity  in  PAGE 
gel-mobility sh ift assays as described by H ead and  P erry  (1974).
Since am phipathy  and  high positive charge density  a re  th e  
s tru c tu ra l fea tu res reported  to be characteristic  of CaM -binding peptides, 
we w orked w ith  several peptides, in  addition to HIV-L and  SIV-L, which 
have one, ne ither, or both of these features. The p rim ary  am ino acid 
sequence and  the  am phipath ic  poten tial of each peptide tes ted  a re  shown 
in  F igure  26. As previously discussed, both HIV-L and  SIV-L have high 
am phipath ic  po ten tial and  high positive charge density. The synthetic 
peptide used  a s  a  positive control, designated MR9, w as previously 
reported  to b ind  CaM  w ith  a n  affinity w ith in  th e  nanom olar range 
(Erickson-V iitanen and  DeGrado, 1987); th is  peptide h as both  h igh  positive 
charge density  and  high  am phipath ic  potential. Two negative control 
peptides w ere also evaluated  for th e ir CaM -binding activities (Figure 26). 
One of these  peptides, designated DG-A, has po ten tial to form a n  
am phipath ic  a-helix , b u t lacks th e  high positive charge th a t  appears to be
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Figure 26. P rim ary  am ino  ac id  sequences a n d  helica l w heel d iag ram s o f 
th e  sy n th e tic  pep tid es em ployed in  CaM -binding assays. Primary amino 
acid sequences (Panel A) and  helical wheel diagram s (Panel B) of HIV-L, 
SIV-L, MR9 (positive control), DG-A (negative control), and  MR7 (negative 
control) showing the  am phipathic potential and positive charge density of 
each peptide. Each residue has been coded by differential shading. 
Residues w ithin non-shaded boxes are  hydrophobic while those w ithin 
shaded boxes are hydrophilic. To fu rther detail side chain characteristics,
th ree  different box-fills have been employed: 111 represents basic, □
acidic, and ESO polar non-charged residues. These assignm ents have been 
m ade according to the  polarity scale of transm em brane helices (Engelman 
et al., 1986). The tryptophan residue of MR9 has been acetylated (Ac).
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a requ irem ent for CaM binding capacity. The negative control peptide 
designated MR7 is a derivative of the  HIV-L peptide; i t  h as th e  exact amino 
acid composition of HIV-L, however, th e  sequence h as been engineered in  
a  effort to elim inate all am phipathic potential of th e  peptide. The MR7 
peptide therefore has high positive charge density , b u t i t  h as little  
am phipath ic  potential.
As expected, the  HIV-L, SIV-L, and th e  positive control peptide 
(MR9) caused a  total shift of CaM tow ard the  cathode (Figure 27A). E ach 
of these  peptides elicited unique shift pa ttern s , possibly due to th e ir  n e t 
positive charge. The shift of CaM m igration tow ard th e  cathode by th e  
binding peptides was as follows: HIV-L > SIV-L > MR9. To determ ine 
w hether th e  a ltered  m igration of CaM was due in  p a r t  to  m ultim erization  
of peptide, binding reactions were carried  out in  b inding buffer containing 
e ither 2 M  or 4 M  u rea  to prevent peptide aggregation. Since th is  effect 
was repeatab le  w hen using  e ither 2 M  or 4 M  u rea , a lte ra tions in  CaM 
m igration appeared to be the  resu lt of the  n e t positive charge of th e  binding 
peptide and no t due to  binding of CaM by different sized peptide 
m ultim ers. The exact concentration of each peptide stock solution an d  the  
CaM stock solution used for these assays w as determ ined by am ino acid 
composition analysis. The resu lts  of these quan tita tive  assays indicated 
th a t  a  15:1 m olar ra tio  of HIV-L and SIV-L to CaM w as used  in  these 
in itia l stud ies while a  3:1 m olar ratio  of MR9 to peptide w as used. N either 
the  DG-A (Figure 27A) or th e  MR7 peptide (data  no t shown) elicited a shift 
in  CaM mobility. These resu lts  dem onstrate  th a t  synthetic  peptides 
corresponding to th e  LLP region of HIV and  SIV have th e  ab ility  to b ind to
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Figure 27. Gel m obility  sh ift assay  d em o n stra tin g  b in d in g  o f  CaM  b y  
s y n th e tic  p e p tid e s . Synthetic peptides corresponding to am phipathic 
segm ents of HIV-1 and SIVmac251 TM proteins as well as several control 
peptides were evaluated for th e ir ability  to b ind CaM in  the  presence and 
absence of calcium. Synthetic peptide was incubated in  th e  presence of 
CaM a t  a  m olar ratio  o f approxim ately 15:1 (for HIV-L, SIV-L, and DG-A) 
or 5:1 (MR9) for 1 hour in  binding buffer containing 4 M  or 2 M  u rea  and 
e ither 0.1 m M  CaCl2 (Panel A) or 2.0 m M  EGTA (Panel B). The synthetic 
peptide/CaM  m ixtures were th en  subjected to non-denaturing  PAGE on a 
12.5% gel containing 4 M  u rea  and  either 0.1 m M  CaCl2 (Panel A) or 2.0 
m M  EGTA (Panel B). The sam ple compositions (Panels A  and B) were as 
follows: A) CaM alone, B) CaM + DG-A (negative control), C) CaM + MR9 
(positive control), D) CaM + HIV-L, E) CaM + SIV-L. Panel A also 
contains sam ples th a t were incubated in  binding buffer containing 2 M  
u rea . The composition of these sam ples is as follows: F) CaM alone, G) 
CaM + DG-A (negative control), H) CaM + MR9 (positive control), I) CaM + 









CaM  in  the  presence of Ca2+.in a  m an n er which is sim ilar to a  well- 
described CaM -binding peptide.
To determ ine w hether b inding of these peptides to CaM  w as a  Ca2+- 
dependen t in teraction , sim ilar assays were perform ed in  th e  absence of 
C a2+. To accomplish th is  the specific C a2+ chelator EGTA w as substitu ted  
in  th e  b inding buffer and  in  each com ponent of the  resolving gel and 
resolving buffer to m ain ta in  CaM  in  its  u n sa tu ra ted  sta te . The rem oval of 
C a2+ resu lted  in  una ltered  m igration  of CaM following incubation  w ith  
CaM -binding peptides (Figure 27B). These studies show th a t  binding of 
CaM by the  LLPs requires th a t  CaM exists in  its  Ca2+-bound conformation. 
Since CaM -dependent enzym es also bind CaM in  a  Ca2+-dependent 
m anner, these  resu lts  suggest th a t  the  LLPs m ay  bind  in  th e  sam e CaM  
site as do CaM -binding proteins.
To evaluate  fu rth er the  CaM binding activ ities of HIV-L and  SIV-L, 
the  relative binding affinity of each peptide was m easured  for by 
perform ing 2-fold d ilutions of each peptide, prio r to addition of CaM, 
followed by gel m obility shift analysis. The resu lts  of th is  experim ent 
reveal th a t  the  HIV-L, SIV-L and MR9 peptides each a re  able to sh ift the  
m igration of CaM a t  a  m olar ra tio  of peptide to CaM as low as 1:1 for MR9 
and 2:1 for HIV-L and  SIV-L (Figure 28). In  addition, the  sh ift p a tte rn  
characteristic  of each CaM -binding peptide w as no t a lte red  w hen m olar 
ra tio s of peptide to CaM were lowered, fu rth er dem onstra ting  th a t  
m ultim ers of peptide are  probably not required  to elicit a  sh ift in  PAGE 
m igration. The negative control MR7 peptide w as unable  to cause a  sh ift 
in  CaM  m igration even a t  15:1 m olar ratio.
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Figure 28. G el m obility  sh ift assay to  determ ine th e minimum m olar ratio  
o f  LLP to  CaM required to induce altered m igration o f  CaM. Each 
synthetic  peptide w as serially diluted 2-fold prior to addition of CaM and  
th e n  incubated  in  th e  presence of CaM for 1 hour in  b inding  buffer 
containing 4 M  u rea  and 0.1 m M  CaCl2. The beginning peptide 
concentration resu lted  in  a m olar ratio  of approxim ately 15:1 for HIV-L, 
SIV-L, MRS), and  MR7 while the s ta rtin g  m olar ratio  o f DG-A to CaM  was 
5:1. The synthetic peptide/CaM  m ixtures were th e n  subjected to non­
d enatu ring  PAGE on a  12.5% gel containing 4 M  u rea  an d  0.1 m M  CaCl2. 
T he sam ple compositions were as follows: Panel A: A) CaM  alone, B) CaM 
+ DG-A (negative control), C) CaM + HIV-L (15:1), D) CaM  + HIV-L (7.5:1), 
E) CaM + HIV-L (4:1), F) CaM + HIV-L (2:1), G) CaM + HIV-L (1:1), H) 
CaM  + SIV-L (15:1), I) CaM + SIV-L (7.5:1), J )  CaM  + SIV-L (4:1), K) CaM + 
SIV-L (2:1), L) CaM + SIV-L (1:1). Panel B: A) CaM alone, B) CaM + DG-A 
(negative control), C) CaM + MR9 (positive control) (5:1), D) CaM + MR9 
(2.5:1), E) CaM + MR9 (1.25:1), F) CaM + MR9 (0.75:1), G) CaM + MR9 
(0.38:1), H) CaM + MR9 (0.19:1), I) CaM + MR7 (random ized HIV-L) (15:1), 
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Phosphodiesterase com petition assays.
To q u an tita te  the  ex ten t to which the  HIV-L and  SIV-L peptides b ind 
CaM, a  s tan d ard  com petition assay  was employed as previously described 
(Schiefer, 1986). In  th is assay, the  activ ity  of th e  CaM -dependent enzyme 
phosphodiesterase (PDE) w as m onitored as a  m easu re  o f CaM -binding. 
The dependence of PD E activity on CaM concentration is dem onstra ted  in  
F igure 29. From  th is  PDE-CaM  calibration curve, th e  concentration of 
CaM required  to stim ulate  50% of CaM -dependent PD E activity was 
derived. W hile holding the stoichiom etries betw een CaM an d  PDE 
constant, increasing  quan tities of MR9 (a known CaM -binding peptide 
which h as a  Kd for CaM of approxim ately 1 X 10-9 M ), HIV-L, SIV-L, and  
the  negative control peptide MR7 were added to the  reaction m ix tu re  and  
PD E activ ity  w as m onitored. The da ta  dem onstrate  alm ost identical 
enzym e inh ib ition  kinetics for MR9, HIV-L, and  SIV-L while two orders of 
m agnitude h igher concentrations of the  negative control peptide MR7 
were required  to in h ib it 50% PDE activity (Figure 30). The am oun t o f each 
peptide required  to inh ib it PDE activity in  th is assay  by 50% is lis ted  in  
Table 4. Applying the  s tan d ard  m athem atical model for determ in ing  
relative affinities using  com petition assays, and  tak ing  th e  affinity  of the  
MR9 peptide as 1 X 10‘9M  (Erickson-Viitanen and  DeGrado, 1987; Table 4), 
th e  resu lts  of these  assays suggest th a t  th e  relative affinity of HIV-L and 
SIV-L for CaM  is  w ith in  th e  nanom olar range.
L entivirus TM bin d ing to CaM.
A lthough th e  gel m obility sh ift assays described above conclusively 
show th a t  synthetic  peptides corresponding to th e  carboxy te rm ina l region
150





-7  -6  -5  -4
Log Calmodulin (g)
O % PDE Activity
Figure 29. S tim u la tion  o f phosphod iesterase  activ ity  b y  calm odulin . The
stim ulatory  effect of calmodulin (CaM) on phosphodiesterase (PDE) was 
m easured in  a standard  PDE assay as previously described (Schiefer, 
1986). W hile holding the PDE concentration constant, varying am ounts of 
CaM were added to a  series of PDE assay m ixtures, and  PDE activity  was 
m easured by m onitoring absorbance over a  12 m inute period. The am ount 
of CaM required to induce approxim ately 50% activation of PDE w as 
determ ined for use in  subsequent experim ents.
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Figure 30. Inh ib ition  o f phosphod iesterase  activ ity  b y  sy n th e tic  LLPs. The
relative affinity of HIV and SIV LLPs for CaM were m easured  in  s tandard  
PD E inhibition assays (Schiefer, 1986). The am ount of CaM required to 
induce 50% m axim al PDE activity, as determ ined previously (Figure 29), 
w as added to each reaction m ixture. V arying quan tities of HIV-L (Panel 
A), SIV-L (Panel B), or th e  negative control peptide MR7 (Panel C) were 
added to a  series of assay m ixtures. The absorbance (265 nm ) of each 
reaction m ixture was m onitored over a 12 m inute period to determ ine the 
PDE activity. R esults of sim ilar experim ents using a  known CaM -binding 
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T able 4. In h ib ition  o f calm odulin* dependent phosphod iesterase  
activ ity  by calm odulin-binding peptid es a
Peptide Inhibitor
HIV-L SIV-L MR9 MR7
Amount6 % Inhibition Amount6 % Inhibition Amaimi6 % Inhibition Amount6 % Inhibition
5700 100.0 6480 78.6 6600 100 6500 95.6
1140 96.7 1296 97.2 1320 92.5 1300 71.7
570 97.8 648 100.0 660 87.4 - > 6 5 0 58.3
114 96.7 130 91.5 132 91.2 130 22.4
57 91.3 64.8 88.6 66 87.4 65 1.5
11.4 80.3 13 82.9 13.2 86.1 13 1.5
_ w 5 .7 66.0 _ w 6 .5 72.9 - > 6 . 6 40.4 6.5 0.0
^ 1 . 1 4 37.4 ^ 1 .3 12.9 1.30 40.4 1.3 1.5
0.57 17.6 .649 11.5 0.66 1.3 0.65 1.5
0.11 12.1 .130 0.0 0.13 15.2 0.13 2.0
°  enough CaM was added to each assay mixture to induce 50% stimulation of PDE activity
6 pmoles peptide added to reaction mixture 
—>  indicates the approximate point of 50% PDE inhibition
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of HIV-1 and  SIV are  able to bind to CaM, they  provide no evidence th a t  
th is  region of len tiv ira l TM proteins are  able to b ind  CaM w hile in  the  
context of the  entire  TM protein. To th is  end, we attem pted  to identify  
virus-specific CaM -binding pro teins from HIV-1 or SlV -infected cell 
ex trac ts as well as from gradient-purified  v irus p reparations.
F irs t, we employed a  previously described m ethod for detecting 
CaM -binding proteins (Billingsley et al., 1990) which is  m odified from  
typical W estern  blot analysis. C ellu lar ex tracts from  HIV-IIIB, HIV-RF, 
an d  SIV/DeltaB670 infected CEM cells, as well as g rad ien t-purified  HIV-1 
an d  SIV/DeltaB670 were resolved via SDS-PAGE on 12.5% gels, resolved 
p ro te ins w ere electrophoretically tran sfe rred  to nitrocellulose m em brane, 
and  CaM -binding pro teins were detected as described in  M ateria ls and  
M ethods (C hapter 2). As expected, m any CaM -binding proteins, 
corresponding to cellularly-derived CaM -binding pro teins, w ere detected 
in  each of the  cell ex tracts (Figure 31). No bands corresponding to th e  TM 
protein  of HIV-1 or SIV/DeltaB670 (41-kDa) were detected in  any of th e  
v irus contain ing  lanes w ith the CaM probe. However, one band  
corresponding to a  protein  of approxim ately 160-kDa, which is  th e  size of 
th e  envelope pro tein  precursor of SIV, w as detected in  th e  SIV-infected 
CEM  cell ex tract. A sim ilar band  w as no t identified in  the  uninfected 
CEM  cell ex trac t suggesting th a t  th is  160-kDa protein  w as virus-coded. In  
addition, fa in t bands corresponding to proteins of approxim ately  65-kDa 
an d  28-kDa w ere detected in  the  g rad ien t purified HIV-1 and 
SIV/DeltaB670 preparations; sim ilar proteins were n o t detected in  
uninfected CEM cell extracts. A lthough these  resu lts  a re  no t definitive,
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Figure 31. D e tec tion  o f C aM -binding p ro te in s  o n  b lo ts u s in g  b io tin y la ted  
C aM  a s  a  p ro b e . HIV-1 and  SIV/DeItaB670-infected cell ex tracts and  
g radient-purified  virions were subjected to SDS-PAGE and  th e  resolved 
p ro te ins were electrophoretically  tran sfe rred  to n itrocellulose m em branes. 
B iotinylated CaM w as th en  used as a probe to identify  CaM -binding 
pro teins in  each preparation . The contents of each lane  probed a re  as 
follows: (A) HIV -IIIB-infected CEM cell extract; (B) HIV-RF-infected CEM 
cell extract; (C) HIV-1 gradient-purified  virions; (D) uninfected CEM cells; 
(E) SIV/DeltaB670-infected CEM cell extract; and  (F) gradient-purified  
SIV/DeltaB670 virions.
156
they suggest th a t HIV-1 and/or SIV/DeltaB670-encoded proteins are able to 
bind to CaM.
To fu rth er address th is question, we perform ed calmodulin 
precipitation assays using each of the HIV-1 and SIV protein preparations 
described above. Following precipitation w ith CaM sepharose, CaM- 
binding proteins from each of these preparations were resolved via SDS- 
PAGE and then  electrophoretically transferred  to nitrocellulose 
m em brane. HIV-1 and SIV-encoded proteins were th en  identified by 
blotting w ith sera from HIV-l-infected hum ans and SIV/DeltaB670- 
infected macaques, respectively. A prelim inary experim ent revealed th a t 
several SIV-specific proteins bound to the CaM sepharose (data not 
shown). SIV TM-specific an tisera  will be employed to definitively show 
w hether either of these SIV encoded CaM-binding proteins are  the  TM 
protein. Sim ilar experim ents w ith HIV protein preparations are  
curren tly  underw ay.
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D iscussion
These studies have shown th a t synthetic peptide analogues 
corresponding to the carboxy term inus of HIV-1 and SIV are  able to bind 
to CaM and in terfere w ith CaM -dependent second m essenger processes.
I t is widely known th a t HIV-infected individuals suffer from 
comprehensive im m une dysfunction, much of which is the  resu lt of the 
inability of im m une cells to become activated and to receive proliferative 
signals. As the prim ary vehicle for Ca2+-m ediated signal transduction, 
CaM plays an  essential role in  these processes. The interaction of the 
carboxy term inus of lentivirus TM proteins w ith CaM explain m any of the  
cellular dysfunctions th a t  have been observed by AIDS researchers.
Several studies have dem onstrated defects in  lymphocyte signal 
transduction th a t are induced by HIV-1 infection (Nye and Pinching, 1990; 
G upta and Vayuvegula, 1987; Hofman et al., 1990). These studies have 
shown th a t  in tracellu lar [Ca2+] in HIV-1 infected cells is elevated and th a t  
inositol polyphosphate metabolism is abnormal. Each of these studies 
reported th a t inositol triphosphate (Ins[l,4,5]P3) and tetrakisphosphate 
(Ins[l,3,4,5]P4) levels in resting T-lymphocytes were chronically elevated in  
HIV-1 infected cells. Both Ins[l,4,5]P3 and Ins[l,3,4,5]p4 are key second 
m essengers th a t are  im portant for protein kinase C activity and therefore 
are involved in  activation pathw ays. I t  is possible th a t in terruption of CaM 
interactions could be involved since CaM -dependent enzymes are involved 
in  the  metabolism of Ins[l,4,5]P3. Several reports have shown th a t 
synthetic peptides homologous to im m unosuppressive regions of HIV and
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o ther retroviral TM proteins (Ruegg et al., 1989b; Cianciolo et al., 1985), 
when conjugated to bovine serum  album in  and added exogenously to 
lymphocyte cultures, a re  able to inh ib it lymphocyte activation by 
in terfering  w ith PKC activation pathw ays (Ruegg and  S trand , 1991; K adota 
et al., 1991). To date, there  have been no reports of unconjugated synthetic 
peptide analogues of HIV-1 envelope pro teins th a t  a lte r  cellu lar processes 
upon exogenous addition to cells in vitro.
HIV-1 infection has been shown to re su lt in  a varie ty  of o ther 
dysfunctions of host cells th a t  can be traced  to an  uncoupling of enzym atic 
processes. F o r instance, lym phokines such as IL-2 and  IFN-y a re  
produced a t  g rea tly  reduced levels in  HIV-1 infected individuals. 
E xpression of IL-2, which is the  p rim ary  proliferative signal for m any 
lymphocyte subtypes (Figure 25), has been shown to be a Ca2+-CaM- 
dependent process; the  CaM an tagon ists cyclosporin A (CsA) and  FK506 
block transcrip tion  of th e  IL-2 gene (Crabtree, 1989; L iu et al., 1991), 
suggesting a  d irect role for CaM in  the  transcrip tion  of IL-2 mRNA. HIV- 
1 infection is also associated w ith defects in  IFN-y which is  ano ther 
lym phokine essen tia l to im m une proliferative cascades (N okta and  
Pollard, 1990). IFN-y induces the  expression of MHC class-II m arkers 
(B asham  and  M erigan, 1983; Collins et al., 1984; Pober et al., 1983), which 
a re  essen tia l for restric tion  of im m une responses (Koide et a l., 1982), and  i t  
m ediates C a2+ influx by a receptor-m ediated calcium  channel (Y asu taka 
et al., 1987; Koide et al., 1988). Studies w ith the  calmodulin inhib itor W7 
have revealed th a t  CaM and CaM -dependent enzyme system s are  involved 
in  IFN-y production (Antonelli et al., 1988) and  class-II m ark er expression
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(Celada and  Maki, 1991). In  vitro studies suggest th a t  HIV-infection is 
also associated w ith  an  increase in  in trace llu la r cAMP and  cGMP levels. 
In  HIV-1 infected MT-4 cells, cAMP and cGMP levels were elevated 40-fold 
by day 8 P I and 4-fold by 4 days PI, respectively (Nokta and  Pollard, 1991). 
One of the  possible m echanism s of elevation of these  cyclic nucleotides is 
th e  inh ib ition  of th e  CaM -dependent phosphodiesterases which degrade 
cyclic nucleotides. In teresting ly , the resu lting  rise  in  cAMP levels m ay 
play a n  im portan t role in  HIV replication as an  artific ial increase  of 
cAMP (by addition of forskolin, an adenylate cyclase activator) resu lts  in  
enhancem ent of HIV-1 replication in  a dose dependent m an n er (N okta 
and  Pollard, 1991). Finally, there  is evidence th a t  HIV-1 infection is  also 
associated w ith  a ltered  phospholipid synthesis, a  process th a t  is  CaM- 
dependent (Szamel et al., 1986; Szamel et al., 1985). Cloyd and  Lynn (1991) 
reported  th a t HIV-1 infected cells grew norm ally for 24-48 hours post­
infection. A fter 48 hours however, the  process of cell division w as slowed 
although host cell DNA, RNA, and p ro tein  synthesis rem ained  unaltered . 
The only detectable m anifestation  of cell in ju ry  w as p e rtu rb a tio n  of lipid 
synthesis. Levels of phospholipid synthesis was decreased w hile n eu tra l 
lip id  synthesis was elevated, resu lting  in  leaky m em branes th a t  becam e 
m ore and  m ore leaky un til cell lysis. The m echanism  of p e rtu rb a tio n  of 
phospholipid synthesis was not clear from these  experim ents. C learly, 
HIV-1 infection can re su lt in  th e  pertu rba tion  of m any enzym atic 
processes of host cells.
The m echanism  of HIV-1-induced enzym atic dysfunction leading  to 
lymphocyte unresponsiveness m ay be sim ilar to th a t  exhibited by  known
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CaM antagonists. Several studies have shown th a t  lym phocytes trea ted  
w ith  CaM antagonists are  left unable to become activated and  to proliferate 
in  response to mitogenic stim ulation (H idaka et al., 1981; S tav itsky  et al., 
1984; W right and Hoffman, 1986; B ritton  and Palacios, 1982). Moreover, 
each of the  HIV-1 rela ted  cellular a ltera tions described above could be 
caused by subversion of CaM activity. The studies described here  suggest 
th a t  th e  carboxyl term inus of HIV-1 and SIV TM m ay m im ic know n CaM 
an tagon ists  by com peting w ith CaM -dependent enzym es for CaM -binding. 
Synthetic  peptides corresponding to th is  potential CaM -binding segm ent of 
TM (designated LLP, C hap ter 5), which share  s tru c tu ra l homology w ith  
know n CaM -binding peptides, b ind CaM in  a  calcium -dependent m an n er 
and  w ith  relatively  high affinity. Addition of these peptides to  stan d ard  
PD E assays resu lted  in  inhibition of enzyme activity sim ilar to th a t  seen 
w hen no CaM w as added to the reaction m ixture. Overall, th ese  resu lts  
suggest th a t  th e  LLP of the  TM protein  of HIV and  o ther len tiv iruses 
should be able to bind to CaM w ithin  the  host cell, th u s  p reven ting  CaM 
from  perform ing its  second m essenger functions th a t  a re  critical for 
cellu lar activation, lym phokine production, phospholipid syn thesis, and  
m any  o th er norm al cellu lar processes.
Due to its  centralized role in  a large num ber of cellu lar processes, 
especially its  m any  functions in teg ral to activation of im m une cells, CaM 
seem s to be a  logical ta rg e t for a v irus th a t  induces im m unosupression. I t  
appears th a t  the  envelope proteins of len tiv iruses, which a re  th e  p rim ary  
cytopathic de te rm inan ts of len tiv iruses, m ay also have ta rg e ted  th is  
essen tia l C a2+-second m essenger. I t  has been previously reported  th a t
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CaM, in  its  Ca2+-unbound state, is a  substrate  for the  proteases of HIV-1 
and HIV-2 (Tomasselli et al., 1991), suggesting an  additional m eans by 
which these viruses m ay subvert CaM -dependent processes.
Although the experim ents described here do not definitively show 
th a t  the  enzyme dysfunctions resulting from lentiv irus infections are 
m ediated by the highly positively charged, am phipathic helical region 
near the  carboxyl end of the TM protein, they do suggest th a t  th is region of 
these viruses could a t  least play a contributing role in  lentiv irus pathology. 
Together, the potential CaM modulation and m em brane perturbation  
properties (discussed in C hapter 5) of th is region of HIV-1 and other 
lentiv iruses m ay play a  pivotal role in lentivirus-induced disease. This 
possibility is very in teresting and certainly m erits fu rther study as i t  
would represen t a  novel mode of viral and/or microbial pathogenesis.
CH A PTER7
DISCUSSION
Acquired immunodeficiency syndrome (AIDS), and  its  etiological 
agent HIV-1, has rapidly become one of the m ost intensively investigated 
diseases known to man. Due to the  incredibly debilitating disease 
syndrome th a t  resu lts from HIV-1 infection, and because of its  100% 
m ortality rate , the HIV virus is also one of the m ost feared pathogens in  
history. M any researchers are currently  attem pting  to develop 
appropriate anim al models of AIDS in  order to provide avenues for 
investigating the pathogenesis of HIV-1, development and  testing  of 
candidate vaccine strategies, and the evaluation of new antiv iral 
therapies. As was previously discussed in C hapter 1, SIV-infected rhesus 
m acaques continue to be the  m ost appropriate anim al model for AIDS. 
B iochem ical a n d  serological analysis o f SIVZDelta B670 p ro te in s
The studies reported here were in itia ted  soon after SIV had  been 
isolated and described as the  etiological agent of an  im m unosuppressive 
AIDS-like syndrome of rhesus monkeys. O ur first efforts were directed 
tow ard the biochemical and  immunological characterization of 
SIV/DeltaB670. Using standard  biochemical procedures we were able to 
identify the SU, TM, CA, and MA proteins of SIV/Delta B670. O ur results, 
described in  C hapter 3, along w ith the  observations of several o ther groups 
have led to a  putative virion model th a t is very sim ilar to th a t  of HIV-1. 
These studies formed the foundation for the firs t successful SIV vaccine
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tr ia l (M urphey-Corb et al., 1989) as well as one of the  firs t reported  
protective SIV subun it vaccine tria ls  (M urpbey-Corb et al., 1991).
In  addition to these  biochemical studies, we utilized several 
com puter a lgorithm s and  m an u a l procedures designed to identify  
secondary stru c tu re  from p rim ary  am ino acid sequences of SU  and  TM of 
SIV. The resu lting  secondary s tru c tu re  models (Figure 10) a re  very 
sim ilar to those predicted for th e  SU and  TM of o ther oncoviruses, 
including HIV-1. A lthough these  s tru c tu ra l m odels a re  h ighly  
speculative, they  m ay serve as a  useful tool for experim ental design. In  
fact, s tru c tu ra l m odeling of th e  TM pro tein  led to the  experim ents 
described in  C hapters 5 and  6 herein.
Site-directed serological studies
D ue to increasing in te re s t in  HIV vaccine developm ent, and  due to 
our in itia l success w ith  both  whole v irus and  su b u n it vaccine approaches, 
our em phasis, an d  th a t  of our collaborators a t  the  T ulane Regional 
P rim ate  C en ter (Michael M urphey-Corb and  associates) sh ifted  tow ard 
th e  in tensive evaluation of protective im m une responses. U sing  synthetic 
peptide methodologies, we employed site-directed serological techniques in  
a n  effort to identify  the  viral correlates of protection aga in st SIV infection. 
Since th e  resu lts  of our su b u n it vaccine tr ia ls  suggested th a t  the  
p resen ta tion  of envelope pro teins of SIV w as essen tia l for eliciting a 
protective im m une response in  vaccinates (M urphey-Corb et al., 1991), we 
concentrated our efforts on the  envelope pro teins of SIV. W hile screening 
serum  panels from  assym ptom atic  m angabey an d  A frican g reen  m onkeys 
a s well as experim entally-infected and  diseased rhesus m acaques
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(discussed in  C hapter 4) we were able to identify several type-specific 
epitopes which a re  imm unogenic in  assym ptom atic m angabeys b u t do not 
elicit hum oral responses in  m acaques. We have also identified potential 
T-cell de term inants of SIV envelope proteins th a t  a re  curren tly  being 
assayed for reactivity  w ith  T-cells from SIV-infected monkeys. Synthetic 
peptides corresponding to these epitopes are  currently  being evaluated as 
subunit vaccine candidates to determ ine w hether they elicit protective 
antibody populations. In  addition, we are  currently  employing synthetic 
peptide methodologies to identify cellular epitopes of SIV envelope 
proteins.
M em brane perturbation and CaM binding properties o f LLP
The secondary s tru c tu ra l characterizations described in  C hap ter 3 
led to the  identification of a  struc tu ra l feature w ithin  the  carboxyl 
term inus of the  TM protein  of several lentiv iruses th a t  was no t identified 
in  any  of th e  oncoviruses surveyed. As discussed in  C hapters 5 and 6, the  
s tru c tu ra l characteristics of th is  TM dom ain were very  sim ilar to those of 
n a tu ra l cytolytic peptides and to calmodulin-binding peptides. O ur studies 
have shown th a t  synthetic peptides corresponding to th is  carboxy term inal 
dom ain of HIV-1 and  SIV (provisionally term ed the  len tiv irus lytic 
peptide, or LLP) also share  functional characteristics w ith  both  n a tu ra l 
cytolytic peptides and  w ith  calmodulin-binding proteins. We have 
hypothesized th a t  th e  LLP region of the  TM protein contributes to v iral 
cytopathogenesis by in terfering  w ith the  cellular calm odulin-dependent 
second m essenger response and, as the  infection progresses, contributes to 
m em brane pertu rbation  of infected host cells contributing to cell death .
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The studies described in  C hapter 5 have shown th a t  th is 
am phipath ic  TM dom ain of len tiv iruses shares functional as well a s 
s tru c tu ra l characteristics of n a tu ra l cytolytic peptides. We have shown 
th a t  fiM  concentrations of HIV or SIV LLP are sufficient to inh ib it 
prokaryotic and eukaryotic cells. M em brane perm eability  studies and 
51Cr-release assays w ith these peptides have fu rth e r suggested th a t  the  
m echanism  of cell pertu rbation  is sim ilar to th a t  u tilized by n a tu ra l 
cytolytic peptides. The resu lts reported in  C hapter 5 m ake a n  in teresting  
case for a  correlation of len tiv irus cytopathicity and  th is  positively 
charged, am phipath ic  TM segm ent.
The resu lts  reported in  C hapter 6 suggest th a t  in  addition to its 
potential role in  cytopathicity, the LLP m ay also in terfere  w ith the  second 
m essenger signalling m echanism s of infected cells. We have shown th a t  
th e  HIV and SIV LLPs bind to calmodulin w ith affinities in  the 
nanom olar range. Since calmodulin is the  p rim ary  cellu lar sensor of 
C a2+, and  since Ca2+ is the  prim ary  signal for activation of m any enzyme 
system s, a lte ra tions in  calm odulin cascade kinetics could resu lt in  the  
uncoupling of m any norm al cellu lar enzym atic processes. As was 
discussed in  C hapter 6, m any of the  m anifestations of HIV infection th a t 
lead  to AIDS could resu lt from subversion of the  calm odulin second 
m essenger system .
Since th e  possibility th a t a  defined region of len tiv irus TM proteins 
m ay contribute to v iral cytopathicity by disturb ing  host cell enzym atic 
processes, by competitively inh ib iting  norm al second m essenger 
signalling and  by pertu rb ing  critical m em brane properties, and  since th is
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would rep resen t a novel pathogenic m echanism , we have determ ined th a t 
fu rther study of the  LLP is w arranted. We have recently  begun more 
intensive study of th is region w ith the ultim ate  goal of answ ering the 
following questions:
1) Are there  critical residues essential to these CaM-binding and 
m em brane perturbative properties of LLPs? One component of th is 
question is the  analysis of the  m echanism s responsible for these 
cytopathic activities. We will a ttem pt to identify specific residues w ithin 
the  LLP sequence responsible for these biologic activities using synthetic 
peptide analogues. These studies will be invaluable for directing future 
site-directed m utagenesis strategies required to te s t our hypothesis with 
isogenic infectious HIV-1 isolates.
2) Does th is LLP, when presented in  the  context of the  folded TM protein, 
have analogous biologic properties. For th is  analysis, HIV-1 TM protein 
in  infected cells, purified virus, or purified to homogeneity will be applied 
to sim ilar biologic assays as described in  question 1.
Results of these studies will define the extent to which the  HIV-1 
LLP pertu rbs m em brane properties and binds calmodulin (CaM), thereby 
inhib iting  CaM -regulated enzym atic processes. The d a ta  obtained will 
also identify the  critical amino acid residues required for these potential 
cytopathic functions. Thus, the  experim ents proposed here will produce 
s tandard  assays and s truc tu ra l inform ation th a t will prove useful in  the 
design of site-directed m utagenesis studies of LLP functions in  infectious 
m olecular clones of HIV-1.
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In  sum m ary , th e  stud ies p resen ted  here  m ake a  su b s tan tia l 
con tribu tion  to  th e  biological an d  im m unological ch arac te riza tio n  of 
SIV /D eltaB670. The in itia l m odeling stud ies p resen ted  here  led  to  the  
iden tification  of a  s tru c tu ra l m o tif w ith in  th e  carboxyl te rm in u s  of 
len tiv iru s  TM  pro teins th a t  m ay  be involved in  th e  cy topathicity  of 
len tiv iruses. O ur re su lts  show th a t  syn thetic  pep tides hom ologous to  th is  
region of HIV an d  SIV TM  p ro te ins have m em brane p e rtu b a tiv e  and  
C aM -binding p roperties, and  th a t  th is  am ph ipath ic  segm ent of len tiv iru s 
TM m ay p a rtic ip a te  in  a  novel m ethod of viral/m icrobial pathogenesis.
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